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In this work, the natural isotopic composition of three essential trace elements - copper, iron 
and zinc - was determined in human whole blood samples. This means that the blood samples 
were collected without intervention of any kind to the isotopic composition. Hence, this study is 
in contrast with tracer experiments - where one or more spikes, (each) enriched in a certain 
isotope or consisting of a radionuclide of the element of interest are used. To be able to work 
with natural variations in isotope ratios, the precision of the measurement technique used 
should be high enough to observe the small differences in the isotopic composition of the 
samples and the elements of interest should have multiple naturally occurring isotopes. The 
technique of choice for this thesis was multi-collector - inductively coupled plasma - mass 
spectrometry. 
For this type of work, both thermal ionization mass spectrometry (TIMS) and multi-collector - 
inductively coupled plasma - mass spectrometry (MC-ICP-MS) can provide the isotope ratio 
precision necessary. Single-collector ICP-MS cannot compete with these techniques if it comes 
to resolving these small differences in isotopic composition. While TIMS is sometimes still 
considered the reference technique, it is nowadays superseded by MC-ICP-MS. The reason for 
this mainly lies in the significantly higher sample throughput and the higher ionization efficiency 
of the ICP, thus also enabling straightforward isotopic analysis of elements with an ionization 
energy > 7 eV, such as the transition metals investigated here. For Cu, e.g., isotopic analysis by 
TIMS has been attempted by several groups and shown to be possible but not trivial to set up. 
In a first approximation, it can be stated that all elements have an isotopic composition that is 
invariant in nature. This is the result of thorough mixing prior to the formation of the solar 
system. There are, however, various reasons why elements may show variations in their natural 
isotopic composition. Still it has been accepted for a long time that only light (positioned in the 
periodic table before Fe) elements and those with one or more radiogenic isotope(s) show 
variations in their isotopic composition. This view had to be adapted as, more recently, it has 
been demonstrated that all multi-isotopic elements show natural variations in their isotopic 
composition as a result of mass-dependent isotope fractionation. Due to their difference in 
mass, isotopes will take part to a slightly different extent (difference in rate and/or equilibrium 
state) in physical processes and/or (bio)chemical reactions. From this, it can be expected that an 
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individual with an aberrant metabolism (= different reactions or up-/downregulated processes 
in the body) will show a different isotopic composition than individuals with a normally 
functioning metabolism. 
The “geochemical community” was the main driving force behind the development of MC-ICP-
MS and most applications are still to be situated in this research field. However, nowadays, also 
biomedical applications are being increasingly explored. The search for natural differences in 
the isotopic composition of essential trace elements in the human body and the exploration of 
the possible applications hereof is a very recent research domain. Nevertheless, the first results 
are promising. A few years ago, Walczyk and von Blanckenburg were the first to report the 
differences in the iron isotopic composition of whole blood between men and women.1 Further 
research on this topic gave more insight in the uptake mechanism of iron in the human body.2 
The same researchers eventually showed that the isotopic composition of iron in whole blood of 
hemochromatosis patients is significantly deviating from values for healthy individuals.3 This 
shows that the isotopic analysis of metabolically relevant transition metals is a promising way to 
gain more insight in the human metabolism and/or to develop new diagnostic tools. In this 
thesis, copper, iron and zinc are the elements of interest since these are the three most 
important trace elements in the human body. 
 
1.1 Goals 
This work will focus on the assessment of the capabilities of copper, iron and zinc isotopic 
analysis to serve as a diagnostic tool for diseases that are, until now, not yet, with insufficient 
certainty, only through an invasive approach or at a late state of progression diagnosable. 
The first three following chapters form the theoretical part. In Chapter 2, the instrumentation of 
ICP-MS is discussed. A closer look is taken to interferences and matrix effects in chapter 3, two 
effects that are typical for ICP-MS in general. The last theoretical chapter (Chapter 4) focuses on 
important aspects of isotopic analysis with MC-ICP-MS in more detail. Here the differences 
between single- and multi-collector ICP-MS are made clear. Together, the theoretical chapters 
should give the reader sufficient background to understand the experimental part of this work. 
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The experimental part describes how the first goal - the development and validation of a 
reliable, accurate and precise method to obtain isotopic compositions for copper, iron and zinc 
in whole blood samples - was realized. This method comprises not only the optimization of a 
measurement protocol and the choice of a suitable data treatment method (Chapter 6), but also 
the optimization of the sample preparation method (Chapter 5), consisting of sample digestion 
and target element isolation. The isolation procedure for copper, iron and zinc published by 
Maréchal et al.4 was fine-tuned for blood samples and different approaches to treat the data 
were compared. 
Once the method was available, analysis of the samples was started. Before the results are 
discussed, Chapter 7 will introduce the reader to the human metabolism of copper, iron and 
zinc. Also previous work and ongoing work on the natural isotopic composition of these 
essential elements in human whole blood is summarized (Chapter 8). 
A first focus of real sample analysis was the documentation of the natural variations in copper, 
iron and zinc in whole blood of apparently healthy individuals (= reference population). Through 
the study of healthy individuals, the influence of external factors, such as diet, gender, age, 
body mass index (BMI), etc., was estimated (Chapters 9 and 10). Although this is not yet the real 
development of a diagnostic tool, also many possible applications, which are not necessarily 
implemented within this PhD, can profit from this information. The information on fractionation 
in the human body can provide more insight into the metabolism of these metabolically 
relevant transition metals. Although copper and zinc are, after iron, the third and second most 
important trace elements in the human body, their metabolism has not yet been completely 
elucidated. In the case of zinc, physicians are searching for a reliable way to determine the zinc 
status of an individual already for more than a decade, but since the zinc concentration in serum 
does not reflect the zinc status on a cellular level, this is not straightforward. Also here, isotopic 
analysis might provide extra opportunities. If differences in the isotopic compositions of copper, 
iron and/or zinc are observed between individuals with different diets, the isotopic analysis of 
these elements can be used to investigate the eating habits of (pre)historical populations as well 
as of animals. If differences based on geographic origin are observed, the isotopic analysis of 
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copper, iron and/or zinc can even be used as a tool for provenancing of human remains in an 
archaeological or forensic context, as is already done using, e.g., Sr isotopic analysis. 
In a last phase, the aim was to compare the isotopic compositions of Cu, Fe and Zn in whole 
blood from the healthy reference population with this in subjects suffering from conditions that 
influence the metabolism of one or more of these elements. These possible differences in 
isotopic composition of whole blood from healthy individuals on one hand and from patients on 
the other can be the basis for a non-invasive diagnostic method. The first medical application 
chosen in this context was the assessment of the relation between the iron isotopic composition 
and the iron status parameters conventionally used in health care (Chapter 11). Secondly, the 
influence of the haptoglobin polymorphism on the iron isotopic composition was investigated 
(Chapter 12). In this context, also samples from patients with hemochromatosis and anemia of 
chronic disease were analyzed. 
Chapter 2 Inductively Coupled Plasma - Mass Spectrometry 
(ICP-MS) Instrumentation 
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Inductively coupled plasma - mass spectrometry (ICP-MS) is a powerful analytical technique for 
the determination of trace elements (< 10-4 g g-1), ultratrace elements (< 10-8 g g-1) and isotope 
ratios in a large variety of applications. ICP-MS was commercially introduced in 1983, which 
makes it a relatively young technique.5 From the beginning on, ICP-MS has known a 
continuously increasing success as an elemental detection technique. This is owing to (i) low 
detection limits (below ng L-1 levels), (ii) wide linear dynamic range, (iii) relatively simple 
spectra, (iv) multi-element character and (v) high sample throughput. In its standard 
configuration, ICP-MS is suited for the introduction of liquid samples, but also solid sample 
introduction is made possible by coupling a laser ablation (LA) or electrothermal vaporization 
(ETV) unit to the ICP-MS instrument.6 Furthermore, there is the possibility of hyphenation with 
separation techniques, such as high performance liquid chromatography, so that ICP-MS can 
also be used in speciation analysis.7 However, next to this vast amount of advantages, there are 
also some negative characteristics. ICP-MS is an expensive technique, not only in terms of the 
purchase of the instruments, but also in terms of maintenance and use. And also the occurrence 
of many interferences (Chapter 3) is not to be taken lightly. 
An ICP - mass spectrometer consists of three essential parts: the ion source, the mass analyzer 
and the detection system. However, several other components are necessary to make an ICP-
MS instrument work. The sample introduction system transfers the sample to the ICP. Since the 
ICP is operated at atmospheric pressure and the mass spectrometer at high vacuum, an 
interface is needed to bridge this difference in pressure between the two compartments. The 
different parts that form an ICP-MS instrument are discussed in this chapter. However, the 
explanation is kept quite short as there is plenty of literature available providing additional 
information. 
 
2.1 Sample introduction 
As in this work, ICP-MS is used for analyzing liquid samples, only this kind of introduction system 
will be discussed. The sample introduction system transports a representative part of the 
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sample into the ion source. For liquid samples, it consists of two parts: the nebulizer and the 
spray chamber.8, 9 
The nebulizer forms the primary aerosol. In a pneumatic nebulizer this aerosol is formed as a 
result of the interaction of a gas stream with the liquid sample, which is aspirated through a 
capillary. In ICP-MS, this gas is Ar. The most commonly used types of nebulizers in ICP-MS are 
the (micro)concentric nebulizers and the cross-flow nebulizers, where the microconcentric 
nebulizer is just a miniature version of the concentric nebulizer. In a concentric nebulizer,10 
shown in  
Figure 2.1, sample and gas capillary are co-axially positioned, with the sample capillary 
surrounded by the gas capillary. The gas capillary is narrowing down at the end, causing the Ar 
gas to accelerate. This acceleration causes a lower pressure at the end of the sample capillary, 
thus aspirating the liquid spontaneously (= Venturi effect). Most often, however, a peristaltic 
pump is used anyway, as in this way the flow is not subject to the possible difference in viscosity 
between samples, blanks and standards, the long-term stability is improved and the sample 
flow rate can be selected. In a cross-flow nebulizer,11 shown in Figure 2.2, the sample capillary 
and the gas capillary are perpendicular to each other. The vertical capillary guides the liquid 
sample, while the horizontal capillary guides the Ar-gas. The gas stream breaks the sample up 
into an aerosol. In theory also this nebulizer is self-aspirating but in practice a peristaltic pump 
most often needs to be used in order to transport the sample to the end of the sample capillary. 
 
Figure 2.1: Concentric nebulizer12 
A
r 
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Figure 2.2: Cross-flow nebulizer9 
 
The aerosol droplets that reach the plasma have to be small enough (< 10 µm diameter) to 
enable efficient desolvatation, atomization and ionization. Larger droplets may cause undesired 
instabilities in the plasma due to an overload with H2O. However, nebulizers produce aerosols 
with droplets up to 100 µm diameter. Hence, a spray chamber is needed for droplet selection 
and for smoothing out pulses caused by the peristaltic pump. In this work, three types of spray 
chambers are used, which are depicted in Figure 2.3. In the Scott-type double-pass spray 
chamber, droplets have to follow a curved trajectory. Those that are too heavy or large will 
impact on the inner wall and are removed by the drain. The impact bead spray chamber works 
according to the same principle but large droplets are stopped by a small internal bead in their 
pathway. In the cyclonic spray chamber, droplets are separated by the centrifugal force. This 
force is stronger for heavy droplets, causing them to hit the wall and to be drained away. With a 
spray chamber, the sample introduction system is very effective in creating a fine aerosol, but 
the introduction efficiency is low. In the case of a traditional 1 mL min-1 nebulizer, only 1-2% of 
the introduced sample will eventually reach the ICP. 
A
r 
Sam
p
le 
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Figure 2.3: Left: Scott-type double-pass spray chamber. Middle: Impact bead spray 
chamber. Right: Cyclonic spray chamber12 
 
 
2.2 Inductively Coupled Plasma (ICP) 
A plasma is defined as a gas mixture at high temperature that contains molecules, atoms, ions 
and electrons. The sample aerosol that enters the plasma is successively desolvatized, atomized 
and ionized. The ICP13-15 is formed at the end of a horizontally positioned torch, most commonly 
made of quartz, consisting of three concentric tubes through which Ar is flowing at different 
flow rates. A picture of the plasma can be seen in Figure 2.4 together with a schematic 
representation. Between the outer tube and the middle tube, the plasma gas or cool gas is 
flowing. This gas maintains the plasma and acts as a thermal barrier between plasma and torch, 
preventing the torch from melting despite the presence of the hot (7 500 K) plasma. Between 
the middle tube and the inner tube, the auxiliary gas passes. It is used to change the position of 
the plasma. The sample gas is flowing through the inner tube, or injector tube, and carries the 
sample aerosol coming from the sample introduction system. It punctures the plasma, causing it 
to have a toroidal shape. 
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Figure 2.4: Inductively Coupled Plasma (ICP)15, 16 
 
Initially, the Ar gas is uncharged. A high-voltage spark, or Tesla discharge, is used to start the 
plasma. It causes ionization of some of the Ar atoms. The resulting ions and electrons are 
transported by the gas flow to the end of the torch, where it is surrounded by a cooled 
induction coil. The coil is commonly made of copper and connected to a radio frequency (RF) 
generator. This RF alternating current produces an intense time-variable magnetic field. The 
charged particles in the plasma will accelerate due to this magnetic field and collide with the Ar 
atoms, causing a chain reaction in which Ar is continuously ionized, thus forming the inductively 
coupled plasma. When the sample is introduced, the analyte ions will also take part in these 
collisions and the accompanying energy transfer. In the ICP, different ionization mechanisms17, 
18 occur. 
Ionization is induced by collisions among ions, atoms and free electrons in the plasma: 
 
  eMeM 2  (2.1) 
 
  eAMAM  (2.2) 
The process described by equation 2.1 is called electron impact. 
Plasma gas 
Auxiliary gas 
Sample gas Induction coil 
Plasma 
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The degree of ionization for a given element can be calculated by the Saha equation: 
 





 







kT
E
h
T
mk
Z
Z
n
nn i
a
i
a
ei exp22
2
3
2

 
(2.3)
 
Where in , en  and in  are the number densities of the ions, free electrons and atoms, 
respectively, iZ  and aZ  are the ionic and atomic partition functions, respectively, m  is the 
electron mass, k  is the Boltzmann constant, T  is the temperature, h  is Planck’s constant and 
iE  is the first ionization energy. It can be seen that the ionization is dependent on the electron 
density, the temperature and the ionization energy of the element in question. When an 
ionization temperature (Tion) of 8 730 K and an electron density (ne) of 4 ∙ 10
15 cm-3 is assumed, 
most of the elements in the periodic table will be ionized over 80 %.19 
Penning ionization is caused by collisions between atoms in their ground state and metastable 
Ar species. 
 
  eArMArM *  (2.4) 
 
  eArMArM **  (2.5) 
Ionization also occurs by charge transfer reactions, caused by collisions between ions and 
atoms. 
 
  MArMAr  (2.6) 
 
*
2 2
  MArMAr  (2.7) 
For effective penning ionization and charge transfer to occur, the energy of the colliding species 
should be similar to the ionization energy of the analyte. In the above equations, it can be seen 
that energy transfer mainly happens with Ar. Hence, the ionizing strength of the plasma is 
determined by the first ionization energy of Ar. This ionization energy is approximately 16 eV,20 
which is higher than the first ionization energy of most other elements. Doubly charged ions are 
less common because the second ionization energy of most elements is well above 16 eV.20 
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2.3 Interface 
Since the ICP operates at atmospheric pressure, while the mass spectrometer operates at high 
vacuum, an interface is needed to bridge this large difference in pressure and at the same time 
to transport the ions effectively and consistently to the mass spectrometer. The interface21 
consists of two co-axial metal cones with a small central orifice; the sampling cone and the 
skimmer, shown in Figure 2.5. By passing each cone, the ions make the transition to higher 
vacuum. After the first extraction of the plasma by the sampling cone, the bundle of ions, 
electrons and neutral species expands supersonically in the expansion zone due to the pressure 
drop. The majority of this expanded gas is pumped away by vacuum pumps. The central part of 
the beam is extracted a second time by the skimmer. 
Sampling cone and skimmer have to consist of a material with high thermal conductivity and be 
acid-resistant. Mostly they are manufactured of Ni or Pt. Pt has better characteristics, but is also 
a lot more expensive than Ni. 
 
 
Figure 2.5: Sampling cone (left) and skimmer (right) 
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2.4 Ion focusing system 
Behind the skimmer, an extraction lens is positioned, which selects the positive ions and 
introduces them into the ion focusing optics. This instrument part consists of electrostatic 
lenses and has the task to select, guide and introduce the positive ions into the mass 
spectrometer. The ion focusing system can be very simple and consist of only one lens, or it can 
be a complicated combination of several electrostatic lenses. 
 
2.5 Mass spectrometer 
The mass spectrometer separates the positive ions, formed in the plasma, from one another 
based on their mass-to-charge ratio. Mass spectrometers are operated under high vacuum to 
avoid collisions between the ions and gas molecules, which would disturb the ion beam. The 
most important characteristics of a mass spectrometer are resolution, abundance sensitivity 
and scan speed.22, 23 
The mass resolution reflects the ability of the mass spectrometer to separate two neighboring 
spectral peaks. Two approaches for calculating mass resolution can be used. Traditionally mass 
resolution of an observed spectral peak is expressed as: 
 
m
m
R

  (2.8) 
with R  the resolution, m  the analyte mass and m  the peak width at 5% of the peak height 
(see Figure 2.6). It is also possible to calculate the resolution needed to resolve two adjacent 
peaks. This is done using the 10% valley equation. In this case, two peaks are considered 
separated from each other if the valley between the peaks does not exceed 10% of the peak 
maximum (see Figure 2.7). For the calculation, equation 2.9 is used. 
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Figure 2.6: Calculation of the resolution of an observed spectral peak.24 
 
 
Figure 2.7: 10 % valley equation: calculation of the resolution needed to resolve two 
adjacent spectral peaks.24 
 
The abundance sensitivity25 is a measure for the contribution of the tail of an adjacent peak to 
the intensity of the analyte. The abundance sensitivity is calculated by dividing the intensity 
(height) of the tail at the mass of the analyte by the intensity of the analyte itself at this mass. 
Instead of using the height at a certain mass, also the area integrated over a certain mass range 
can be used.  
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The scan speed is the speed with which the mass spectrometer can scan the mass spectrum or 
switch from one mass to another. This characteristic is especially important when working with 
transient signals or isotope ratios. 
There are three types of mass spectrometers that are commercially deployed in ICP - mass 
spectrometry: (i) the quadrupole filter (Q-MS), (ii) the double-focusing sector field mass 
spectrometer (SF-MS) and (iii) the time-of-flight mass spectrometer (TOF-MS). The above 
mentioned characteristics are different for the three types of mass spectrometers, so that each 
of them has its own advantages and disadvantages. Hereafter the two types of mass 
spectrometers used in this work are explained in more detail: the quadrupole filter and the 
sector field mass spectrometer. 
 
2.5.1 Quadrupole filter 
A quadrupole filter23, 26 consists of four parallel cylindrical or hyperbolical rods made of or 
coated with conducting material. The diagonally opposite rods form pairs onto which a voltage, 
consisting of a direct current (DC) component and an alternating current (AC) component is 
applied. The voltages applied on both pairs, have the same magnitude but are opposite in 
charge at all time. A schematic representation of the quadrupole is given in Figure 2.8. 
If only the effect of the alternating current is taken into account, all ions are focused towards 
the middle of the quadrupole filter during half of the period, when the rods have a positive 
charge. The other half period they are attracted by the rods and defocused. If the AC frequency 
is high enough (radio frequency, RF), a sufficiently heavy ion will only be influenced by the 
average potential on the rods. In other words, sufficiently heavy ions are only influenced by the 
DC component. Lighter ions are to an important extent influenced by the AC component as well. 
Whether or not a light ion, influenced by the alternating component, is removed from the ion 
beam when defocused depends on the time needed to reach a quadrupole rod. 
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Figure 2.8: Quadrupole filter.27 
 
The potential on the first pair of rods (Figure 2.9a) consists of a positive DC component and an 
AC component and can be represented as: 
 tVU sin  (2.10) 
with U the DC component, V the amplitude,  the frequency and t  the time. Heavy ions are 
focused and ions with a m/z below a certain threshold are sufficiently accelerated towards the 
quadrupole rods and removed from the ion beam. 
The second pair of rods (Figure 2.9b) shows a potential given by; 
    tVU sin  (2.11) 
The DC component is negative and will defocus heavy ions, while the trajectory of the light ions 
will be sufficiently corrected by the AC component to prevent removal. 
The quadrupole mass spectrometer operates as a mass filter and hence transmits at any given 
time ions with a mass-to-charge ratio within a narrow window (approximately one atomic mass 
unit wide) only. Only ions with mass-to-charge ratio high enough to pass one pair of rods and 
low enough to pass the other pair of rods will show a stable trajectory through the quadrupole 
Detector 
AC and DC voltages 
Ion Source 
Stable ion path 
Unstable ion path 
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filter (Figure 2.9c). The magnitude of the voltage on the rods determines which mass-to-charge 
ratio is passing through. 
 
 
Figure 2.9: Operation principle of the quadrupole filter.24 
 
The voltage can be changed continuously or discontinuously. In the former case, the total mass 
range is scanned, hence the name scanning. When in contrast, one only wants to monitor a 
couple of predefined masses, the voltages are discontinuously changed. This is called peak 
hopping. 
Although the mass resolution of a quadrupole filter is limited to around 300, it shows a high 
scan speed. It is also more robust than a sector field instrument and has a relatively low 
purchase price. 
a) 
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2.5.2 Sector field mass spectrometer 
While the quadrupole filter act as a mass filter, the sector field mass spectrometer23, 28 
separates the ions form one another in space as a function of their mass-to-charge ratio. The 
mass spectrometer is a combination of a magnetic sector and an electrostatic sector. Both are 
shown in Figure 2.10 and Figure 2.11 respectively and are discussed below. 
2.5.2.1 Magnetic sector 
The magnetic sector separates the ions according to their m/z ratio. In this sector, the ions are 
first accelerated over a potential difference by which they gain kinetic energy. 
 qVmvEkin 
2
2
1
 
(2.12) 
 In equation 2.12 the following parameters appear: 
- kinE  is the kinetic energy of the ion. 
- m  is the mass of the ion. 
- v is the speed of the ion in m/s. 
- q  is the charge of the ion. 
- V  is the accelerating potential difference. 
 
 
Figure 2.10: Operating principle of the magnetic sector in a sector field ICP-MS.23 
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Afterwards, the ions enter a magnetic field 

B . They will undergo the Lorentz force (equation 
2.13) and describe a circular path. 
 qvBBvqFL 







 (2.13) 
Because the Lorentz force is perpendicular to the speed of the ion, the force on the ion path can 
also be written as: 
 
r
mv
F
2
  (2.14) 
When combining equations 2.13 and 2.14 and replacing v  using equation 2.12, the radius of the 
ion in the magnetic field can be described as; 
 
qB
Vm
r
2
  (2.15) 
Hence, at a constant acceleration voltage V and constant magnetic field B , the radius of the 
ion trajectory is only dependent on the mass-to-charge ratio. Since the detector (§ 2.6) is fixed, 
the radius of the nuclide of interest should be altered for it to reach the detector. This can be 
done by either adapting the magnetic field strength (B-scanning) or the acceleration voltage (E-
scanning). Mostly E-scanning is used, but when higher mass intervals have to be bridged, B-
scanning is used. 
When entering the magnetic field, the ions show a certain spread in kinetic energy. However, 
only if all ions have the same kinetic energy at the moment they enter the magnetic field, ions 
with the same m/z will be focused into the same point. Otherwise, peaks corresponding to ions 
with different m/z may overlap. Hence, the energy spread will limit the resolving power of the 
magnetic sector and an electrostatic sector is added for energy focusing. 
2.5.2.2 Electrostatic sector 
An electrostatic sector consists of two bent electrode plates to which a potential equal in 
magnitude but with opposite sign is applied. Ions are first accelerated over a potential 
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difference, so equation 2.12 is valid here. The force exerted on the ion when passing through 
the electric field E makes them follow a circular path (equation 2.14). And the force that the 
ions undergo is also given by; 
 qEF   (2.16) 
When combining all equations, mentioned above, the radius of the trajectory of the ions 
travelling through the electric field is given by; 
 
qE
E
r kin
2
  (2.17) 
From equation 2.17, it can be seen that the radius depends on the ion’s energy-to-charge ratio 
when the electric field strength is constant. Hence, ions with the same kinetic energy are 
focused in the same point regardless of their mass. The addition of the electrostatic sector 
radically improves the mass resolution but also less ions will eventually reach the detector, thus 
lowering the transmission efficiency. 
 
 
Figure 2.11: Electrostatic sector.24 
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2.5.2.3 Double-focusing 
In a double-focusing setup, the electrostatic and magnetic sector are combined in such a way 
that the dispersions of the ion beam in both sectors eliminate each other. In this way, ions with 
a different kinetic energy or direction and the same m/z will be focused in the same point. There 
is both energy and directional focusing. There are three different geometries that give rise to 
double-focusing: Mattauch-Herzog, Nier-Johnson and reversed Nier-Johnson geometry.22 
 
 
Figure 2.12: Mattauch-Herzog (top) and Nier-Johnson (bottom) geometry.24 
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- With Mattauch-Herzog geometry (Figure 2.12a), all ion beams are focused in one focal 
plane. This geometry makes it possible to monitor the entire mass spectrum 
simultaneously. 
- With Nier-Johnson geometry (Figure 2.12b), the electrostatic sector is placed in front of 
the magnetic sector. This geometry doesn’t make it possible to monitor the entire (or a 
large part of) mass spectrum but, since the separation in space only happens at the end, 
this geometry can be used in MC-ICP-MS, discussed in § 4.2. When the two sectors are 
switched, the geometry is called reversed Nier-Johnson. In the latter setup, the ion beam 
can travel less hindered through the instrument as the majority of the ions are removed 
in the first sector. This significantly improves the abundance sensitivity and the 
background signal. 
The sector field mass spectrometer shows the highest mass resolution. This resolution depends 
on the width of the entrance and exit slits. The narrower the slits, the higher the resolution. 
However, the increase of resolution also comes with a lower transmission efficiency, which 
causes lower sensitivity. The mass resolution offered by a Thermo Scientific Element XR (see § 
6.1) sector field mass spectrometer can be varied from ~300 (low resolution, LR) over ~4000 
(medium resolution, MR) to ~10 000 (high resolution, HR). The effect of changing the resolution 
on a sector field mass spectrometer and the need for it is illustrated in detail in § 3.1. 
 
2.6 Detection 
2.6.1 Electron multiplier 
An electron multiplier22, 23, 29 can consist out of one continuous as well as several discrete 
dynodes. The front end of the detector is put at a negative potential for the detection of 
positive ions, while the back end is neutral. The detector surface is coated with a semi-
conducting material that readily releases electrons. The ions are accelerated towards it and 
secondary electrons are released by the resulting impact. These electrons are on their turn 
accelerated towards the backside of the detector. On the go, they can on their turn collide with 
the detector surface, thus liberating extra electrons. With every collision, around three 
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electrons are released. This multiplication process causes an avalanche of electrons and the final 
pulses thus created are counted. An electron multiplier with one continuous dynode often has 
the shape of a horn and is shown in Figure 2.13, while the electron multiplier with discrete 
dynodes is shown in Figure 2.14. 
 
 
Figure 2.13: Post horn shaped electron multiplier with continuous dynode.30, 31 
 
 
Figure 2.14: Electron multiplier with discrete dynodes.32, 33 
 
At low ion beam intensity, electron multipliers are used in pulse counting mode, as explained 
above. However the treatment of each pulse takes some time. This time is called the dead time 
τ, as the detector is not able to treat other pulses. Hence, the detected signal will be lower than 
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the actual signal and correction is needed. At higher count rates, the influence of the dead time 
increases and the lifetime of the detector is shortened significantly. At such high ion beam 
intensities it is preferable to measure in analog mode. Here, the resulting current is measured. 
With recent detection systems, the switch between counting mode and analog mode is 
automatic. When using an electron multiplier with discrete dynodes, it is also possible to 
measure the amplified current on one of the earlier dynodes, thus extending the lifetime of the 
detector. 
 
2.6.2 Faraday collector 
A Faraday collector23 (see Figure 2.15) is a metal beaker (cup) grounded with a high resistance 
(typically 1011 Ω). When a positive ion beam impacts on the cup, the ions are neutralized with 
electrons coming from the ground, inducing a potential difference over the resistance according 
to Ohm’s law ( IRU  ). 
The Faraday cup is extremely robust and has a very long life-time as it does not suffer from 
damage to the multiplier system at high count rates. It also does not have a dead time, making 
it very useful when working with high count rates. On the other hand, a Faraday collector has a 
lower sensitivity than an electron multiplier and a slow time constant precluding fast scanning. 
Hence, it is the detector of choice for the static measurements with a MC-ICP-MS but for multi-
elemental detection with SC-ICP-MS, the electron multiplier is the better option. 
 
Figure 2.15: An array of Faraday collectors34 (left) and a schematic representation of 
a Faraday collector (right). 
Chapter 3 Interferences and matrix effects 
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As mentioned in Chapter 2 on ICP-MS instrumentation, the presence of interferences is one of 
the disadvantages of ICP-MS. However, most of these interferences can be overcome by 
adapting the sample preparation and/or the measurement methodology. In this section, the 
different types of interferences and their causes will be discussed. To obtain trustworthy results, 
it is important that the influence of these interferences is diminished to negligible levels or that 
mathematical corrections are performed. This will also be addressed in this section. 
 
3.1 Spectral interferences 
When the signal at a certain mass-to-charge ratio is the sum of contributions from the analyte 
and from one or more other ions, one speaks about a spectral interference or spectral overlap. 
Due to the low (about 1 u) mass resolution of a quadrupole filter, spectral overlap occurs when 
two or more ions have the same nominal mass. 
There are several types of interfering ions. The most important type are the polyatomic or 
molecular ions consisting of elements from the matrix of the sample, the surrounding air (H, N, 
O), the solvent and of course, the plasma gas (Ar) itself. The vast amount of ions coming from 
the surrounding air and the plasma gas makes it virtually impossible to avoid the formation of 
interfering species by reactions in the plasma. Next to the spectral overlaps by Ar-containing 
ions, the oxides form the most common group of interfering polyatomic species. When using 
aqueous solutions, a significant population of oxygen atoms will be present in the plasma, 
forming MO+ ions. The extent of oxide formation depends on the amount of water that is 
actually introduced into the plasma and the flow rate of the sample gas, since this determines 
the position of the regions with maximum M+ and MO+ density in the plasma. When the flow 
rate is increased, the dissociation of the MO+ ions will occur more downstream and the amount 
of oxides will rise since non-dissociated MO+ ions reach the interface and hence, the mass 
spectrometer. Ideally, the extraction should only occur after all MO+ particles are dissociated. A 
second type of interfering ions are the doubly charged ions. For elements with a second 
ionization potential energy lower than the first ionization energy of Ar, the formation of doubly 
charged ions is possible. These interferences are much less frequent than those from molecular 
  32 |Interferences and matrix effects  
ions. Just like with the oxides, the amount of doubly charged ions depends on the sample gas 
flow. The third type of interfering species are the isobaric interferences. Isobars are defined as 
nuclides of different chemical elements that have the same number of nucleons (e.g., 87Sr and 
87Rb). 
There are several different techniques to deal with the interferences mentioned above.35 Below 
these techniques are mentioned and explained.  
Selection of an appropriate nuclide. 
If the most abundant isotope of the target element is subject to interference, another isotope, 
free of interference, can be monitored. In the case of isobaric interferences, all elements, 
except In, have at least one isotope that is measurable interference-free. 
Mathematical correction 
It is also possible to correct for an interference mathematically, relying on the isotopic 
abundances of the isotopes of the interfering element. In the case of the determination of Sr 
through its 87Sr isotope in the presence of Rb, the intensity of the 85Rb signal is monitored and 
through the known and constant 87Rb/85Rb ratio, the contribution of 87Rb to the signal at m/z 87 
can be calculated and corrected for. 
Blank correction 
When concentrations are determined, it is important to always include the analysis of a 
procedure blank. This blank went through the total sample preparation procedure, but no 
sample was added. Subtraction of the signal obtained for the procedure blank from the signal 
for the sample not only corrects for possible contamination from reagents and recipients, but 
also for some spectral interferences. However, this method is limited to less severe forms of 
spectral overlap and cannot correct for matrix-based interferences. 
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Aerosol desolvation 
The amount of O atoms, occurring in the plasma can be reduced by introducing less solvent in 
the ICP. By means of desolvation devices, this amount is significantly lowered. When working 
with this technique also a ten-fold increase in analyte signal intensity can be obtained. 
Cool plasma conditions 
Cool plasma conditions are obtained by lowering the RF Power of the ICP and increasing the 
sample gas flow rate. In these conditions, NO and O2 molecules are no longer dissociated 
completely. These molecules are capable of transferring an electron to Ar-containing species, 
thus lowering the signal intensity of these interfering ions drastically. 
Appropriate sample preparation. 
During digestion, it is advantageous to only use HNO3 and/or H2O2, as these reagents do not 
contain additional elements that aren’t already present in air or water. During sample 
preparation, it is also possible to isolate the target element from the concomitant matrix. 
However, this generally is a time-consuming and labor-intensive task. Hence, isolation should 
only be performed when absolutely necessary.  
Other plasma gas.36 
Next to Ar, also other gases or mixtures of Ar with another gas can be used as a plasma gas (e.g., 
Ar + He). 
Collision/reaction cell23, 37 
The collision/reaction cell is a universal and flexible way of dealing with interferences, for 
instruments equipped with a quadrupole mass spectrometer. The cell is positioned between the 
interface and the mass analyser (see Figure 3.1) and consists of a multipole (2n + 2 parallel 
metallic rods) in an enclosed cell, which can be filled with gas. The multipole can be a 
quadrupole, a hexapole or an octopole. The former can filter the ions according to their mass-
to-charge ratio, while the other only have ion guiding capabilities. 
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Filling the cell with a gas will lead to collisions and reactions of the ions coming from the plasma 
with this gas. When using a reactive gas, the reactions will be more effective in overcoming 
spectral overlap than the collisions. The reaction gas will react with the interfering ion and 
neutralize it or convert it into a product ion with another mass-to-charge ratio. Alternatively, 
the gas can react with the analyte ion, converting it into a molecular ion, which can be 
measured interference-free. The possible forms of these selective reactions between the 
analyte ion or the interfering ion and the reaction gas are electron transfer and “true” chemical 
reaction. It is important to realize that only exothermal chemical reactions will take place in the 
reaction cell.  
In another approach, an inert collision gas (mostly He) can be used. In this case, energy 
discrimination is relied upon to separate the analyte ion from the interfering (molecular) ion. A 
molecular ion is slowed down considerably more by collisions than an atomic ion. As a result of 
a decelerating voltage in front of the mass analyser, these molecular ions will not reach the 
quadrupole and thus no longer contribute to the signal. This approach is called kinetic energy 
discrimination and is represented in Figure 3.2. 
The use of a collision/reaction gas can also give rise to additional interfering species as a result 
of unwanted reactions in the cell. Also here, to prevent these polyatomics from reaching the 
mass analyzer, energy discrimination can be used. If the collision/reaction cell is equipped with 
a quadrupole, the newly formed interfering ions can also be rejected out of the cell by mass 
filtering. 
Although the introduction of the collision/reaction cell in the 1990s was a breakthrough for 
quadrupole mass spectrometry, there is not a single gas or gas mixture suited to deal with all 
spectral inferences. Hence, when one needs to determine multiple interfered elements, it still is 
best to use a sector field instrument that can operate at higher mass resolution (see below). 
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Figure 3.1: Schematic representation of a quadrupole instrument, equipped with a 
collision/reaction cell. 
 
 
 
Figure 3.2: The principle of energy discrimination.38 
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High mass resolution23, 39 
The mass resolution of a sector field mass spectrometer can be enhanced by narrowing down 
the entrance and exit slits of the mass spectrometer. In this way, signals that overlap at low 
resolution can be resolved. However, the higher resolution comes with a lower transmission 
efficiency causing the signal intensity to go down. With present-day instruments, a mass 
resolution of 10 000 can be achieved. But for some interferences even this high mass resolution 
is not enough to separate the overlapping signals (e.g., 87Sr and 87Rb). 
The Thermo Scientific Element XR (§ 6.1), used in this work has three predefined resolution 
settings: low resolution (LR, R ≈ 300), medium resolution (MR, R ≈ 4 000) and high resolution 
(HR, R ≈ 10 000). When changing from low resolution (LR) to medium resolution (MR) or from 
medium resolution to high resolution (HR), the signal intensity goes down with a factor 10 and 
4, respectively. In Figure 3.3 and Figure 3.4, the effect of changing the resolution is illustrated 
for 56Fe+, interfered by 40Ar16O+, and 41K+, interfered by 40Ar1H+. 
 
  
Figure 3.3: Effect of working at higher mass resolution on 56Fe+, interfered by 
40Ar16O+. a) LR, b) MR.40 
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Figure 3.4: Effect of working at higher mass resolution for 41K+, interfered by 40Ar1H+. 
a) LR, b) MR and c) HR.40 
 
 
3.2 Non-spectral interferences 
Non-spectral interferences or matrix effects are induced by the presence of the matrix of the 
sample in the plasma. The matrix elements can enhance or suppress the signal of the target 
nuclide(s). In § 4.3, mass discrimination is elaborated on as a specific form of matrix effect that 
needs special attention in isotope ratio determination, and the methods used to correct for 
mass discrimination are also described in detail. More general techniques for dealing with non-
spectral interferences are listed below.41 
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Dilution. 
It is the absolute amount of matrix elements that determines the influence on the signal. Self-
evidently, the analyte concentration cannot be too low to start with in order to be able to apply 
this simple measure. And also after dilution, the signal intensity needs to be high enough. 
Internal standard. 
An equal amount of one or more elements (= the internal standard, IS) is added to blanks, 
samples and standards. The influence of matrix effects on the signal is assumed to be equal for 
the internal standard and the target element(s). It is important to choose the internal standard 
in such a way that it resembles the target element to the largest extent in plasma behavior and 
is not or only in negligible amounts present in the sample. When working with an internal 
standard, all calculations are performed with the ratio of signal intensities for the analyte and 
internal standard (IA/IIS). 
Matrix matching. 
When the matrix composition of the standards is matching that of the samples as closely as 
possible, the signals of the target elements will be affected by matrix effects to the same extent 
in the standards and the samples. However, an accurate knowledge of the matrix composition 
of the samples is needed for this method to work. Hence, the more complex the matrix is, the 
more challenging matrix matching is. 
Single standard addition. 
Compared to matrix matching, single standard addition is a more simple approach. For this 
technique, each sample is measured twice. Once as such and once with a known amount of 
added standard. In this way, the standard is actually measured in the sample matrix, thus matrix 
effects are corrected for. 
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Alternative sample introduction system or sample preparation. 
Isolation of the target element by an alternative sample preparation protocol or sample 
introduction system (e.g., ETV) reduces matrix effects to a minimum. More information on 
element isolation can be found in § 5.5. In this work, Cu, Fe and Zn are isolated from the whole 
blood matrix. The reason for this is to be found in the phenomenon of mass discrimination as a 
special form of non-spectral interference, described in § 4.3. 
Isotope dilution.42 
In isotope dilution, an accurately known amount of the target element is added to the samples 
prior to sample preparation (or as soon as possible). This “spike” has a well-known isotopic 
composition that deviates from the natural isotopic composition of the samples. The resulting 
isotope ratios are measured and the exact amount of target element in the samples can be 
calculated. The concentration result obtained by isotope dilution ICP-MS (ID-ICP-MS) is 
characterized by a very high accuracy and precision, impossible to reach with other techniques 
for concentration determination. 
Chapter 4 Isotopic analysis 
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4.1 Isotopes 
Isotopes are nuclides of the same element, with a different number of neutrons in their nucleus. 
In chemistry, a certain nuclide can be represented as XAZ . The number of protons, equal to the 
atomic number Z, in a nucleus determines the kind of element X. When dealing with isotopes, 
the atomic number is often omitted as this information is already inherent to the element 
symbol. Isotopes do have a different number of neutrons in their nucleus and hence, the mass 
number A, which is the sum of the number of neutrons and that of protons, makes is possible to 
distinguish between different isotopes. Containing only positively charged protons and neutral 
neutrons, the positive charge of the nucleus is compensated by the negatively charged 
electrons, which reside in a cloud around the nucleus. The nucleus and the electron cloud 
together form the atom. In Figure 4.1, the three naturally-occurring isotopes of hydrogen are 
shown to illustrate this paragraph with an example. The fact that each isotope has one proton 
makes them all variants of hydrogen. The identity of the isotope is given by the number of 
neutrons. From left to right, the isotopes are protium (1H) with zero neutrons, deuterium (2H) 
with one neutron, and tritium (3H) with two neutrons. 
 
 
Figure 4.1: The three naturally-occurring isotopes of hydrogen. (© Dirk Hünniger) 
 
  44 |Isotopic analysis  
It is important to emphasize that different isotopes are occurring in nature and that the term 
“isotope” not necessarily links with radioactivity. Except for 22 elements (9B, 19F, 23Na, 27Al, 31P, 
45Sc, 55Mn, 59Co, 75As, 89Y, 93Nb, 103Rh, 127I, 133Cs, 141Pr, 159Tb, 165Ho, 169Tm, 197Au, 209Bi, 231Pa and 
232Th), all elements have at least 2 (up to 10) naturally occurring isotopes. The relative 
abundance of an isotope is calculated as the amount (number of atoms N or number of moles n) 
of this certain isotope divided by the total amount of the element from which this is an isotope. 
In analytical chemistry, information on the isotopic composition of a material is often provided 
under the form of a ratio of the amounts of two isotopes: 
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(4.1) 
Often, the most abundant isotope is used as the denominator. 
As a first approximation, it can be stated that the isotopic composition of the elements is 
constant in nature. This is due to thorough mixing during the formation of our solar system. 
Isotope dilution and tracer experiments are based on this assumption. In tracer experiments, a 
stable isotopic tracer with aberrant isotopic composition is added to a natural system and the 
induced change in isotopic composition of the target element Is used to monitor a physical or 
(bio)chemical process.43 
Variations in isotopic composition do occur and can have various origins. (i) When a long-lived 
radionuclide decays, a daughter nuclide is formed. The formation of these radiogenic isotopes 
will change the isotopic composition of a material over time. For example, 87Rb decays into 87Sr 
by emitting a β- particle and an anti-neutrino. Wherever there is Rb, the isotopic composition of 
this element will be the same, but it is extremely slowly changing over time. For Sr, however, 
the isotopic composition does not only vary with the time, but also depends on the amount of 
Rb present. (ii) In extraterrestrial materials, some elements may show an isotopic composition 
not known on Earth. (iii) In the upper atmosphere, the radioactive nuclide 14C is formed by the 
interaction of cosmic radiation with 14N. There is a dynamic equilibrium between the formation 
and the decay of 14C. Hence, as long as the amount of cosmic radiation entering the atmosphere 
is the same, the isotopic abundance of 14C will remain the same. In times of higher solar activity, 
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a higher amount of 14C in the atmosphere is observed (see Figure 4.2). (iv) Man-made variations 
in the isotopic composition of the elements can be realized through a variety of processes. A 
common example is the enrichment of uranium for its use as fuel in a fission reactor for the 
production of nuclear energy. Finally, (v) the process of isotope fractionation also causes natural 
variations in isotopic composition. As this phenomenon is the cause for the variation in the 
isotopic composition of Cu, Fe and Zn in human blood, analyzed in this work, it is discussed in 
somewhat more detail below. 
 
 
Figure 4.2: Correlations between the relative abundance of 14C and solar activity, 
expressed as number of sunspots. Note that since 1950, the δ14C record has been 
distorted by nuclear testing. Sunspot data in red is reconstructed data as before 
1749, there were only sporadic observations of the number of sunspots. 
(© Leland McInnes) 
 
As the chemical properties of an atom are mainly determined by the number of protons and 
electrons, isotopes of the same element possess largely identical chemical properties. Due to 
their relative difference in mass, however, different isotopes of the same element may take part 
to a slightly different extent in physical processes and/or in (bio)chemical reactions. Both 
differences in reaction rate (kinetics) and in equilibrium state (thermodynamics) have been 
described.43, 44 
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In thermodynamic isotope fractionation, an equilibrium is reached between two chemical 
species, phases or molecules. Here, both species, phases or molecules will contain the element 
of interest in a different isotopic composition. In general, the heaviest isotope accumulates in 
the denser phase or the component with the strongest binding environment. For example, 
when water is evaporating, the vapor will be enriched in the 16O isotope, while the remaining 
liquid will be enriched in 18O. 
Kinetic isotope fractionation mainly depends on differences in reaction rate between the 
isotopes in unidirectional reactions. The product will be enriched in the lighter isotope, as this 
will react slightly faster (see Figure 4.3). These isotopic effects are influenced by ambient 
parameters such as pH and temperature. 
 
 
Figure 4.3: Cartoon, illustrating kinetic isotope fractionation.45 
 
The extent of isotope variation depends on the relative difference in mass between the isotopes 
considered and on the extent to which elements take part in processes wherein there is a 
change in bonding environment. Reactive elements have a higher chance to undergo isotope 
fractionation, while inert material will never show isotope fractionation. For light elements, the 
relative difference in mass between the isotopes is larger, leading to larger differences in 
reaction rate and equilibrium state. As, in this case, the extent of isotope fractionation depends 
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on the mass, this is also called mass-dependent isotope fractionation. For a long time it was 
accepted that – except for those elements containing one (e.g., Sr) or more (e.g., Pb) radiogenic 
isotopes – the heavier elements show an isotopic composition that is constant in nature. This 
view had to be adapted as, more recently, it has been demonstrated that all multi-isotopic 
elements show natural variation in their isotopic composition as a result of mass-dependent 
isotope fractionation. As a general rule, elements that can occur in the environment in different 
oxidations states will show more isotopic variation. In addition to mass-dependent 
fractionation,46-48 mass-independent isotope fractionation49, 50 has also been observed. 
Because the variations in isotopic composition due to isotope fractionation can be very small, it 
is easier to express them as the relative difference with respect to a reference value than to 
report the absolute isotope ratio (equation 4.1). The relative difference can be multiplied by 
1 000, and thus expressed in permil, or by 10 000 to obtain values that are easy to work with. 
The respective equations for the calculation of δ (‰) and ε are given in equation 4.2 and 4.3. In 
these equations R represents the absolute isotope ratio. 
   0001‰ 
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referencesample
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4.1.1 Fe 
Fe possesses four naturally occurring stable isotopes, 54Fe, 56Fe, 57Fe and 58Fe, which (on 
average) represent 5.845, 91.754, 2.119 and 0.282 % of the total amount, respectively.51 
Differences in iron isotopic composition are expressed in δ values, calculated by equation 4.4, 
where x can be 56Fe, 57Fe or 58Fe. Mostly the δ56Fe value is used when only one value is given for 
the isotopic composition.
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(4.4) 
The most abundant iron isotope 56Fe is of particular interest as it represents the most common 
endpoint of nucleosynthesis in stars and during the formation of the solar system. Hence, the 
isotopic analysis of geological material, and more specifically, meteorites, can provide important 
information on the formation of Earth and other planets. 
In presolar grains (= solids that condensed around stars that died before the solar system was 
formed), and more specifically, in silicon carbide solar grains, the largest anomalies in iron 
isotopic composition of up to several hundred permil relative to the terrestrial composition was 
found. However, this finding was not always duplicated by later studies.52 Refractory inclusions 
are solids in meteorites, believed to have formed during cooling of our solar system. Hence, 
these have the same age as the solar system. They show an enrichment in 58Fe of up to 300 ‰. 
The solar system contains many different kinds of objects but there seems to be an isotopic 
homogeneity of the solar system on a planetary scale, suggesting thorough mixing of the 
elements, or at least of Fe.52 The silicate Earth has an approximately homogeneous isotopic 
composition, being enriched by 0.039 ± 0.008 ‰ amu-1 in the heavy isotopes of Fe relative to 
IRMM-014 (an isotopic reference material for Fe, see § 6.3.1). Although, on Earth’s surface, 
relatively large variations in isotopic composition of iron are found in some sediments or 
aqueous minerals, which were mostly produced in aqueous low-temperature environments 
(e.g., up to 0.45 ‰ due to redox reactions52, up to 0.43 ‰ due to adsorption processes52 and up 
to 1.4 ‰ due to precipitation53), the Fe isotope fractionation at high temperatures appears to 
be limited to variations lower than 1 ‰ in rocks from the crust and the mantle. For plants and 
animals, Fe is fractionated towards enrichment in its lighter isotopes along the food chain with 
around 1 ‰ per trophic level,1 pointing to preferred uptake of lighter isotopes. 
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4.1.2 Zn 
Zn has five naturally occurring isotopes, 64Zn, 66Zn, 67Zn, 68Zn en 70Zn, with average abundances 
of 48.63, 27.90, 4.10, 18.75 and 0.62 %, respectively. The exact value of the average relative 
atomic mass of zinc is still a matter of debate, but for now it is put at 65.38(2).54 The latter is also 
the reason why at the start of this PhD research, an internationally accepted certified Zn 
isotopic reference material still didn’t exist. Such a standard, however, is not essential as we can 
express the Zn isotopic composition relative to a selected standard material, but the absence of 
a certified isotopic reference material makes inter-laboratory comparison more complex as 
among different labs, different standards are used. 
For zinc, the δ values are calculated using the following equation 
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(4.5) 
Where x corresponds to the nominal masses 66, 67, 68 or 70. Because of the very low 
abundance of 70Zn, its natural abundance is generally not measured, although, applications with 
70Zn spikes are common. 
In the natural environment, Zn only exists in the +2 oxidation state and its primary sources in 
the geosphere are the two ore minerals sphalerite (ZnS) and smithsonite (ZnCO3). Zn doesn’t 
take part in redox reactions, and hence, the expected variations in isotopic composition are 
relatively small. The largest variations in δ66Zn values are found in extraterrestrial material, 
ranging from +6 to -4 ‰. The main origin for this larger variation in isotopic composition is 
evaporation and condensation, as can be seen in Figure 4.4. On Earth, the δ66Zn values of 
geological materials are clustered around 0.5 ‰.55 
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Figure 4.4: The major processes inducing Zn isotope fractionation. The lengths of the 
arrows show the range of observed δ66Zn variations. The grey arrows refer to 
extraterrestrial material, while the green arrows refer to variations on Earth.56 
 
4.1.3 Cu 
In contrast to Fe and Zn, Cu has only two naturally occurring isotopes, 63Cu and 65Cu with 
average abundances of 69.17 and 30.83 %, respectively. Cu has two naturally occurring 
oxidation states (Cu(I) and Cu(II)), making it prone to redox reactions. This and the fact that 
copper engages in various complexes results in significant isotope fractionation up to 14 ‰.53 
These variations in isotopic composition can only be expressed as one δ value: 
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(4.6) 
Hence, in human blood, larger variations in  isotopic composition are expected for Cu than for 
Zn. 
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4.2 Multi-collector ICP-MS 
TIMS is, although nowadays to some extent already superseded by MC-ICP-MS, the standard 
technique for isotopic analysis of metals and metalloids. In TIMS, the element of interest is 
isolated and loaded on a metal filament. By resistive heating of the filament in vacuum, the 
element of interest is thermally ionized, whereupon the ions are separated according to mass-
to-charge ratio in the MS and detected. Although the accuracy of MC-ICP-MS was good from the 
beginning, the precision was poorer than with TIMS.57 But MC-ICP-MS improved rapidly over the 
years and soon the between-run uncertainties became very similar to those of state-of-the-art 
TIMS. Moreover, the ICP is capable of ionizing elements with high ionization energies that are 
difficult to analyze with TIMS. This and the large sample throughput of MC-ICP-MS gives this 
technique a tremendous advantage over conventional TIMS. 
 
 
Figure 4.5: Simultaneous monitoring of the isotopes of interest (isotope 1 and 
isotope 2) automatically corrects for signal drift and instability, leading to higher 
isotope ratio precision with MC-ICP-MS.24 
 
Multi-collector ICP-MS instruments are especially developed for isotope ratio measurements. 
These instruments offer the highest possible precision because the simultaneous monitoring of 
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the different isotopes of interest automatically corrects for signal instabilities (Figure 4.5). In 
single-collector ICP-MS, the precision on the isotope ratio is limited by the ICP as a noisy ion 
source. MC-ICP-MS instruments always include a sector field mass spectrometer, since spatial 
separation is needed to be able to detect the different isotopes of interest simultaneously. This 
also implies that double-focusing geometries with the magnetic sector positioned after the 
electrostatic sector are necessary. 
Another feature of sector field mass spectrometers aiding high isotope ratio precision are the 
flat-topped peaks. These are necessary for high precision isotope ratio measurements as small 
fluctuations in the position of the ion beam with respect to the detector will not result in 
variations in the signal intensities. Flat-topped peaks are obtained in SF-MS by the use of a wide 
exit slit and a narrower entrance slit, causing the ion beam to be smaller than the exit slit width 
(Figure 4.6). With these settings however, ions with the same nominal mass (e.g., 56Fe+ and 
40Ar16O+) are not separated from one another because the instrument operates at a low mass 
resolution of approximately 400. When determining Fe isotope ratios, it is mandatory to resolve 
the target ions signals from those of otherwise interfering Ar-containing polyatomic ions as 
isotope ratios are extremely vulnerable to spectral interferences, because they aim at resolving 
very small differences in isotopic composition. In single-collector ICP-SF-MS, working at a higher 
mass resolution is the most elegant and straightforward way to cope with spectral interferences 
(see § 3.1). However, in such an instrument the increase in resolution is accompanied by a 
change in peak shape from flat-topped to triangular, thus deteriorating the isotope ratio 
precision. It was a challenge for MC-ICP-MS manufacturers to maintain the flat-topped peaks at 
higher mass resolution. In practice, this is achieved by reducing the width of the entrance slit by 
moving one side only, while the width of the exit slit is not changed. It is possible to solve the 
problem in this way because the signal(s) of an (the) interfering species is (are) always located 
on one side of the target signal. The difference in peak shape between this “pseudo” high 
resolution and regular high resolution is shown in Figure 4.6. For the isotopic analysis of Cu, Fe 
and Zn, pseudo high resolution was used. For more information on this approach, the reader is 
referred to § 6.3.2. 
 
Isotopic analysis | 53  
 
Figure 4.6: Effect of entrance and exit slit width on the peak shape and the mass 
resolution. Top: Low resolution, Middle: Pseudo high resolution, Bottom: High 
resolution.40 
 
 
4.3 Mass discrimination 
4.3.1 The principle 
Mass discrimination is isotope fractionation introduced by a spectrometer. The extraction and 
transmission efficiencies of an ion depend on its mass. The transmission efficiency is given by 
the ratio of the amount of ions of mass Mi, reaching the detector and the amount of ions of 
mass Mi, entering the mass analyzer. As the transmission efficiency is higher for the heavier of 
any of two isotopes in MC-ICP-MS, the measured isotope ratios show a bias with respect to the 
corresponding true value. This phenomenon is referred to as mass discrimination and needs to 
be corrected for. Since the ICP is operating under steady-state conditions, mass discrimination is 
relatively constant, however fluctuations do appear as the ICP is a rather noisy ion source, while  
analysis run times of several hours are sometimes needed for the mass discrimination to 
stabilize (see Figure 4.7). Instrument mass discrimination in ICP-MS is typically of the order of 1 
% per mass unit, but considerably larger for light elements (25 % per mass unit for Li).58 
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Figure 4.7: Evolution of mass discrimination affecting 66Zn/64Zn with time.56 
 
The concomitant matrix and even the target element concentration affect the extent of mass 
discrimination. As a result, in isotopic analysis using MC-ICP-MS, the target element is typically 
isolated from the concomitant matrix and the pure element fractions obtained are all diluted to 
the same concentration. The  standards show the same target element concentration and are 
made up in the same medium. 
A variety of phenomena is assumed to contribute to mass discrimination.59 These phenomena 
may affect the ion transmission efficiency in a relatively smooth mass-dependent way, but are 
not entirely understood yet. The most important contribution to mass discrimination most 
probably comes from the space-charge effect.23, 25, 60 When leaving the interface region, the ion 
beam is still neutral. The positive ions are attracted by a negatively charged extraction lens, 
while the neutral compounds and the negatively charged ions and electrons are removed by the 
vacuum pumps. The positive ions coming from the plasma are all moving at approximately the 
same speed, determined by the abundantly present Ar atoms. This means that heavier ions will 
have higher kinetic energy and will push the lighter ions away from the center of the ion beam 
due to electrostatic repulsion. This gives origin to beam divergence and a variation in 
composition; the center of the beam will be enriched in the heavier of any two isotopes. 
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Although the ion focusing lenses force the ions to the center of the beam as much as possible, 
this space-charge effect still causes measurable deviations of the observed isotope ratio from 
the corresponding true value. Nozzle separation in-between the sampling cone and the skimmer 
also gives rise to mass discrimination in the same direction. In the interface, the light isotopes 
are preferably removed by the vacuum pumps, leading to an enrichment of the ion beam in the 
heavier isotopes. 
 
4.3.2 Laws and models 
Different models25, 59 for describing mass discrimination as a function of mass have been 
proposed over the years. The laws that are commonly used for MC-ICP-MS are originally derived 
for TIMS. Although there is a significant difference between the time-dependent mass 
fractionation - observed in TIMS - and the static mass discrimination - observed in ICP-MS - the 
lack of a law that is able to accurately describe mass discrimination has led to the use of the 
same laws in ICP-MS. 
The most simple model is where the transmission efficiency, and therefore also the extent of 
mass discrimination, varies linearly with mass, as shown in Figure 4.8 and results in the linear 
law, given by the following equation: 
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 (4.7) 
With trueR the true isotope ratio, expR the measured ratio, linear the linear mass discrimination 
factor and m the difference in mass between the two isotopes in the ratio R . Although very 
simple, this model is functional to a remarkably high degree of accuracy. However, it is 
mathematically inconsistent for isotope ratios: if two ratios fractionate according to the linear 
law, the ratio of these ratios does not. 
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Figure 4.8: Transmission efficiency as a function of mass.59 
 
Next to the linear law, also the power law (equation 4.8) and exponential law (equation 4.9) 
exist. Actually these two laws are deduced from the same models and will at least to the first 
order, lead to the same results for trueR . Hence, the terms are also used interchangeably in 
literature. A similar law, which is not deduced from the same model is Russell’s law (equation 
4.10).61  
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In equations 4.8 and 4.9, the ε values are mass discrimination factors per mass unit, thus 
assuming that all isotope ratios where, for example, the two isotopes differ by one mass unit 
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(e.g., 6Li/7Li and 206Pb/207Pb) are equally influenced by mass discrimination. This is by no means 
correct. The Russell equation (4.10) does take into account the absolute mass of the isotopes 
involved, so that Li and Pb do show a different mass discrimination behavior. Hence, the latter 
equation often gives better results. 
 
4.3.3 Correction 
For each of the different laws mentioned above, there are also different ways of determining 
the mass discrimination factor ε or β. The methods most commonly used for correction for mass 
discrimination are described below. The vast amount of correction methods available makes it 
difficult to select the most appropriate approach for a certain application. The correction for 
mass discrimination is not an easy task and, in addition, the terminology used in the literature 
for describing the correction methods is not universal. Here, the terms internal and external are 
used synonymously with simultaneous and sequential analysis of the sample and the standard. 
In literature, internal and external are also used to denote whether or not for sample and 
standard isotopes of the same element are monitored. 
4.3.3.1 External standardization 
External standardization is a correction method for mass discrimination that cannot be used for 
TIMS as it assumes that mass discrimination is constant over time. Here, the isotope ratio data 
obtained for a sample is referenced to the value obtained for an isotopic standard. In practice, 
the samples and a standard, containing the pure target element with known isotopic 
composition, are measured one after the other. This approach is also called sample standard 
bracketing (SSB) if every sample measurement is preceded and followed by that of a standard. 
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Figure 4.9: Schematic representation of the principle of mass discrimination 
correction by external standardization. 
 
In external standardization, it is assumed that the variation in mass discrimination with time is 
linear (Figure 4.9). Hence, the bias affecting the sample result equals the average relative 
deviations from the true isotope ratio displayed by the standard, measured just before and just 
after the sample. This leads to the following equation: 
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With: - trueR  the true isotope ratio for the sample 
 - expR  the measured ratio for the sample 
 - truestdR , the certified isotope ratio for the standard 
 - 1exp,stdR and 2exp,stdR the measured isotope ratio for the standard, measured just 
before and just after the sample, respectively. 
This method is not capable of correcting for small differences in mass discrimination between 
sample and standard caused by a slight difference in matrix composition. A requirement for 
bracketing is that the mass discrimination is relatively stable with time and that the mass 
discrimination behavior of standards and samples is the same. Hence, matrix matching of 
samples and standards is necessary: pure element fractions, all with the same (within 30 %) 
concentration should be used. SSB is the most simple mass discrimination correction method as 
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no prior knowledge of the relationship between the extent of mass discrimination and isotope 
mass is required. 
4.3.3.2 Internal normalization 
With elements that have two or more naturally occurring isotopes that are not radiogenic, it is 
possible to normalize the measured ratio to an invariant isotope ratio of the same element.62 
Through the measured and the true value of this invariant isotope ratio, the mass discrimination 
factor can be calculated using one of the laws mentioned in § 4.3.2. This factor can then be used 
to correct the other isotope ratios. 
This method is used for the determination of the isotopic composition of elements with 
radiogenic isotopes (e.g., Sr). Here, it is assumed that the differences in isotopic composition are 
only caused by enrichment in the radiogenic isotope, while the effect of isotope fractionation is 
neglected.  Of course, isotope fractionation can also occur for these elements, but its influence 
on the isotopic composition will be much smaller than the influence of radioactive decay of the 
long-lived parent radionuclide. As a result, this correction method cannot be used for studying 
isotope fractionation of the elements considered in this work. 
4.3.3.3 Internal standardization 
The mass discrimination in ICP-MS appears, to a first order, to be a relatively simple function of 
mass, such that elements in the same mass region display a nearly identical mass discrimination. 
By doping the samples with an element in the same mass range and with a known isotopic 
composition – the internal standard -  information on  the discrimination the target element 
undergoes is obtained. 
In internal standardization, different approaches exist. The most simple is to assume that the 
mass discrimination factor is the same for both the added internal standard and the analyte 
element. To avoid this assumption, the relation between the mass discrimination factors of 
internal standard and analyte element, respectively, can be documented, making it possible to 
calculate the mass discrimination factor for the analyte in the samples, relying on the 
experimentally determined mass discrimination factor for the internal standard. This is known 
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as the regression model, for which also different approaches exist.4, 63-65 In Figure 4.10, the 
internal standardization method is schematically represented. 
 
 
Figure 4.10: Principle of internal standardization. 
 
Internal standardization, in literature often called external normalization,62, 64 is a more versatile 
method of correction than external standardization and internal normalization because matrix 
matching is not necessary per se and invariant ratios of the target element are not necessary. 
Also they exploit to a much higher extent the advantages of multi-collector ICP-MS by 
measuring the isotope ratios for internal standard and target element simultaneously.  
But on the other hand, assuming that mass discrimination behavior of the target element and 
the doping element is the same is also not without risk. And even the regression model, 
documenting the relation between the mass discrimination of both elements, has its limitations: 
(i) the mass discrimination relationship ( analytedopant  / ) has to be constant over the analytical 
session, (ii) this relationship, established from measurements of standards, also has to hold for 
the samples and (iii) it is necessary to have a certain spread of mass discrimination observed for 
the standards used as otherwise no trustworthy regression can be obtained.66 The latter is 
illustrated in Figure 4.11. It is possible to define the relation between the mass discrimination 
factors of the two different elements better by doping the pure standards with different 
amounts of matrix. This will produce a larger degree of spread in extent of mass discrimination 
than with pure standards.66 It remains interesting to calculate the isotope ratios with bracketing 
and internal standardization for the same measurement session. If both methods give the same 
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result, this is an indication that the sample preparation effectively removed the matrix and that 
there are no significant amounts of contaminants present.67 
 
 
Figure 4.11: Illustration of the necessity for sufficient variation in mass 
discrimination to obtain a reliable regression line. 
 
4.3.3.4 Combinations 
During mass discrimination correction, the methods mentioned above are commonly combined 
to obtain correction methods that are more versatile and combine the advantages of the above 
mentioned methods for mass discrimination correction. 
An example of a measurement of Cu standards, doped with Zn is given in Figure 4.12. Near the 
end of the 3.5 hour measurement session, a sudden shift in mass discrimination is seen for the 
JMC Cu standard. If the JMC Cu solutions were samples with unknown isotopic compositions 
and no internal standard would have been used, this shift would be observed as a different 
isotopic composition for Cu as the mass discrimination for the bracketing standard, NIST SRM 
976, remains constant. However, with the JMC-ZnLyon present as an internal standard for 
monitoring the changes in mass discrimination, it becomes possible to correct for this non-linear 
change in mass discrimination, presumably caused by insufficient matrix matching. 
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The 66Zn/64Zn ratio normally maintains a relatively constant value when switching between two 
Cu standards, indicating that mass discrimination is unchanged. However, a shift in the 66Zn/64Zn 
ratio occurs prior to the final measurement of JMC Cu. 
 
 
Figure 4.12: SSB measurements of the isotopic difference between two Cu standards 
(NIST 976 (open triangles) and JMC Cu (open squares)), which are both doped with 
JMC Zn (open diamonds) to act as an internal standard for mass discrimination 
monitoring.68 
 
In essence, the calculation of δ or ε (equations 4.2 and 4.3) values agrees with bracketing 
(equation 4.11). Hence, working with relative isotopic compositions and correcting for mass 
discrimination through internal methods is always a combination of two methods. The exact 
methods used in this work are explained in more detail in § 6.3.3. 
4.3.3.5 Double spike 
Mass discrimination can also be corrected for using the double spike technique69 if the element 
of interest has at least four isotopes. For two of these isotopes, the relative isotopic abundance 
is significantly enhanced by adding an enriched spike to the sample. The double spike method 
circumvents the problems of internal normalization and internal standardization. One does not 
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need to use a second element and hence, no correction is needed for the difference in mass 
discrimination behavior between the target element and the doping element. Also there is no 
ratio that is considered constant, so that this method is also applicable for measuring small 
differences in isotopic composition due to isotope fractionation. 
Correcting for mass discrimination using a double spike in the determination of isotopic 
compositions is a variation on the isotope dilution technique for concentration determinations. 
The sample is measured once without spike and once with admixed spike. It is then possible to 
calculate the mass discrimination constants and the true ratio of the sample. 
Disadvantages of the double spike method are that (i) two measurements of the sample are 
needed, (ii) the need for high-purity enriched double spikes with known isotopic composition, 
(iii) the requirement to have at least four isotopes of the target element, (iv) the relatively 
complicated calculations and (v) potential memory effects, contaminating the sample 
introduction system with material of non-natural isotopic compositions.  A major strength of the 
double spike method, which has led to the rapid adoption of this not trivial technique, is that 
the mass discrimination factor can be directly determined for each sample, eliminating bias due 
to variations in matrix. 
Chapter 5 Sample preparation 
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For isotopic analysis using MC-ICP-MS, sample preparation typically consists of digestion (§ 5.4) 
and subsequent target element isolation (§ 5.5). During sample preparation, it is of great 
importance to prevent contamination. In general, contamination is the presence of a minor and 
unwanted constituent (contaminant) in a material, in a physical body, in the natural 
environment, at a workplace, etc. In the context of this work, the contaminant will mostly be 
the target element itself (Cu, Fe or Zn), but not that originally present in the sample. The four 
major sources of contamination are (i) the atmosphere wherein the sample preparation is 
performed, (ii) impurities in the reagents used, (iii) recipients, such as beakers, used during 
digestion and isolation, and (iv) the analyst him/herself.70 
Contamination from the atmosphere (airborne) and reagents are eliminated to the largest 
possible extent by working in a clean lab (§ 5.1) and by only using ultra-pure acids and ultra-
pure water (§ 5.2.1), respectively. Moreover, one has to check the reagents regularly and assure 
that the clean room and clean room garments are cleaned regularly and adequately. If 
beneficial, also recipients are cleaned prior to sample preparation to limit contamination from 
these materials (§ 5.2.2). 
 
5.1 Clean lab 
A clean room, is an environment that has a low level of pollutants. A clean room is used in many 
different fields, such as semiconductor manufacturing, biotechnology, life sciences, … and, of 
course, isotopic analysis. Depending on the application, the pollutants that need to be averted 
are dust, airborne microbes, aerosol particles and chemical vapors. A picture of the clean lab of 
the A&MS unit is given in Figure 5.1. 
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Figure 5.1: The clean lab of the A&MS research group in the basement of building 
S12. 
 
As the main function of the clean room in our research facility is to provide a metal-free sample 
preparation environment, furniture and material for construction inside the room is made out 
of polymers. Even the plugs are plugged in in a central panel that is sealed from the rest of the 
clean room and only the plastic-coated cable is allowed to really enter. Examples of these 
special polymer materials are given in Figure 5.2 to Figure 5.5. TRESPA is used for the work 
benches, cupboards and side panels, PMMA (Poly methyl methacrylate) for the laminar flow 
fume hoods, the door and the front panel of the clean lab power supply, PP (Polypropylene) for 
the table top in the laminar flow fume hoods and the sink, PVDF (Polyvinylidene fluoride) for 
screws, legs of the under bench units and the toggle screws of the clean room cabinet and the 
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laminar flow fume hoods and finally PTFE (Polytetrafluorethylene) and similar polymers are 
used for sliding rods of the laminar flow fume hoods, hot plates and door hinges. Materials 
inside the clean room are especially designed to be easy to clean and release a minimum 
amount of particles. One exception to this “no metals rule” are the chairs that contain 
aluminum parts. However, this is not a problem as Al is mono-isotopic, so that it’s not amenable 
to isotopic analysis. 
 
 
 
 
  
Figure 5.2: Details of a PMMA door in the 
A&MS clean lab with PTFE hinges. 
Figure 5.3: Hot plates (PTFE) in the fume 
hoods (PMMA) and their connection to 
outside sockets. 
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Figure 5.4: One of the sinks (PP) and taps 
for different types of water. From left to 
right: Milli-Q water, RO water, normal tap 
water. 
Figure 5.5: General electronics in the 
clean lab. 
 
To make sure contaminating particles cannot enter when the door is opened, the clean lab is 
kept at a slightly positive pressure compared to the adjacent areas. The temperature is also 
constant at 22°C, as well as the humidity (at 30% rH). This also applies to the measurement 
rooms housing the ICP-MS instruments and the MC-ICP-MS measurement room. When entering 
one of these rooms with controlled environment, a sticky carpet needs to be crossed with the 
intention of removing particles from footwear or lab carts. 
Clean rooms are classified according to the number and size of particles permitted per volume 
unit of air. To describe the quality of a clean room, the ISO 14644-1 standard is used. The ISO 
standard is based on the number of particles per cubic meter, whereas in the older classification 
system (US FED STD 209E), a cubic foot was used as volume unit. To put the numbers given 
below into perspective, the ambient air outside in a typical urban environment contains 35 000 
000 particles per cubic meter in the size range of 0.5 μm and larger in diameters, corresponding 
to an ISO 9 clean room, while an ISO 1 clean room allows only less than one particles in that size 
range per cubic meter and only 10 particles per cubic meter of 0.1 μm and larger (see Table 5.1). 
The clean room at the A&MS group is an ISO 4 clean room. This agrees with a maximum of 10 
000 particles of a diameter of 0.1 µm and larger per m³. In the older classification system, this 
kind of clean room is called a class 10 clean room. Nowadays, ISO 4 is considered very clean. As 
Sample preparation | 71  
mentioned above, also the measurement rooms are under controlled ambient conditions. Here, 
class 1 000 or ISO 6 purity levels are maintained. Particle levels are usually tested using a laser-
based particle counter. 
 
Table 5.1: The ISO 14644-1 standard for clean room classification, compared to the 
older US FED STD 209E. 
Class 
maximum particles/m³ FED STD 209E 
≥0.1 µm ≥0.2 µm ≥0.3 µm ≥0.5 µm ≥1 µm ≥5 µm equivalent 
ISO 1 10 2.37 1.02 0.35 0.083 0.0029 
 
ISO 2 100 23.7 10.2 3.5 0.83 0.029 
 
ISO 3 1 000 237 102 35 8.3 0.29 Class 1 
ISO 4 10 000 2 370 1 020 352 83 2.9 Class 10 
ISO 5 100 000 23 700 10 200 3 520 832 29 Class 100 
ISO 6 1.0×106 237 000 102 000 35 200 8 320 293 Class 1 000 
ISO 7 1.0×107 2.37×106 1 020 000 352 000 83 200 2 930 Class 10 000 
ISO 8 1.0×108 2.37×107 1.02×107 3 520 000 832 000 29 300 Class 100 000 
ISO 9 1.0×109 2.37×108 1.02×108 35 200 000 8 320 000 293 000 Room air 
 
 
To maintain particulate-free air, the air that enters the clean lab from outside is filtered to 
remove dust. For that purpose, a stack of filters with decreasing pore size in the main air 
handling unit, positioned outside the building is deployed. Then the incoming air is further 
purified with the High-efficiency particulate air (HEPA) filter unit, located in the basement and 
transported to the clean room using a PP duct work, where it is supplied near the ceiling in a 
diffuse manner by textile channels. In the clean room itself – not in the air lock and the balance 
room – a metal-free suspended ceiling made of acid-resistant tissue is installed underneath the 
textile channel. It homogenizes the air flow and distributes the air evenly across the whole 
surface of the ceiling. In the clean lab of the A&MS group a laminar, or unidirectional flow 
system is relied on to refresh the air in the clean lab and the fume hoods. This is a prerequisite 
for clean rooms with purity levels of ISO 7 or better. Air that enters the clean room is directed 
downwards from the ceiling in a constant stream. Near the floor, the lab air is removed through 
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perforated ducts and part of the inside air is recirculated again into the ventilation system. Here 
the air from the lab is mixed with fresh air from the main air handling unit, to be reintroduced in 
the clean room through the HEPA filter unit. The principle of operation is shown in Figure 5.6. In 
Figure 5.7 a turbulent air flow, as used in older or less pure clean room designs,  can be seen. 
 
 
Figure 5.6: Air flow pattern for a laminar 
flow clean room. 
(© Rudolf Simon) 
 
Figure 5.7: Air flow pattern for a 
turbulent flow clean room. 
(© Rudolf Simon) 
 
The clean room can only be entered through an air lock. In this intermediate area, overalls, 
safety shoes, overshoes, gloves and goggles are put on. In Figure 5.8, the garment for working in 
the A&MS clean lab is shown, while in Figure 5.9 the air lock of the A&MS clean lab can be seen. 
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Figure 5.8: Garment for working in 
the clean lab. 
 
Figure 5.9: The air lock. 
 
As mentioned above, a clean room is not used routinely, but only in certain demanding 
circumstances. The decision for working in a regular lab or in the clean lab is made by taking 
three issues into consideration: (i) the actual risk of contamination, (ii) the concentration of the 
target element in the samples and (iii) the expected range in isotopic composition that is 
expected. Elements with high abundances in the lab environment, such as iron and zinc, will be 
more prone to contamination. When a certain amount of external material enters a sample, this 
will not only change the concentration of the target element, but potentially also its isotopic 
composition. Whether this change is significant will depend on the initial concentration in the 
sample as well as on the difference in isotopic composition between the element in the sample 
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and in the contaminating material. When originally there is very little (below ppb level) of the 
target element present, a small amount of contamination will already have a significant 
influence on the isotopic composition of the samples. 
In the case of isotopic analysis of Cu, Fe and Zn in human whole blood, the concentration of Fe 
might be high enough to work in a normal lab. However, the viability of this was not tested as 
for Zn and Cu, which were determined in physically the same samples, clean lab sample 
preparation was necessary. This is due to the high risk of contamination of Zn and the 
expectance of low differences in isotopic composition between samples. 
 
5.2 Reagents and recipients 
5.2.1 Acids and water 
5.2.1.1 Water 
Five different kinds of water are available in the labs of the A&MS group. From least pure to 
purest: normal city water, demineralized (DeMi), reversed osmosis (RO), Elix and Milli-Q water 
can be distinguished. In the clean room, every sink has three taps. These can be seen in Figure 
5.4. From left to right, there are the taps for Milli-Q H2O, RO water and city water. In the regular 
labs, there are also taps for DeMi water.  
Milli-Q H2O, also called type 1 or ultra-pure water is the purest kind of water and has a 
resistivity of ≥ 18.2 MΩ cm at 25°C. Because water is an excellent solvent, ultra-pure water is 
easily contaminated by airborne chemical substances and by compounds extracted from 
recipient materials. This is why Milli-Q H2O is only prepared just before use. Elix water is sent 
through the Milli-Q Element system (Figure 5.10) (Millipore SAS, Molsheim, France) where it 
goes through multiple purification steps. First, a dual wavelength UV-lamp is used to kill bacteria 
and to reduce the levels of organic molecules. UV light at a wavelength of 254 nm is used for the 
former and 185 nm for the latter. Afterwards the Q Gard Purification Pack is used to remove 
ions and organic molecules from the feed water, after it was exposed to the UV radiation. The Q 
Gard is a consumable and should be replaced after 180 days or when the resistivity is below a 
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certain set point, whichever comes first. Downstream of the Q Gard is the Quantum ICP 
Ultrapure Cartridge, containing mixed bed ion exchange resin. It removes trace levels of ions 
and organics and acts as a safety device, which captures any contaminant released by the Q 
Gard when it is exhausted. It is recommended to exchange this ion exchanger together with the 
Q Gard. So far the inside of the Milli-Q Element. On the outside, an Optimizer LW Final Filter is 
present, containing an electronics grade 0.1 µm membrane filter, constructed of ultra-high 
density polypropylene. It is used to remove particulate material while maintaining a low ionic 
level of contaminants. When Milli-Q water is not taken, the water is recirculated through the 
system from this point. When Milli-Q water is taken, it passes through a Millipak final filter 
(Figure 5.11). This 0.22 µm membrane filter removes all particles and bacteria with a size larger 
than the filter pore size, which are retained on the filter surface. The Millipak final filter should 
be changed together with the Q Gard and the Quantum ICP Ultrapure Cartridge. For sample 
preparation and dilutions, Milli-Q H2O is always used. Elix, type 2, or pure water is not available 
as such in the clean lab. It is only used as feed for the Milli-Q system and it has a resistivity of ≥ 5 
MΩ cm at 25°C. RO water or type 3 water has a resistivity of ≥0.05 MΩ cm at 25°C and is used to 
rinse beakers, flasks, tubes, etc. DeMi water is not available in the clean room, but it is in the 
normal labs. Together with the city water, this has not been used during this work. 
 
 
Figure 5.10: The Milli-Q Element filter system in the clean room for the production 
of Milli-Q H2O from Elix H2O. 
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Figure 5.11: The 0.22 µm Millipak final filter, the last step in the production of Milli-
Q H2O from Elix H2O. 
 
5.2.1.2 Nitric acid 
Nitric acid (HNO3) is an oxidizing acid that will dissolve most metals. This acid has poor oxidizing 
strength at low concentration (< 2 M), but in its concentrated form, it is a strong oxidizer. Nitric 
acid is the most commonly used acid for digestion of organic matter. The oxidizing power of 
nitric acid is enhanced by increasing the reaction temperature or pressure. 
Concentrated (14 M) HNO3 of pro analysis (p.a.) grade is bought from Chem-lab and further 
purified in-house by sub-boiling distillation. A sub-boiling distillation works according to the 
same principles as a normal distillation. A liquid is evaporated, the vapor is cooled and the 
condensate is collected in a second vessel. During sub-boiling distillation, the temperature is 
kept below the boiling point of the acid. Since the liquid is not boiling, no air bubbles are 
present and contaminants will be virtually absent in the vapor phase. The acid collected as 
distillate is much purer than the pro analysis acid that was started with. All surfaces of the sub-
boiling device coming in contact with acids consist of highly pure TFM, PTFE or PFA. Unless 
stated otherwise, sub-boiled acid has been used throughout this work. 
5.2.1.3 Hydrochloric acid 
Hydrochloric acid (HCl) is a non-oxidizing acid with poor reducing properties. Many metal 
carbonates, peroxides and alkali hydroxides are readily dissolved with HCl. Although HCl is 
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reacting with most metals itself, it is most often combined with a second acid. The best know 
example of such a combination is aqua regia (HCl:HNO3, 3:1).
70 
Pro analysis HCl is purchased from Chem-lab and further purified in-house through sub-boiling 
distillation to obtain ultra-pure concentrated (12 M) HCl. The procedure is practically the same 
as for HNO3, but the sub-boiling unit used for the purification of HCl is made of quartz. 
5.2.1.4 Hydrogen peroxide 
Hydrogen peroxide (H2O2) is a strong oxidizer. It can react explosively with many organic 
compounds, especially in more concentrated form. Usually, H2O2 is combined with an acid 
because its oxidizing power increases with acidity.70  
For this work, however, H2O2 (≥30%, TraceSELECT® Ultra, Sigma-Aldrich) has merely been used 
in trace amounts to make sure the target elements were present in their highest oxidation state 
during target element isolation (§ 5.5). 
 
5.2.2 Consumables and sample recipients 
For all the consumables and recipients that come in contact with the samples or reagents, tests 
were performed to see (i) whether or not prior cleaning gave lower blanks and (ii) how the 
cleaning should be preferably done. These tests focused on Zn as this is the most 
contamination-prone element under investigation in this work. The other elements under 
investigation, Fe and Cu are present in sufficiently high concentration or are much less 
contamination-sensitive, respectively. In § 5.6 it can be seen that blank levels are also 
acceptable for these elements. 
Some results were obtained before this research project was started; other only during this 
research project. In any case, all recipes for cleaning provided in this section are substantiated 
by experiments and statistical evaluation. All results represented below are obtained through 
measurements on the Element XR (see Chapter 6 for more details). The conclusions only apply 
to Zn, a very contamination-prone element. As a result, for other elements with lower 
  78 |Sample preparation  
contamination risks, it may not be necessary to pre-clean consumables. It is important to figure 
this out as pre-cleaning is labor-intensive and time-consuming. 
For sample digestion and evaporation of the digest and pure element fractions, reusable Teflon 
Savillex beakers are used. These beakers stay in the clean lab and are thoroughly cleaned after 
every use. The cleaning procedure has been investigated before and is in use for quite some 
time. Hence, it was not further investigated in this work. The procedure is as follows: 
1. Remove the caps from the beakers, empty the beakers and rinse the beakers and caps 
with Milli-Q H2O. 
2. Put all beakers and caps in an RBS 35 basic soap (Carl Roth GmbH) bath for 24 hours. 
3. Subsequently, wash the beakers and caps with Milli-Q H2O so that they are visibly clean. 
4. Fill the beakers about half with 7 M p.a. HNO3, screw the caps and put the closed 
beakers on a hot plate at 110°C for 24 hours. 
5. Repeat steps 3 and 4 and rinse the beakers and caps again with Milli-Q H2O. 
6. Fill the beakers about half with 6 M p.a. HCl, screw the caps and put the closed beakers 
on a hot plate at 110°C for 24 hours. 
7. Rinse the beakers and caps with Milli-Q H2O and repeat step 6. 
8. Rinse the beakers and caps with Milli-Q H2O and put them on a hot plate at 110°C until 
dryness. 
9. Close the beakers and store them in the cupboard. 
For concentration measurements, the samples are diluted in centrifuge tubes. When metal-free 
15 mL PP tubes (525-0460, VWR International) are used, pre-cleaning is not needed. However, 
for the regular 15 mL PP centrifuge tubes (525-0149, VWR International), it has been proven 
that pre-cleaning does make a difference.71 In this work, a closer look was taken at the cleaning 
method. A first batch of twenty tubes was filled with ca. 1.4 M p.a. HNO3 and kept at 110°C for 
24 h. This concentration was chosen as it is high enough to remove all relevant contaminants as 
the samples that will be inserted into these tubes will be in ca. 0.3 M HNO3 (= 2% HNO3). The 
second batch was also cleaned with ca. 1.4 M p.a. HNO3 but was only shaken for 10 min. Both 
batches of tubes were, after rinsing with Milli-Q H2O, filled with ca. 0.14 M HNO3. After 24 h, the 
Zn concentration in these ca. 0.14 M HNO3 solutions was determined. In the first batch of tubes, 
which were cleaned with ca. 1.4 M p.a. HNO3 at 110°C for 24 h, 0.26 ± 0.30 µg L
-1 of Zn was 
found, while in the second batch, which was only shaken for 10 min with ca. 1.4 M p.a. HNO3, 
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0.45 ± 0.75 µg L-1 was found. No significant difference in blank levels was observed between the 
two batches of tubes. However, the variation in blank values was much smaller for the first 
batch than for the second batch. Hence, normal 15 mL PP centrifuge tubes (VWR International) 
were cleaned in two steps. First, they are filled with ca. 1.4 M p.a. HNO3 and kept at 110 °C for 
24 h. After rinsing them with Milli-Q H2O, they are filled with Milli-Q H2O and again kept at 
110°C for 24 h. Finally, they are rinsed with Milli-Q H2O and allowed to dry. 
For isotopic analysis, samples are diluted in microcentrifuge tubes. From earlier experience, it 
had become clear that the microcentrifuge tubes from Eppendorf have a higher level of 
cleanliness than the microcentrifuge tubes from Carl Roth GmbH or VWR International. 
However, even for Eppendorf tubes, pre-cleaning is preferred. Eppendorf tubes are not 
significantly cleaner after cleaning, but the standard deviation on the blanks is much smaller. 
Microcentrifuge tubes are pre-cleaned in two steps. First, the micro centrifuge tubes are put in a 
500 mL Savillex beaker, which is filled with ca. 1.4 M p.a. HNO3 and put on a hot plate at 110°C 
for 24 h. In the second cleaning step, the micro centrifuge tubes are put in a 500 mL Savillex 
beaker filled with Milli-Q H2O and put on the hot plate at 110°C for 24 h. In-between the two 
steps, the microcentrifuge tubes are rinsed with Milli-Q H2O. Afterwards, the Milli-Q H2O is 
removed and the Savillex beaker, containing the cleaned micro centrifuge tubes, is again put on 
the hot plate at 110°C until dryness. 
The pipet tips are also pre-cleaned, but not in the same way as the micro centrifuge tubes, since 
similar tests as for the centrifuge tubes and microcentrifuge tubes show that this cleaning 
method causes more contaminants to be present than without cleaning. One batch of pipet tips 
was cleaned according to the procedure mentioned above for the microcentrifuge tubes, 
another batch was not cleaned. For the contamination test, 4 pipet tips were put together in a 
cleaned PP centrifuge tube from VWR International. The tubes were filled with 12 mL of ca. 0.14 
M HNO3. After 24 h, the Zn concentration was determined in the tubes. The tubes with cleaned 
tips eventually contained 0.21 ± 0.32 µg L-1 Zn, while the tubes with uncleaned tips contained 
0.17 ± 0.06 µg L-1 Zn. When using a pipet tip, just before pipetting samples, the appropriate 
volume of concentrated HNO3 is pipetted and removed, followed by Milli-Q H2O. When 
pipetting strong acids, the pipet interior needs to be protected from the acid vapors. This can be 
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accomplished by using pipet tips with a filter or by inserting a filter directly into the pipet (see 
Figure 5.12 a and b, respectively). 
 
 
Figure 5.12: When pipetting concentrated acids, the pipet can be protected against 
the corrosive vapors by a) using a filter tip or b) inserting a filter directly into the 
pipet. 
 
The PE bottles, used for preparing acids of appropriate concentration from the concentrated 
sub-boiled acids were also tested. Also here, it has been proven previously that cleaning is 
necessary.71 A first batch was cleaned by shaking them for 10 min with ca. 1.4 M p.a. HNO3, a 
second batch by rinsing them three times with Milli-Q H2O. Subsequently, they were filled with 
ca. 0.14 M HNO3 and after 24 h, the Zn concentration was determined in these solutions. The 
a) 
b) 
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first cleaning method appeared to be significantly more effective than the second method. Also 
the standard deviations are lower in case of the first method. However, when testing the PE 
bottles from both batches again after 1 week, the amount of Zn in the ca. 0.14 M HNO3 solution 
had risen to almost 1 mg/L. Hence, the bottles expected to be used were filled with ca. 0.7 M 
HNO3 or ca. 0.5 M HCl and stored as such, until they were needed. Although the bottles will also 
be used for much higher acid concentrations, this concentration was chosen (i) for safety 
reasons and (ii) since a concentration of 0.14 M HNO3 also seemed able to leach out 
contaminants. Bottles that were stored with HNO3 were then used for HNO3-containing 
solutions, while those stored with HCl were used for HCl-containing solutions. Acids were freshly 
prepared daily to make sure that contaminant levels stayed as low as possible. 
 
5.3 Sample collection 
The whole blood samples analyzed in this study originate from around 100 Belgian volunteers 
who all had read and signed an informed consent form concerning this study. Blood donors had 
to complete a questionnaire that provided information about their physique, job and dietary 
habits. A separate questionnaire was made for the women participating in the research project 
assessing the effect of menstruation on the isotopic composition of the target elements 
(Chapter 10). These questionnaires can be found as appendices A1 and A2, respectively. The 
informed consent form is provided as appendix B. 
This research project was approved by an independent commission for medical ethics 
connected to the Ghent University Hospital and is performed according to the guidelines for 
good clinical practice and the statement of Helsinki, emplaced to protect volunteers 
participating to experiments. The approval form from this ethical commission can be found as 
appendix C. 
Venous blood was drawn and each blood sample was collected in a BD Vacutainer® or a 
VenosafeTM blood tube, specifically suitable for trace element analysis (Figure 5.13). These Li-
heparin- or K2EDTA-treated whole blood samples were analyzed for their isotopic composition 
of Cu, Fe and Zn. The first 10 ml of the volunteer’s blood was used for pre-rinsing the needle. In 
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the case of the reference population, these first 10 mL were collected in serum blood tubes to 
also obtain a serum sample from these individuals. The blood was allowed to clot and was 
centrifuged (at 1000 g for 10 min) at room temperature. The supernatant serum was collected 
for determination of the iron status parameters, needed for assessing the relationship between 
the iron isotopic composition of human whole blood and these parameters (Chapter 11). If no 
serum samples were needed, the first 10 mL of the blood was collected in cheaper urine tubes 
and thrown away. 
Immediately after collection, the blood and serum samples were stored at -20°C until sample 
preparation commenced. 
 
 
Figure 5.13: The blood collection tubes specifically suited for trace element analysis 
from BD Vacutainer® (top) and VenosafeTM (bottom). 
 
 
5.4 Sample Digestion 
When handling human blood, one needs to be careful as such samples are considered 
biohazardous. Also the blood from healthy individuals falls under this term as it is considered a 
potentially infectious substance.  As can be seen in Figure 5.14, recipients with blood are 
marked with the biohazard symbol. This is not necessary anymore once the blood is acid-
digested, because then all possible microorganisms, viruses or toxins from a biological source 
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that can affect human health are destroyed. Material that has (possibly) been in contact with 
the blood should be discarded in special containers. Not all materials that are used can be 
thrown away afterwards (e.g., pipets, fume hoods …). These should be disinfected afterwards. 
The easiest way of doing this is with 70 % MeOH. 
Normally, forward pipetting is used, but for blood reversed pipetting is used. The reverse 
technique is especially suitable for liquids that have high tendency to foam or have high 
viscosity. These characteristics both apply for blood. Below, the technique is explained as it is 
written in the manual of the pipet: 
1. Depress the thumb button all the way to the second stop. Place the tip just under the 
blood surface (2-3 mm) and smoothly release the thumb button until the starting 
position. 
2. Withdraw the tip from the blood tube, touching the edge tube to remove excess. 
3. Deliver the preset volume by smoothly depressing the thumb button to the first stop. 
Hold the operating button at the first stop. The blood that remains in the tip should not 
be included in the delivery. 
4. The remaining blood can now be discarded from the tip or delivered back into the blood 
tube. 
 
In the case of elemental assay of blood, sample preparation can merely consist of dilution, as 
blood is already liquid. However, for isotopic analysis, it is necessary to isolate the target 
element(s) from the concomitant matrix. As described in § 5.5, this is accomplished using 
chromatographic separation. In order to do this, the target element(s) need(s) to be present in 
ionic form. For Cu, Fe and Zn in blood this is not the case, as they are bound to amino acids and 
other biomolecules. 
The common practice for digestion of blood is using microwave-assisted acid digestion. In this 
way, blood can, depending on the settings of the microwave unit, be digested within one hour.3, 
72, 73 However, in the A&MS group of Ghent University, the microwave digestion unit is (i) not 
located in the clean room, but in a normal lab, and (ii) is used for many different types of 
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samples, thus increasing contamination risks. Hence, it was decided to digest the blood samples 
in the clean lab in closed Savillex beakers on a hot plate. 
As the ICP is a hard ionization source and blood is already a solution, it is impossible to 
determine through concentration measurements, whether the blood sample is completely 
digested or not. ICP-MS analysis of whole blood and digested whole blood should give exactly 
the same results. Hence, for this step, visual observation was relied upon as the only indication 
for total digestion (Figure 5.15). To digest 3 mL of whole blood, 7 mL of 14 M HNO3 was added. 
60 mL Savillex beakers were used to prevent sample losses due to sometimes intense foaming. 
This mixture was kept at 110°C for 14 hours (overnight). In the beginning, frequent opening of 
the samples was necessary to release pressure. 
The digest thus obtained was evaporated to dryness at 95°C and the residue redissolved in the 
appropriate medium for element isolation: 5 mL 8 M HCl + 0.001 % H2O2.  
 
 
Figure 5.14: Savillex beaker with blood, just after addition of 7 mL 14 M HNO3. 
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Figure 5.15: Savillex beaker with digested blood. 
 
 
5.5 Target element isolation 
The simultaneous isolation of Cu, Fe and Zn from the whole blood matrix was realized through 
anion exchange chromatography. The resin used, commercially available as AG MP-1, consists of 
small polymer beads, which are a copolymer of styrene and divinylbenzene. On these polymer 
beads, positively charged quaternary ammonium groups are present (Figure 5.16).  
 
 
Figure 5.16: Schematical representation of an AG MP-1 polymer bead with active 
group in chlorinated form. 
 
To enable isolation of the target elements, they have to be converted into negatively charged 
chlorine complexes (CuCl3
-, FeCl4
- and ZnCl3
-). Hence, the samples have to be evaporated and 
the residue thus obtained redissolved in HCl medium. For the Cu and Fe to elute at the 
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appropriate time, they have to be present in their highest oxidation states: Fe3+ and Cu2+. For 
that purpose, 50 µL of H2O2 was added just before isolation and the mixture was allowed to 
stand for 1 hour. In this step, a small amount of precipitation was formed. Hence, the samples 
were centrifuged (4 min, 4000 rpm) before starting element isolation.  
To determine the fraction of Cu, Fe and Zn in the precipitate, a whole blood standard, 
SeronormTM Trace Elements Whole Blood L-3 was prepared as described above. The sample was 
filtered with a syringe filter. First, the filter was pre-cleaned by passing 10 mL of 8 M HCl 
through it. When passing 14 M HNO3 through the filter the precipitate was redissolved. The 
amount of Cu, Fe and Zn in this solution was compared with the actual amount of Cu, Fe and Zn 
present in the original sample. As the precipitation was shown to contain negligible amounts of 
the target elements only – 0.24 ± 0.23 %, 0.93 ± 0.94 % and 0.66 ± 0.27 % of the total amount 
present for Cu, Fe and Zn, respectively – no further investigation of the origin of the 
precipitation was performed. 
The Cu, Fe and Zn complexes are reversibly bound to the resin. Since the chlorinated matrix 
components form less stable complexes and/or show no or much lower affinity to the stationary 
phase, these elements will elute faster. By decreasing the HCl concentration Cu, Fe and Zn will 
elute according to the stability of the complexes formed. Cu elutes first, followed by Fe and at 
last Zn. In other words, the elements are separated from one another according to their 
complex stability. 
 
5.5.1 Selection of the method to be optimized and resin volume 
In a first preliminary test, two methods taken from literature, one adapted from Maréchal et al.4 
and one published by Borrok et al.,74 were tested on their isolating capabilities using an 
elemental standard of 50 µg of each of the target elements Cu, Fe and Zn only. Both protocols 
are described in Table 5.2 and Table 5.3, respectively.  
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Table 5.2: Protocol for Cu, Fe and Zn isolation, adapted from Maréchal et al.4 
Medium mL Process 
7 M HCl + 0.001 % H2O2 1 sample load 
7 M HCl + 0.001 % H2O2 10 matrix elution 
7 M HCl + 0.001 % H2O2 10 Cu elution 
2 M HCl + 0.001 % H2O2 15 Fe elution 
Milli-Q H2O 1 Rinse 
0.5 M HNO3 8 Zn elution 
 
 
Table 5.3: Protocol for Cu, Fe and Zn isolation, according to Borrok et al.74 
Medium mL Process 
10 M HCl + 0.001 % H2O2 1 sample load 
10 M HCl + 0.001 % H2O2 4 matrix elution 
5 M HCl + 0.001 % H2O2 6 Cu elution 
1 M HCl 4 Fe elution 
Milli-Q H2O 4 Zn elution 
 
 
Both methods were used with two different amounts of resin: 0.5 mL and 2 mL. The elution 
profiles were obtained by following these protocols and collecting and analyzing 1 mL elution 
aliquots individually. These aliquots were measured on the Element XR as described in § 6.1. 
The elution profiles thus obtained are displayed in Figure 5.17 to Figure 5.20. 
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Figure 5.17: Elution profile obtained for an elemental standard of Cu, Fe and Zn 
through the protocol of Maréchal, using 0.5 mL AG MP-1. 50 µg of Cu, Fe and Zn was 
loaded onto the resin. Sl = fraction eluted after sample load; mx = 1 mL of matrix 
elution, aliquot x; Cux = 1 mL of Cu elution, aliquot x; Fex = 1 mL of Fe elution, 
aliquot x; Znx = 1 mL of Zn elution, aliquot x. 
 
 
 
Figure 5.18: Elution profile obtained for an elemental standard of Cu, Fe and Zn 
through the protocol of Maréchal, using 2 mL AG MP-1. 50 µg of Cu, Fe and Zn was 
loaded onto the resin. Sl = fraction eluted after sample load; mx = 1 mL of matrix 
elution, aliquot x; Cux = 1 mL of Cu elution, aliquot x; Fex = 1 mL of Fe elution, 
aliquot x; Znx = 1 mL of Zn elution, aliquot x. 
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Figure 5.19: Elution profile obtained for an elemental standard of Cu, Fe and Zn 
through the protocol of Borrok, using 0.5 mL AG MP-1. 50 µg of Cu, Fe and Zn was 
loaded onto the resin. Sl = fraction eluted after sample load; mx = 1 mL of matrix 
elution, aliquot x; Cux = 1 mL of Cu elution, aliquot x; Fex = 1 mL of Fe elution, 
aliquot x; Znx = 1 mL of Zn elution, aliquot x. 
 
 
Figure 5.20: Elution profile obtained for an elemental standard of Cu, Fe and Zn 
through the protocol of Borrok, using 2 mL AG MP-1. 50 µg of Cu, Fe and Zn was 
loaded onto the resin. Sl = fraction eluted after sample load; mx = 1 mL of matrix 
elution, aliquot x; Cux = 1 mL of Cu elution, aliquot x; Fex = 1 mL of Fe elution, 
aliquot x; Znx = 1 mL of Zn elution, aliquot x. 
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Both elution profiles that were obtained from columns with a resin bed of 0.5 mL show that Cu 
is already eluted in the matrix fraction. Also Fe and Zn are eluted too soon. However, pure 
fractions are obtained for Fe and Zn using both protocols, while only the Maréchal protocol 
gives a pure Cu fraction. In addition, recoveries are quantitative. For the elution profiles that 
were obtained from columns with a resin bed of 2 mL, Cu, Fe and Zn are starting to elute within 
the appropriate fractions. Both protocols show Cu tailing into the Fe fraction and the Borrok 
protocol also shows Fe tailing in the Zn fraction. Hence, the method for the simultaneous 
isolation of the target elements Fe, Zn and Cu, described for several geological materials by 
Maréchal4 was further fine-tuned to make it applicable to digested whole blood samples. First, 
the acid concentrations were slightly altered taken into account the information provided in 
Figure 5.21. Here, the logarithm of the distribution coefficient between the stationary phase 
(resin) and the mobile phase (acid) is given as a function of HCl concentration for a series of 
elements. The distribution coefficient is a measure for the affinity of the target element 
complex for the resin. When log D goes below zero the affinity of the element for the acid 
becomes greater than the affinity for the resin. For elution of the matrix elements, 8 M HCl + 
0.001% H2O2 was used as Fe
3+ and Cu2+ seem slightly better retained at this acid concentration. 
Although the affinity for the stationary phase is slightly lower for the Zn complexes in this 
medium it is still high enough for Zn to be retained by the resin. Cu is eluted with 5 M HCl + 
0.001% H2O2 to decrease the retention of the Cu complex. Fe is eluted with 0.6 M HCl as this is 
the lowest acid concentration for which Zn will still be retained by the resin. Finally, Zn is eluted 
with 0.7 M HNO3. In theory also Milli-Q H2O can be used in this step to elute the Zn fraction. 
However, Zn2+ is more stable in acidic medium, which is also beneficial during evaporation 
processes (see § 5.6). 
Prior to isolation, Bio-Rad Poly-Prep columns were filled with 2 ml of the resin and a PE stopper 
was placed on top of the resin bed to prevent tailing due to resin swirling up. 
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Figure 5.21: Anion exchange distribution functions, taken from Kekesi et al.75 
 
 
5.5.2 Optimization of the protocol 
For optimization, a whole blood standard, SeronormTM Trace Elements Whole Blood, further 
referred to as seronorm, was used. This standard is available in three levels of (added) trace 
elements and heavy metals: L-1, L-2 and L-3. L-1 resembles natural blood samples, while L-2 and 
L-3 have increased amounts of trace elements present. For some elements, L-3 shows a tenfold 
increase in concentration relative to natural blood (L-1). For the optimization process, L-3 was 
chosen. By working with this standard with elevated levels of the trace metals, it is assured that 
the isolation protocol, as developed here, is suited for a large range of blood samples. The 
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seronorm standard was reconstituted according to the procedure explained in § 5.4. For every 
isolation test, 4.6 mL of the 8 M HCl + 0.001 % H2O2 solution containing the digested sample was 
loaded onto the resin. The first 4.6 mL of elute are collected together as the first aliquot. 
Afterwards, individual aliquots of 1 mL of mobile phase are brought onto the column and the 
corresponding elute collected individually. 
During optimization of an element isolation protocol, the amount of eluent needed to strip off 
the different fractions separated from each other is determined. The initial protocol by 
Maréchal et al.4 was so long that the total elution profile could not be obtained within one day. 
Hence, the optimization was split in two phases. In a first phase, the separation of the matrix 
and the isolation of the first eluting target element, Cu is handled. In a second phase, the pure 
elution of Fe and Zn was studied. 
For the matrix elution, not all elements present in seronorm were investigated. The focus was 
on the elements for which the concentration is ≥ 50 µg L-1 in seronorm L-1. In Figure 5.22, the 
elution profile of these elements is shown. The only element with a concentration above 50 µg 
L-1 that is not present in the elution profile is B. For this element a good elution profile could not 
be obtained, probably because of losses during the evaporation step preceding the isolation.76 It 
is expected that if traces of B are present in the Cu, Fe or Zn fractions, these will also be 
removed through evaporation (see § 5.4). 
Most of the matrix elements are eluted using 4 mL of 8 M HCl + 0.001% H2O2 and Cu starts to 
elute in the 10th mL, which is after total elution of the matrix elements. There is also no Fe or Zn 
present in the matrix fraction, as can be seen in Figure 5.22. The matrix element that is eluting 
the slowest and hence, forms the limiting factor is Br. After repeating characterization of the 
elution profile to check repeatability of the protocol and reusability of the resin (see Figure 5.23 
and Figure 5.24), it was decided to use 8 mL of 8M HCl + 0.001% H2O2 for matrix elution. From 
Figure 5.23 and Figure 5.24, it can also be seen that the elution profiles remained very similar 
when repeating the protocol with reused resin. This proves that the protocol is reliable and that 
the reuse of the resin does not significantly influence the isolation. The resin can be used at 
least three times. 
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Figure 5.22: Elution profile for elements (≥ 50 µg L-1 in Seronorm Trace Elements 
Whole Blood L-1) in Seronorm Trace Elements Whole Blood L-3 reference material. 
Sl = ~ 5 mL fraction of (8 M HCl + 0.001 % H2O2) for matrix elution after sample load, 
mx = 1mL of (8 M HCl + 0.001 % H2O2) for matrix elution aliquot x. 
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Figure 5.23: Elution profile for some main 
elements in Seronorm Trace Elements 
Whole Blood L-3 with resin that is used for 
the second time. Sl = ~ 5 mL fraction of (8 
M HCl + 0.001 % H2O2) for matrix elution 
after sample load, mx = 1 mL of (8 M HCl + 
0.001 % H2O2) for matrix elution aliquot x. 
 
Figure 5.24: Elution profile for some 
main elements in Seronorm Trace 
Elements Whole Blood L-3 with resin 
that is used for the third time. Sl = ~ 5 
mL fraction of (8 M HCl + 0.001 % H2O2) 
for matrix elution after sample load, mx 
= 1 mL of (8 M HCl + 0.001 % H2O2) for 
matrix elution aliquot x. 
 
After Cu / matrix separation was optimized, the focus was on obtaining pure fractions of Cu, Fe 
and Zn. As in the preliminary test, 10 mL was not sufficient to elute all the Cu and some tailing 
of the Cu profile occurred, it was decided to use 12 mL of 5 M HCl + 0.001% H2O2 and to add a 
PE stopper on top of the resin bed to prevent the resin from swirling up. For Fe and Zn, 10 mL of 
0.6 M HCl and 0.7 M HNO3 were used for elution, respectively. In Figure 5.25, an elution profile 
is shown where the matrix fraction is collected in 1 mL aliquots just as the first five 1 mL aliquots 
of the Cu fraction. The rest of the Cu fraction was collected in one aliquot. The same goes for 
the Fe and Zn fraction. The figure demonstrates that the protocol gives pure fractions of Cu, Fe 
and Zn. A later test of the total isolation proved quantitative recoveries (recoveries are 98.53 % 
for Cu, 98.75 % for Fe and 97.63 % for Zn (n=3)). The only element that is present in the Fe and 
Zn fraction is Br. This is not expected to be a serious contamination as the total recovery of Br 
equals 97.01 % (n=3). Although some elution profiles do show absence of Br in all target 
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element fractions, it was not possible to achieve this consistently. Br cannot cause spectral 
interference. The isotopic analysis of the seronorm standard showed that this occasional 
presence of this element in the Fe or Zn fraction did not give rise to measurable deviations in 
the isotope composition obtained. 
Figure 5.25: Elution profile for elements (≥ 50 µg L-1 in Seronorm Trace Elements 
Whole Blood L-1) in Seronorm Trace Elements Whole Blood L-3 reference material. 
Sl = ~ 5 mL fraction of (8 M HCl + 0.001% H2O2) for matrix elution after sample load, 
mx = 1 mL of (8 M HCl + 0.001% H2O2) for matrix elution aliquot x, Cux = 1 mL of (5 
M HCl + 0.001% H2O2) for Cu elution aliquot x, Fe = 10 mL of 0.6 M HCl for Fe elution 
and Zn = 10 mL of 0.7 M HNO3 for Zn elution. 
 
Now that it was demonstrated that the analyte elements are eluting quantitatively as pure 
fractions using the protocol mentioned above, it was determined how much acid is needed to 
elute each of the target elements, Cu, Fe and Zn. The result of this experiment is shown in 
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Figure 5.26. It can be seen that the 12 mL used for Cu elution is more than sufficient to obtain a 
pure Cu fraction. However, decreasing the amount of 5 M HCl + 0.001% H2O2 used for Cu elution 
from 12 mL to 10 mL is not an option as it was proven before that 10 mL is not always sufficient. 
Although 99% of all Fe is present in the third mL of the Fe fraction, small amounts of iron are 
eluting until the 7th mL. For the elution of Zn, 8 mL are needed until the blank level is reached. 
The final protocol for cleaning and isolation is summarized below. 
 
 
Figure 5.26: elution profile for Cu, Fe and Zn in Seronorm Trace Elements Whole 
Blood L-3 after matrix elution with 8 mL 8 M HCl + 0.001% H2O2. Cux = 1 mL 5 M HCl 
+ 0.001% H2O2 for Cu elution, aliquot x; Fex =1 mL 0.6 M HCl for Fe elution, aliquot x 
and Znx = 1 mL 0.7 M HNO3 for Zn elution, aliquot x. 
 
Prior to isolation, the AG MP-1 resin needs to be cleaned and conditioned. Fresh resin is washed 
three times with Milli-Q H2O in a PE flask. This is done by adding Milli-Q H2O, letting the resin 
beads settle and decanting the supernatant. Then, 2 mL of the resin, suspended in Milli-Q H2O 
for easy transfer, is put in a Bio-Rad Poly-Prep column. Once inside the resin is cleaned with the 
following steps: 
1. 5 mL of 7 M HNO3. In this medium, no elements are retained on the resin. 
2. 5 mL of Milli-Q H2O 
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3. Add stopper 
4. 5 mL of 8 M HCl 
5. 5 mL of Milli-Q H2O 
6. 5 mL of 0.7 M HNO3 
7. 5 mL of Milli-Q H2O 
 
If the resin is reused, the possibility exists that a slightly yellow eluent is obtained when cleaning 
with 5 mL of 8 M HCl (step 4). In this case it is necessary to repeat steps 2 and 4 until a colorless 
eluent is obtained. After cleaning, the resin is conditioned using 10 mL of 8 M HCl + 0.001% 
H2O2. The sample is loaded in 8 M HCl + 0.001% H2O2 and target element isolation is achieved by 
following the protocol described in Table 5.4. 
 
Table 5.4: Protocol for Cu, Fe and Zn isolation, optimized in this work for whole 
blood. 
Medium ml process 
8 M HCl + 0.001 % H2O2 ~5 sample load 
8 M HCl + 0.001 % H2O2 8 matrix elution 
5 M HCl + 0.001 % H2O2 12 Cu elution 
0.6 M HCl 7 Fe elution 
0.7 M HNO3 8 Zn elution 
 
 
5.5.3 On-column isotopic fractionation 
The chromatographic isolation can be accompanied by on-column isotopic fractionation, as 
observed by Maréchal et al.77 for Cu, Fe and Zn. The different isotopes of an element can 
participate to a slightly different extent to physical processes, in this case the reversible ion 
exchange with AG MP-1 in the chlorinated form. Due to this on-column isotopic fractionation, 
one isotope can elute slightly faster than another, causing a variation in isotopic composition of 
the eluting element during elution. 
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Also in this work, on-column isotope fractionation is observed for Cu, as well as for Fe and Zn, as 
shown in Figure 5.27, Figure 5.28 and Figure 5.29, respectively. These figures are acquired using 
elemental standards of the three elements. For Cu, individual 1 mL aliquots were collected but 
only in the first ten mL (Cu1 - Cu10) sufficient Cu was present for isotopic analysis. The separate 
aliquots were diluted to a concentration of 1 mg L-1 and the isotopic composition was 
determined relative to the isotopic composition of the elemental standard prior to isolation. 
The same was done for Zn. However, aliquots of 500 µL were collected because Zn is eluting in a 
narrower volume range. In this way, 14 individual aliquots (Zn1 - Zn14) were obtained. Fe is 
eluted in an even more narrow volume range than Zn, so individual aliquots of 250 µL were 
collected (40 aliquots: Fe1 - Fe40). Also for Fe and Zn, only aliquots with a sufficient amount of 
target element were diluted and measured. 
The trend observed in Figure 5.27, Figure 5.28 and, to a lower extend in Figure 5.29 is not easily 
explainable and further elucidation was considered beyond scope. But since all the elements of 
interest show on-column isotopic fractionation, quantitative recovery is crucial for obtaining 
accurate results from isotopic analysis. In the previous section, it was mentioned that a recovery 
of at least 97% was obtained with the optimized protocol. Taking into account the measurement 
uncertainty this can be considered as quantitative. In this way, the problem is circumvented. 
Indeed, when comparing the isotopic composition of the elemental standard before and after 
isolation, the results were identical within experimental uncertainty. 
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Figure 5.27: On-column isotopic fractionation during the elution of Cu with 5 M HCl 
+ 0.001% H2O2. 
 
 
Figure 5.28: On-column isotopic fractionation during Fe elution with 0.6 M HCl. 
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Figure 5.29: On-column isotopic fractionation during Zn elution with 0.7 M HNO3. 
 
 
5.6 Interference check and procedure blanks 
Although the matrix elements are removed by the element isolation step and, in this way, most 
of the possible interfering species are eliminated from the Cu, Fe and Zn fractions before MC-
IPC-MS measurement, some species will remain present due to the plasma gas, entrained air, 
the solvent, the counter ion and memory effects. Potential interferences have been summarized 
in Table 5.5. Interferences were checked for by high resolution (HR) scanning of the spectral 
area around the mass of the target isotopes. These scans were performed for the Cu, Fe and Zn 
fractions, obtained after sample digestion and element isolation of a seronorm standard. They 
were obtained with a Thermo Scientific Element XR single-collector sector field ICP-MS 
instrument (§ 6.2). 
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Table 5.5: Interfering species originating from the plasma gas, entrained air, the 
solvent and counter ion and memory effects and identified through high resolution 
scanning.78 
Isotope Interference 
54Fe 38Ar16O+, 40Ar14N+, 35Cl18O1H+, 37Cl16O1H+ 
56Fe 40Ar16O+, 40Ar15N1H+, 37Cl18O1H+, 40Ar15N1H+ 
57Fe 40Ar17O+, 40Ar16O1H+ 
58Fe 40Ar18O+, 40Ar17O1H+ 
63Cu / 
64Zn / 
65Cu / 
66Zn / 
67Zn 35Cl16O16O+ 
68Zn 35Cl16O17O+ 
 
For 54Fe, 56Fe, 57Fe and 58Fe, interference from molecular ions: 40Ar14N+, 40Ar16O+, 40Ar16O1H+ and 
40Ar18O+ was very clearly observed in the HR scans given in Figure 5.30Fout! Verwijzingsbron 
niet gevonden. to Figure 5.33. Luckily, these interferences can be separated relatively easy from 
the corresponding analyte signals by working at higher mass resolution. 
 
 
Figure 5.30: HR scan around 54Fe 
 
Figure 5.31: HR scan around 56Fe 
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Figure 5.32: HR scan around 57Fe 
 
Figure 5.33: HR scan around 58Fe 
 
For 67Zn and 68Zn, interference from 35Cl16O2
+ and 35Cl16O2
1H+, respectively, were observed 
(Figure 5.36 and Figure 5.37). Other potential interfering ions for these two Zn isotopes, as well 
as ions potentially interfering with the measurement of the other isotopes of Zn were not 
distinguishable from the background signals, as shown in Figure 5.34 to Figure 5.35. The 
interferences observed for Zn can all be avoided by measuring in medium resolution mode with 
the Neptune. However, the interference from 35Cl16O2
+ and 35Cl16O2
1H+ can also be diminished 
by evaporation of the Zn fractions and redissolving the residue in 0.7 M HNO3.
79 The influence of 
such an evaporation step is shown in Figure 5.38 and Figure 5.39. Due to the spectral “clean up” 
thus realized, the Zn fractions were always evaporated twice and the respective residues 
redissolved in 0.7 M HNO3 as an extra step in the sample preparation method. Although the two 
Cu isotopes do not suffer from interferences containing chlorine, these fractions were also 
evaporated twice. This is because Zn was added to these samples as an internal standard for 
mass bias correction (see § 4.3 for theory and § 6.3.3) and hence, the presence of chlorine-
borne ions can influence the isotope ratio that is obtained. High resolution scans around the 
mass of the Cu isotopes did not show any interfering species with a sufficient signal intensity to 
distinguish them from the background level (see Figure 5.40 and Figure 5.41). 
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Figure 5.34: HR scan around 64Zn 
 
Figure 5.35: HR scan around 66Zn 
 
 
Figure 5.36: HR scan around 67Zn 
before evaporation steps 
 
 
Figure 5.37: HR scan around 68Zn 
before evaporation steps 
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Figure 5.38: HR scan around 67Zn 
after two evaporation steps 
 
Figure 5.39: HR scan around 68Zn 
after two evaporation steps 
 
Figure 5.40: HR scan around 63Cu 
 
Figure 5.41: HR scan around 65Cu 
 
In Table 5.6, it is shown that there are many more possible interferences than those mentioned 
during discussion of the HR scans. Only the interferences that are important when working with 
blood and remain after the evaporation steps are shown in black, the other, for which the 
intensity is expected to be negligible are shown in grey. All the former interferences contain the 
following elements: Mg, Na, Al, Si, P, S, Ca, Ba, K and Ti. To further investigate these 
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contaminants, procedure blanks were tested for these elements and an elution profile for these 
elements was composed for seronorm. 
 
Table 5.6: Interfering species that are present due to the matrix.78 Those that are 
relevant for blood are shown in black, the others are shown in gray. 
Isotope Interference 
54Fe 54Cr+, 108Pd++, 108Cd++ 
56Fe 112Cd++, 112Sn++, 40Ca16O+, 39K17O+, 40K16O+ 
57Fe 114Sn++, 114Cd++, 39K18O+, 38Ar9F+, 40Ca17O+, 41K16O+ 
58Fe 58Ni+, 116Sn++, 116Cd++, 42Ca16O+, 23Na35Cl+, 40Ca18O+ 
63Cu 47Ti16O+, 36Ar27Al+, 126Te++, 126Xe++, 40Ar23Na+, 45Sc18O+, 46Ti16O1H+, 
31P16O16O+ 
64Zn 64Ni+, 48Ti16O+, 32S32S+, 36Ar28Si+, 40Ar24Mg+, 46Ca18O+, 128Xe++, 46Ti18O+, 
128Te++, 47Ti16O1H+, 46Ti17O1H+, 32S16O16O+, 31P16O17O+ 
65Cu 47Ti18O+, 32S16O17O+, 36Ar29Si+, 38Ar27Al+, 48Ti17O+, 40Ar25Mg+, 48Ti16O1H0, 
49Ti16O+, 130Xe++, 130Te++, 130Ba++, 50Ti17O1H+, 32S33S+, 33S16O16O+, 
31P17O17O+ 
66Zn 38Ar28Si+, 50Ti16O+, 36Ar30Si+, 50Cr16O+, 33S33S+, 40Ar26Mg+, 49Ti17O+, 
47Ti18O1H+, 132Xe++, 132Ba++, 48Ti17O1H+, 49Ti16O1H+, 34S16O16O+, 32S17O17O+ 
67Zn 51V16O+, 33S34S+, 36Ar31P+, 40Ar27Al+, 50Ti17O+, 50Ti16O1H+, 134Ba++, 134Xe++, 
48Ti18O1H+ 
68Zn 50Cr18O+, 34S34S+, 32S36S+, 40Ar28Si+, 36Ar32S+, 51V17O+, 50Ti18O+, 136Ba++, 
136Ce++, 136Xe++, 50Ti17O1H+, 36S16O16O+, 34S17O17O+ 
 
 
For the procedure blanks, the sample preparation method was followed for Milli-Q H2O as a 
“mock sample”. After every step of the sample preparation, 100 µL of the sample was taken and 
diluted with ca. 0.3 M HNO3. Then the concentration of the main matrix elements in whole 
blood (see Figure 5.22) and elements that can form interfering species was determined. From 
this test, it was seen that the procedure blank gradually rises (see Table 5.7). Just after the 
element isolation step, however, a drastic drop in contaminants was observed. The most critical 
steps appear to be the evaporation steps. Hence, evaporation was preferably carried out at 
moments when there were not a lot of people working in the clean lab (e.g., at night). Also for 
this reason, the samples were always evaporated on a separate hot plate. As the blank levels 
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rise less in the evaporation steps after element isolation compared to the evaporation step prior 
to redissolving in the appropriate medium for element isolation, it is proven that evaporation 
indeed can be done without significant contamination if sufficient care is taken. In general, the 
procedure blanks can be considered acceptable, as for most elements, except for Ca and P, the 
concentration is not significantly higher than in freshly prepared 2% HNO3. 
The elution profile, obtained with seronorm, for Mg, Na, Si, S, P, Ba and K is shown in Figure 
5.22, while for Al, Ti and Ca, the elution profile can be found in Figure 5.42. These two figures 
show that only for Ti and Al no adequate elution could be obtained. However, Ti is only present 
in the total procedure blank in a concentration close to or below the detection limit. and 
contamination of Al is virtually unavoidable as it is the third most abundant element on Earth 
and present in the clean room as part of the chairs. 
Also the procedure blanks for Cu, Fe and Zn were analyzed. After appropriate dilution (1 mg L-1) 
of the samples, the procedure blank on average accounted for 0.435 %, 0.021 % and 0.011 % of 
the amount of Zn, Cu and Fe, respectively. 
 
 
Figure 5.42: Elution profile for elements that may form interfering species in the ICP, 
for a Seronorm Trace Elements Whole Blood L-3 standard. 8 mL of 8 M HCl + 0.001 % 
H2O2 was used for elution of the matrix (m1-8), 12 mL of 5 M HCl + 0.001 % H2O2 for 
Cu elution (Cu1-12), 7 mL of 0.6 M HCl for Fe elution (Fe) and 8 mL of 0.7 M HNO3 
for Zn elution (Zn). 
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Chapter 6 Measurements and data treatment 
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6.1 Elemental assay 
For measuring the concentrations of the target element in the Cu, Fe and Zn fractions, a Thermo 
Scientific XSeries II instrument (Figure 6.1) was used. The XSeries II is an ICP – mass 
spectrometer equipped with a quadrupole filter for mass selection. Sample introduction was 
accomplished using a concentric nebulizer combined with an impact bead spray chamber. The 
instrument is equipped with third generation hexapole-based collision cell technology (CCT) 
with the capability of kinetic energy discrimination (KED). An electron multiplier with discrete 
dynodes was used for ion detection. 
 
 
Figure 6.1: Thermo Scientific XSeries II quadrupole-based ICP-MS instrument with 
Collision Cell Technology (CCT). 
 
For all concentration measurements in the Cu, Fe and Zn fractions, external calibration was 
relied on. For this purpose, a calibration line was constructed on the basis of measurement data 
for external standards with concentrations of 0, 5, 10, 25, 50 and 100 µg L-1 of the target 
elements. Ga was added to act as an internal standard for Fe, while Co was used as an internal 
standard for Cu and Zn. Normalization versus the internal standard corrects for possible matrix 
effects and/or signal instability. 
  112 |Measurements and data treatment  
The signals for the isotopes of Cu, Fe and Zn suffer from spectral interference. Most of these 
interferences are already excluded by the target element isolation, described in § 5.5. The 
calibration lines for the Cu (63Cu and 65Cu) and Zn (64Zn and 66Zn) isotopes monitored are shown 
in Figure 6.2 and Figure 6.3, respectively. They are characterized by an excellent correlation 
between the elemental concentration and the internal standard and blank-corrected intensity, 
as demonstrated by the R² value and the low background (intercept). Hence, Cu and Zn can be 
measured using the XSeries II instrument operated in standard mode. The typical instrument 
settings for the measurement of these elements are given in Table 6.1 and Table 6.2. These 
parameters are optimized daily for maximum sensitivity and signal stability. Also the formation 
of oxide and doubly charged ions is kept at a sufficiently low level, as checked by monitoring the 
CeO+/Ce+ and Ba++/Ba+ ratios.  
 
 
Figure 6.2: Calibration lines for 63Cu and 65Cu, obtained with the XSeries II 
instrument operated in standard mode. 
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Figure 6.3: Calibration lines for 64Zn and 66Zn, obtained with the XSeries II instrument 
operated in standard mode 
 
 
Table 6.1: Instrument settings and data acquisition parameters for determination of 
Cu, Fe and Zn using the XSeries II instrument operated in standard mode. 
Instrument settings   
RF Power (W) 1200 
Plasma gas flow rate (L min-1) 13 
Auxiliary gas flow rate (L min-1) 0.7 - 0.8 
Sample gas flow rate (L min-1) 0.8 
Sample uptake rate (µL min-1) 500 
Sampling cone Ni, 1.1 mm aperture 
Skimmer Ni, Xt type, 0.75 mm aperture 
data acquisition parameters   
Detector mode Dual 
Scan mode Peak hopping 
Sweeps 300 
Dwell time (ms) 10 
replicate time (s) 38.5 
number of replicates 3 
Number of nuclides monitored 7 
Nuclides monitored 54Fe, 56Fe, 59Co, 63Cu, 64Zn, 65Cu, 66Zn, 69Ga 
y = 0.0184x + 0.0363 
R² = 0.9991 
y = 0.0111x + 0.0215 
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For Fe, however, the calibration lines for the most abundant isotopes, 54Fe and 56Fe, show 
substantial intercepts (background levels) due to the occurrence of the interfering species 
40Ar14N+ and 40Ar16O+, as can be seen in Figure 6.4 and Figure 6.5. Hence, for measuring the Fe 
concentrations the instrument was operated in the CCT mode. The tuning for operation in CCT 
mode must be performed after the standard tuning. CCT mode tuning also includes 
reoptimization of some of the lens settings. Normally, the voltages on the Focus lens and D2 
lens and the Pole bias and the Hexapole bias need to be changed. Sometimes also changing the 
voltages applied to the D1, Da, L1 and L2 lenses is necessary. The typical values for the lenses in 
standard and CCT mode are shown in Table 6.2. The instrument settings and data acquisition 
parameters in Table 6.1 are still valid for the CCT mode. 
 
 
Figure 6.4: Calibration line of 54Fe, obtained with the XSeries II instrument operated 
in standard mode. 
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Figure 6.5: Calibration line of 56Fe, obtained with the XSeries II instrument operated 
in standard mode. 
 
 
Table 6.2: Typical values for the lenses in standard and CCT mode (XSeries II 
instrument). 
  
standard 
mode CCT mode 
Focus (V)   13.3 -10 
D2 (V) -140 -100 
Pole bias (V)   0.5 -20 
Hexapole bias (V) -4.0 -17 
 
 
For measurements in CCT mode, a premixed gas, containing 7 % H2 in He, flows through the 
collision/reaction cell. The flow rate of this gas also needs to be optimized to obtain a maximum 
ratio of signal (from the analyte) to background (caused by the interference) intensity. For this 
purpose, the reaction gas flow rate was varied in steps of 1 mL min-1 between 1 and 8 mL min-1. 
A standard solution containing 10 µg L-1 of Fe and a blank solution were measured at each value 
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to obtain the signal and background intensities, respectively. From Figure 6.6, it is clear that the 
ideal flow rate lies between 4 and 5 mL min-1. In this region the same test was repeated with 
steps of 0.1 L min-1 and the corresponding results are shown in Figure 6.7. The line presenting 
the ratio of signal to background however, does not show a clear maximum. Hence, a flow rate 
of 4.5 L min-1 was adapted at the beginning of all measurement sessions and this flow rate was 
optimized (within the 4-5 mL min-1 range) every time for the best results. In Figure 6.8, the 
calibration line obtained at this reaction gas flow rate is shown. It is characterized by a much 
lower intercept (background) and a better correlation coefficient than the calibration line 
obtained in standard mode. 
 
 
Figure 6.6: Normalized intensities for the 56Fe+ signal, the 40Ar16O+ background and 
the resulting signal to background ratio versus the H2/He flow rate in the range from 
1 to 8 L min-1. 
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Figure 6.7: Normalized intensities for the 56Fe+ signal, the 40Ar16O+ background and 
the resulting signal to background ratio versus the H2/He flow rate in the range from 
4 to 5 L min-1. 
 
 
 
Figure 6.8: Calibration lines for 54Fe and 56Fe, obtained with the XSeries II instrument 
operated in CCT mode. 
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For the analysis of the different aliquots of the elution profiles, which have a more complex 
matrix composition than the pure Cu, Fe and Zn fractions, the Thermo Scientific Element XR 
instrument was used. The Element XR (Figure 6.9) is a sector field ICP - mass spectrometer with 
reverse Nier-Johnson geometry. By operating it at higher mass resolution, the Element XR is 
capable of avoiding spectral overlap. In this way, it can tackle more challenging samples in a 
more straightforward way than the quadrupole-based XSeries II instrument. The Element XR 
was used with a concentric nebulizer and a cyclonic spray chamber for sample introduction and 
is equipped with a triple mode detection system for extension of the linear dynamic range. This 
detection system consists of an electron multiplier, which can be operated in pulse counting 
mode or analog mode, and a Faraday collector. Switching between the different modes is fully 
automatic. 
 
 
Figure 6.9: Thermo Scientific Element XR sector field ICP-MS instrument with reverse 
Nier-Johnson geometry. 
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The elements that were determined are represented in Table 6.3 with the nuclide that was 
monitored, their limit of detection (LOD) and the resolution needed for interference-free 
measurement. The LODs given here are obtained by measuring ten blank solutions, multiplying 
the standard deviation on the signal intensities by 3 and converting the signal intensity obtained 
to a concentration. In Table 6.4, the instrument settings and data acquisition parameters used 
are summarized. These settings are optimized daily to obtain maximum signal intensity and 
stability, combined with a sufficiently low oxide and doubly charged ion formation. 
For all concentration measurements using the Element XR, external calibration was relied on. 
For this purpose, a calibration line was constructed based on the measurement data for external 
standards with concentrations of 0, 2, 5, 10 and 20 µg L-1. Ga was added as an internal standard 
to correct for matrix effects and/or signal instability as this element was not present in a 
significant amount in the sample and was positioned in the middle of the mass range of the 
elements of interest. 
Table 6.3: All the elements that were determined using the Element XR with the 
nuclide monitored, the resolution needed for interference-free measurement and 
limit of detection. 
Isotope Resolution LOD (µg L-1) 
11B Low 0.4 
23Na Low 2 
85Rb Low 0.04 
137Ba Low 0.001 
24Mg Medium 0.007 
27Al Medium 0.2 
28Si Medium 0.08 
31P Medium 2 
32S Medium 4 
44Ca Medium 3 
47Ti Medium 0.009 
56Fe Medium 2 
63Cu Medium 0.4 
66Zn Medium 0.02 
77Se Medium 0.7 
39K High 0.8 
79Br High 0.02 
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Table 6.4: Instrument settings and data acquisition parameters for the 
measurements on the Element. 
Instrument settings 
 
Rf Power (W) 1200 
 
Plasma gas flow rate (L min-1) 15 
 
Auxiliary gas flow rate (L min-1) 0.85 
 
Sample gas flow rate (L min-1) 1.0 - 1.1 
 
Sample uptake rate (µL min-1) 200 
 
Sampling cone Ni; 1.1 mm aperture diameter 
 
Skimmer Ni; H type, 0.8 mm aperture diameter 
Data acquisition parameters 
 
Scan type E-scan 
 
Runs 3 
 
Replicates 4 
 
Samples per peak 20 
 
Segment duration (s) 0.25 
 Measurement time per replicate (ms) 1 
 
 
6.2 High resolution scans 
In the search for possible interferences affecting the target isotopes, the Element XR sector field 
ICP-MS instrument was used to perform high resolution (HR) scans in a limited mass range 
around the spectral peak of the target isotopes. The results of these mass scans are shown in § 
5.6. The instrument settings used for this purpose are the same as for the concentration 
measurements (see Table 6.4). The parameters used for these HR scans are shown in Table 6.5. 
The number of peaks is chosen such that the channels are 0.0001 u wide. For each of the target 
elements, a mass range including all isotopes of interest was covered in one scan. Afterwards 
the spectral sections of interest were selected manually. 
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Table 6.5: Data acquisition parameters entered in the software of the Element XR for 
obtaining high resolution scans of the mass ranges of interest for Cu, Fe and Zn.  
Isotope Number of peaks scan range (u) 
Cu 2380 62.8662 - 64.9923 
Fe 3015 55.8788 - 57.9908 
Zn 4760 63.8651 - 67.9921 
 
 
6.3 Isotopic analysis 
For isotopic analysis, a Thermo Scientific Neptune instrument (Figure 6.10) was used. The 
Neptune is a multi-collector ICP-MS instrument that was commercially introduced in 2000. It 
combines the excellent ionization efficiency of the ICP as an ion source with a double-focusing 
sector field mass spectrometer of Nier-Johnson geometry. The instrument has three resolution 
modes, referred to as low, medium and high resolution, but in fact the higher mass resolution 
settings both provide pseudo-high resolution to maintain the flat-topped peaks, required for 
high-precision isotope ratio determination. The beam intensity of up to nine target isotopes can 
be monitored simultaneously by a Faraday collector array, consisting of a fixed central cup and 4 
movable cups on each side of it. In the A&MS group, the Neptune is equipped with a 100 µL 
min-1 PFA nebulizer and a high-stability spray chamber, consisting of a combination of a Scott-
type and a cyclonic sub-unit, for sample introduction. 
Under optimal conditions, a precision (internal precision or repeatability) of 0.002 % RSD can be 
achieved in low resolution mode. In the higher resolution modes, slightly lower precisions are 
attainable. 
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Figure 6.10: Thermo Scientific Neptune MC-ICP-MS instrument. Top: Schematic 
overview of the components and geometry,34 Bottom: The Neptune instrument at 
S12 
 
 
6.3.1 Standards for isotopic analysis 
When using a δ value, the isotope ratio determined for a sample is expressed as a relative 
difference to a homogeneous and preferably widely distributed isotopic reference material. For 
Cu, Fe and Zn, the certified isotopic reference materials are still very new and the δ values 
reported in literature are still commonly calculated relative to materials that are not recognized 
as isotopic reference materials, making inter-laboratory comparison much harder. The certified 
isotope reference materials most commonly used in isotopic analysis of Cu, Fe and Zn are given 
in Table 6.6, along with their certified isotopic compositions.  
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Table 6.6: The certified isotope reference materials used in this work and the 
abundances of the different isotopes. For the standards from IRMM, all 
uncertainties indicated are expanded uncertainties and apply to the last two digits. 
For the standard from NIST, the indicated uncertainties are overall limits of error 
based on the sum of 95 % confidence limits for the means and upper bounds for the 
effects of known sources of possible systematic error. 
Certified isotope reference material abundances (atom %) 
NIST SRM 976 63Cu 69.174 ± 0.020 
 
65Cu 30.826 ± 0.020 
IRMM-014 54Fe 5.845 (23) 
 
56Fe 91.754 (24) 
 
57Fe 2.1192 (65) 
 
58Fe 0.2818 (27) 
IRMM-3702 64Zn 49.1704 (83) 
 
66Zn 27.731 (11) 
 
67Zn 4.0401 (18) 
 
68Zn 18.4483 (69) 
 70Zn 0.6106 (11) 
 
 
In-house isotopic standards were also prepared for Cu, Fe and Zn and are further referred to as 
A&MS-Cu, A&MS-Fe and A&MS-Zn, respectively. These standards were prepared from 
commercially available 1 g L-1 stock solutions (Inorganic Ventures, The Netherlands; lot C2-
CU02116 for A&MS-Cu, lot D2-FE03110 for A&MS-Fe and lot D2-ZN02061 for A&MS-Zn). The in-
house standards were used to reduce the consumption of the valuable isotopic reference 
materials and to make it possible to calculate and hence, check the delta values for Cu and Fe 
for the in-house standard, as for these two elements, only one reference material with known 
isotopic composition is available: NIST SRM 976 for Cu and IRMM-014 for Fe. For Zn, next to 
IRMM-3702, also the so-called JMC-ZnLyon standard is commonly used as a reference material 
and hence, its delta value, relative to IRMM-3702 is well known. However, this reference 
material is not available anymore. A small amount of JMC-ZnLyon standard was made available to 
the A&MS group by Dr. Christophe Cloquet from the CRPG research Institute in Nancy, France. 
The in-house standard for Zn was always measured together with the JMC-ZnLyon for profound 
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characterization, so that it can eventually replace JMC-ZnLyon completely. The isotopic 
composition of the in-house standards and of JMC-ZnLyon was determined relative to NIST SRM 
976 for Cu, to IRMM-014 for Fe and to IRMM-3702 for Zn and the delta values thus obtained are 
shown in Table 6.7. All delta values in this thesis will be expressed relative to the isotopic 
reference materials mentioned above (NIST SRM976, IRMM-014 and IRMM-3702), unless stated 
otherwise. 
 
Table 6.7: Delta values for Cu, Fe and Zn in the in-house isotopic standards, relative 
to the isotopic reference materials for Cu, Fe and Zn. Uncertainties are external 
precisions (2s, period = 4 year). 
Standard SRM delta              Value 
A&MS-Cu (n = 63) NIST-976 δ65Cu 0.228 ± 0.006 ‰ 
A&MS-Fe (n = 43) IRMM-0.14 δ56Fe 0.46 ± 0.02 ‰ 
  
δ57Fe 0.67 ± 0.02 ‰ 
A&MS-Zn (n = 82) IRMM-3702 δ66Zn -7.06 ± 0.02 ‰ 
  
δ67Zn -10.55 ± 0.06 ‰ 
  
δ68Zn -13.98 ± 0.07  ‰ 
JMC-ZnLyon (n = 24) IRMM-3702 δ66Zn -0.30 ± 0.04 ‰ 
  
δ67Zn -0.44 ± 0.17 ‰ 
    δ68Zn -0.57 ± 0.09 ‰ 
 
 
6.3.2 Method development and validation 
6.3.2.1 Fe 
When developing a new method for isotopic analysis of a target element using the Neptune MC-
ICP-MS instrument, the first step is to select a suitable cup configuration, i.e. the position of the 
Faraday cups, relative to the center cup. As mentioned above, the Neptune has a total of nine 
Faraday cups available. For the measurement of Fe isotope ratios, only six are used (see Table 
6.9). Prior to optimizing the selected cup configuration, a standard, containing the target 
element (and the selected internal standard) needs to be aspirated and the instrument 
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parameters need to be tuned for the elements of interest. The instrument settings and data 
acquisition parameters for measurements with the Neptune are also given in Table 6.9. 
For Fe, all isotope ratio measurements require medium resolution (MR), because of spectral 
interference from Ar-based polyatomic ions. For the Fe isotope measurement, the samples were 
diluted to 1 mg L-1 of Fe. Ni is added, also in a concentration of 1 mg L-1, as an internal standard 
relied on for mass discrimination correction, as described further on (§ 6.3.3). 
Since at the beginning, no cup configuration enabled the simultaneous measurement of all the 
Fe and Ni isotopes of interest and tuning is most obvious for the most abundant isotope, 56Fe 
was steered into the center cup (“set” button in Figure 6.11). The center cup was centered at 
this mass (“peak center” button in Figure 6.11) to ensure it is measured in the center of the flat-
topped peak. The instrument settings were optimized using the signal intensity for this isotope. 
When the maximum signal intensity was reached, the isotope that will actually be measured at 
the center cup was steered into the center cup (58Fe) and peak centering was carried out, as can 
be seen in Figure 6.12. When measurements are conducted for which a cup configuration 
already exists, tuning is possible with the correct isotope in the center cup, using the signal of 
the most abundant isotope collected in another cup. 
 
 
Figure 6.11: A screen shot of the “scan control” tab in the tuning software of the 
Thermo Scientific Neptune. 
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Figure 6.12: The result of “peak centering” after steering the 58Fe beam into the 
center cup. The bold line is the actual position where static measurement is carried 
out and the normal line is the theoretical middle of the flat-topped peak. 
 
The signals of the other nuclides of interest – 54Fe monitored in L4, 56Fe in L2, 57Fe in L1, 60Ni in 
H1 and 62Ni in H2 – should all be shifted with a certain number of nominal mass units to the left 
(for H cups) or to the right (for L cups), in accordance with their difference in mass with respect 
to the nuclide monitored in the center cup when comparing mass scans of the different cups. 
Figure 6.13 shows a section of the mass spectrum, as obtained through a mass scan of the range 
of the Fe and Ni isotopes. Checking the appropriate position of the cups can be facilitated by 
overlapping the signals thus obtained to check their relative positions. When all cups are located 
perfectly, the spectral peaks should nicely overlap, as is the case at nominal mass 58 in Figure 
6.14. At this point, it is important to point out that the masses on the x-axis are always 
expressed for the center cup. The software is programmed in this way and hence, this cannot be 
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changed. Hence, when monitoring signals of other cups than the center cup, one should always 
take in mind the shifts represented in Figure 6.13. 
If there is no perfect overlap, a ruler can be used to determine the distance a cup has to be 
moved to make the signals align. For larger distances, the mass scan option can be used, while 
for smaller distances the peak scan option suffices. 
 
 
Figure 6.13: Spectral section obtained through a mass scan in the range of the Fe 
and Ni isotopes. 
 
After optimization of the cup configuration, the instrument is switched to MR mode and the 
peak alignment is rechecked. Making sure that the low mass side of the different spectral peaks 
is well aligned is very important in this phase because this is the side where the interference-
free plateau appears in the case of the transition metals. By making sure the low mass sides are 
aligned, the interference-free plateaus will be correctly positioned. The final result of these 
optimization steps is shown in Figure 6.14. 
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Figure 6.14: Result of peak scan after optimization of the cup configuration for Fe, 
showing the alignment of the different peaks, monitored by the different cups, in 
MR. 
 
The last step is to determine where the Fe+ signal intensity can be measured interference-free 
during static measurement. Since the overlap of 40Ar16O+ on 56Fe+ gives rise to the most severe 
interference, 56Fe will be used to determine this location. In Figure 6.14, it can be seen that the 
plateau for 56Fe is indeed the narrowest. A peak scan is performed for a standard and a blank 
solution. The blank solution will only show the peak of 40Ar16O+, while the standard solution will 
provide a peak with contributions from both 56Fe+ and 40Ar16O+ (see Figure 6.15). The blank is 
considered negligible when its signal is below 0.1 % of the signal of the standard. Hence, the 
location where the signal intensity should be measured for 56Fe+ is where the contribution from 
40Ar16O+ reaches this value. In this case, this is at mass 57.896 u (the masses in the peak scans 
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are always expressed for the center cup) and thus, 57.896 is filled in in the cup configuration file 
as the center cup mass. Since all positions of the other cups are determined relative to that of 
the center cup and the peaks are aligned, the measurement of the signal will be carried out at 
the left hand side of each of the peaks. 
 
 
Figure 6.15: A peak scan around 56 u, showing the  contribution of the 40Ar16O+ 
interference. 
 
After optimization, the measurement protocol needs to be validated for obtaining correct 
isotope ratios. As at the start of this thesis the isotopic composition of the in-house isotope 
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standard was not known, there was no way to test if the δ values obtained for it, relative to the 
IRMM-014, were correct. Hence it was decided to analyze (sample preparation and 
measurement) one of the seronorm standards and compare the results with previously 
published data. From Table 6.8, it is clear that our Fe isotope ratio results show good agreement 
with the previously published values. 
 
Table 6.8: Delta values for Fe for SeronormTM Trace Elements Whole Blood. 
Seronorm value 
from REF Seronorm δ56Fe/54Fe δ57Fe/54Fe 
this work OK0337 -2.45 ± 0.07 -3.65 ± 0.08 
73 OK0336 -2.30 ± 0.08 -3.41 ± 0.13 
73 404108 -2.37 ± 0.12 -3.56 ± 0.16 
73 MR9067 -2.34 ± 0.10 -3.56 ± 0.17 
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Table 6.9: Instrument settings and data acquisition parameters for the isotopic 
analysis of Cu, Fe and Zn using the Thermo Scientific Neptune MC-ICP-MS 
instrument. 
Instrument settings   
 Rf Power (W) 1200 – 1300 
 
Plasma gas flow rate (L min-1) 15 
 
Auxiliary gas flow rate (L min-1) 0.6 - 0.7 
 
Nebulizer gas flow rate (L min-1) 0.9 - 1.0 
 
Sample uptake rate (µL min-1) 100 
 
Guard electrode Connected 
 
Sampling cone Ni; 1.1 mm aperture diameter 
 
Skimmer Ni; H type, 0.8 mm aperture diameter 
 
Lens settings Optimized for maximum analyte signal intensity 
 
Resolution mode Medium 
Data acquisition parameters   
 
Scan type Static; multi-collection 
 
Number of blocks 9 
 
Number of cycles / block 5 
 
Integration time (s) 4 
 
Magnet settling time (s) 0 
 
Cup configuration for Fe measurements L4: 54Fe, L2: 56Fe, L1: 57Fe, C: 58Fe, H1: 60Ni, H3: 62Ni 
 Cup configuration for Cu and Zn measurements L3: 63Cu; L2: 64Zn, L1: 65Cu, C: 66Zn, H1: 67Zn, H2: 68Zn 
 
 
6.3.2.2 Cu and Zn 
The cup configuration optimization and development of the measurement protocol for Cu and 
Zn isotopic analysis is identical and the corresponding data acquisition parameters are also 
given in Table 6.9. This is a result of the fact that Cu was added as an internal standard to the Zn 
sample and vice versa. As for Fe, both analyte and internal standard concentrations were equal 
to 1 mg L-1. The method for development of the cup configuration for Cu and Zn will not be 
described in detail, as it is very similar to the method for the optimization of the cup 
configuration for Fe isotopic analysis. Peak scans performed using the Neptune did not provide 
any indication of spectral overlap and thus, isotopic analysis in low resolution (LR) mode seemed 
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possible. However, in literature, it can be found that Cu and Zn isotope ratios are commonly 
measured in MR. 
To further confirm absence of spectral overlap, measurement results obtained for selected 
samples in LR mode were compared with those obtained in medium mass resolution (MR) 
mode. For these measurements, the same instrument settings and data acquisition parameters 
were used as mentioned before, only the number of blocks was reduced to 5. For selecting the 
proper location for static mass scanning in MR, measurements were performed every 0.002 u 
starting from the left edge of the peak to the middle of the peak. In Figure 6.16 the 63Cu signal is 
shown because here the clearest plateau was observed (the masses on the x-axis are again 
center cup masses). The value plotted on the y-axis is the difference between the signal 
intensity and the signal intensity of the first measurement (on the edge of the peak), multiplied 
by 1000. In the graph, a plateau can be distinguished between 65.892 and 65.906 u. Hence, it 
was decided to measure in the middle of this plateau, at a center cup mass of 65.898. 
 
Figure 6.16: Peak scan for 63Cu+ showing the signal intensity (expressed in δ values 
relative to the first measurement) relative to the center cup mass (66Zn) 
 
Although the difference in intensity between the interference-free plateau and the middle of 
the peak was very small, delta values obtained for Cu and Zn in LR mode occasionally deviated 
from those obtained in MR mode. This could be an indication of a very low amount of 
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interfering species still being formed. As an additional test, the concentrations of parent 
elements potentially forming interfering ions were monitored in a batch consisting of 10 
samples. It was indeed found that, sometimes, Na was present in a significant concentration. 
Hence, the bias between LR and MR results mentioned above can probably be explained as a 
result of the occasional presence of Na, giving rise to the formation of 40Ar23Na+, interfering with 
63Cu. Probably, this interference was missed during the Element XR HR scans because Na is not 
always present. Hence, all further isotope ratio measurements were always performed in MR 
mode for Cu and Zn as well. With the optimized method for isotopic analysis of Zn in whole 
blood, the δ values obtained for the seronorm standard agree with the values found in 
literature (see Table 6.10). For Cu, no values for the seronorm standard were found in literature. 
However, since the same method is used for Cu and Zn, there is no reason not to trust the 
results for Cu. 
 
Table 6.10: Delta values for Cu and Zn for SeronormTM Trace Elements Whole Blood. 
Zn values are expressed relative to JMC-ZnLyon here. 
Seronorm value 
from REF Seronorm δ66Zn/64Zn δ68Zn/64Zn δ65Cu/63Cu 
this work OK0337 0.33 ± 0.03 0.68 ± 0.10 0.37 ± 0.11 
Reference 73 OK0336 0.31 ± 0.06 0.62 ± 0.07 
 Reference 73 404108 0.30 ± 0.06 0.63 ± 0.07 
 Reference 73 MR9067 0.34 ± 0.04 0.66 ± 0.07 
  
 
6.3.3 Data treatment and quality control 
The raw measurement data obtained using the Neptune were corrected for mass discrimination 
offline. This means that the software of the instrument did not perform any corrections. For 
data treatment, all 45 data points (5 cycles per block * 9 blocks = 45 cycles) of a measurement 
were used instead of the average value of the measurement. A value that was more than 2s 
away from the average was considered an outlier and was removed after the mass 
discrimination correction steps. The standard deviation on the measured values was 
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determined by calculating the standard deviation on the accepted mass discrimination 
corrected values. The errors on the values for the samples are expressed as two times this 
standard deviation. 
Several methods for mass discrimination correction were used simultaneously. The first method 
used is the SSB (bracketing) method (§ 4.3.3.1). Additionally, two internal standardization 
methods were applied. One was a simple model, where the mass discrimination constants of 
the internal standard and the analyte element were considered identical. The other was the 
regression model, first described by Woodhead (§ 4.3.3.3).63 For both internal standardization 
methods, Russell’s law was used to calculate the mass discrimination factors. The last approach 
used for mass discrimination correction was the modified SSB method, described by Mason et 
al.68, which is a combination of bracketing and internal standardization. When applying this 
method, the first step is to calculate the δ value of the target element in the sample, relative to 
its bracketing standards. This step is correcting for the linear variations in mass discrimination, 
as does the normal SSB method. Then, δ values are also calculated for the internal standard in 
the sample, relative to the internal standard in the bracketing standards. As the isotopic 
composition of the internal standard is the same in the standards and the samples, this δ value 
is an indication for the non-linear shift in mass discrimination. The mass discrimination 
corrected δ value of the target element is then obtained by merely subtracting the δ value of 
the internal standard from the δ value of the target element. 
After the data treatment, the results of the different methods were compared. Generally, the 
results obtained were very similar, indicating good matrix matching and thus, reliable results. If 
results from different methods did deviate, the success rate for obtaining correct δ-values for 
standards was highest in case of mass bias correction through the method adapted from 
Woodhead.63 Hence, all δ values presented in this thesis are calculated with Woodhead’s 
method, unless stated otherwise. 
The accuracy of the results was also monitored. At the beginning of each analytical session, 
standard solutions and quality control samples were measured to check whether the MC-ICP-
MS instrument provided adequate results. Standard solutions of NIST SRM 976 were used for 
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Cu, of IRMM-014 for Fe and of IRMM-3702 and JMC-ZnLyon for Zn. The quality control “samples” 
were A&MS-Cu, A&MS-Fe and A&MS-Zn. Delta values for all standards can be found in Table 6.7 
along with the long-term external precisions. Only when the delta values for these quality 
control samples did not show any significant bias with respect to the delta values obtained in 
previous measurements, the measurement session was started. Otherwise, additional tuning 
was performed. 
Most of the samples were analyzed twice. Delta values were only accepted if both the delta 
values for the corresponding certified isotopic reference material measured directly before and 
after the sample and the results for the in-house standards, analyzed for quality control 
purposes every 4 - 5 samples, were adequate. The final delta values, presented in this work, are 
the averages of the accepted delta values. 
Afterwards, in the case of Fe and Zn, the final delta values were plotted in a 3-isotope plot 
(δ67Zn vs. δ66Zn, δ68Zn vs. δ66Zn and δ57Fe vs. δ56Fe) to test whether the results testify of normal 
mass-dependent fractionation and do not indicate bias due to contamination, spectral overlap 
or matrix effects.80 The fractionation line obtained should agree with the following equations: 
 ZnZn 6667 5.1    (6.1) 
 ZnZn 6668 2    (6.2) 
 FeFe 5657 5.1    (6.3) 
An example of such a fractionation line is shown in Figure 6.17. Although for some 
measurement sessions, the standard deviation on the slopes was rather high (probably as a 
consequence of the relatively narrow range of delta values obtained), the slopes mostly 
matched the values to be expected. Only for Zn, some measurement sessions did not provide an 
experimental fractionation line in agreement with the theoretical fractionation line. The results 
of these sessions were rejected and the samples measured within these sessions were 
reanalyzed, if possible. As copper only has two stable isotopes, this test was not possible for this 
element. 
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Figure 6.17: A three-isotope plot with the experimental mass fractionation line, in 
agreement with the theoretical mass-dependent fractionation line. The plotted δ 
values are obtained for part of the reference population, measured on February 3rd, 
2012. 
 
 
6.4 Statistical analysis 
After data collection, statistical methods were applied to the data sets to trace down significant 
differences in the isotopic compositions between different groups of samples or to reveal 
existing trends. This paragraph provides a short overview of all the statistical methods used in 
this work and shortly explains what they are used for. 
The first two methods described here are univariate methods. This means that the difference in 
means is only tested for one variable at the same time (e.g., δ56Fe or δ66Zn). The next three 
statistical methods are multivariate methods where different variables are taken into account at 
the same time (e.g., δ56Fe and δ66Zn). Multivariate methods can be used for dimension 
reduction with minimal loss of information. 
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6.4.1 Student’s t-test 
A t-test81 can be used to investigate whether or not the mean of a set of samples is significantly 
different from the corresponding true (or assumed true) value or whether there is a significant 
difference between the means of two sampled groups. 
There are different types of t-tests, but the one used in this work is the “independent-samples t-
test”. In this case, the groups of samples share the variable of interest (e.g., δ56Fe), but there is 
no overlap between membership of the two groups. A clear example is the difference in δ56Fe 
between males and females. An individual is either male or female and thus, uniquely belongs 
to one of the two groups investigated. 
When using a t-test, it is hypothesized that the means are not significantly different (null 
hypothesis). The value of t is calculated together with the corresponding p-value, which is  
based on the Student’s t distribution. This p-value actually represents the probability of the 
observed value of t. Most commonly a value of p below 0.05 leads to rejection of the null 
hypothesis. In this case the t-test is said to be performed on the 95 % confidence level, since 
there is a ≤ 5 % chance a correct null hypothesis is not accepted. 
 
6.4.2 ANOVA 
Like a t-test, also analysis of variance (ANOVA)81, 82 is a statistical tool to compare mean values 
of a specific variable for different sampled groups. But where a t-test compares only two 
groups, ANOVA is able to compare many. When using ANOVA, the variance between the groups 
and the variance within the groups is compared. When the variance between the groups is 
larger than the variance within the groups, this indicates that at least one group mean is 
significantly different from the other group means for this specific variable. In practice, an F-
value is calculated for this purpose, together with the probability (p) of this observed F-value. If 
ANOVA is performed on the 95 % confidence level, p should be < 0.05 to reject the null 
hypothesis (all group means are not significantly different) 
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If all group means are not equal, a post hoc test is needed to identify which group mean(s) 
show(s) a significant difference. There are two kind of post hoc tests. The first one is an a priori 
test called the LSD (Least Significant Difference) test and is used for planned comparisons. This 
test is used when one of the groups is the reference to compare the others to. The second type 
of post hoc test is an a posteriori test for unplanned comparisons, called the Scheffé test. This 
test is used to compare groups where there is no reference group. 
 
6.4.3 PCA 
Principal component analysis (PCA)82 is a statistical method for dimension reduction. PCA 
converts a set of possibly correlated variables into a new and smaller set of uncorrelated 
variables (= principal components), which are a linear combination of the original variables. The 
first principal component has the largest variance. This means that the first principal component 
contains the largest part of the total information that was present in the total set of original 
variables. 
When there are more than three variables, the data cannot be represented graphically. When 
the amount of variables can be reduced to three or less PC, the data can be represented with 
minimal loss of information. The plot in which the samples are represented with their new PC 
values is called a score plot. When PCA is used, it is also possible to represent the original 
variables as a function of the PCs in a loading plot. From this plot, it can be deduced what kind 
of information is contained in which variables and which variables contain similar information. 
 
6.4.4 HCA 
For the human eye, it is quite simple to recognize groups. For a computer, this is much more 
difficult. Hierarchical cluster analysis (HCA)81, 82 can be used to form groups (= clusters) of 
objects that are similar. Cluster analysis can be achieved by various algorithms that differ 
significantly in their notion of what constitutes a cluster and how to efficiently find them. 
Popular notions of clusters include groups with small distances among the cluster members, but 
Measurements and data treatment | 139  
a cluster can also be recognized by comparing the density of the data points. The method that 
works best should be determined for each data set independently. 
 
6.4.5 Discriminant analysis 
Linear discriminant analysis81, 82 (LDA) is a method used to find a linear combination of features 
which characterizes or separates two or more classes of objects or events. The difference with 
HCA is that in LDA one knows in advance what the categories are that one wants to find. The 
difference with PCA is that LDA explicitly attempts to model the difference between the classes 
of data. PCA on the other hand does not take into account any difference in class.83 
Normally there are three steps when performing discriminant analysis. The first step is the 
training. Here data that belong to known classes will be used to determine the discriminant 
functions. These functions are used to describe the classes. After the training, a validation step 
is carried through. In this step, the discriminant functions are used on the data that belong to 
known classes to test if the model is able to assign the object to the correct class. If this is the 
case, the model can be used for unknown objects. 
In this work, only the first two steps were used as there were no objects from which the class 
was unknown. However, this also provides information whether or not the expected classes are 
really present in the population analyzed. 
 
6.4.6 Correlation tests 
Correlation81, 82 is expressed with a number between -1 and 1, where a correlation of +1 
designates a perfect positive correlation and a correlation of -1 a perfect negative correlation. A 
positive correlation indicates that as the value of one variable increases, the value of the other 
variable also tends to increase. In case of a negative correlation, a decrease of the first value will 
result in a decrease of the other. The closer the correlation value is to |1|, the stronger this 
tendency; and the closer the correlation value is to 0, the weaker this tendency. 
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Mostly, the correlation is presented as the letter r. This Pearson r is predicated on the 
assumption that the two variables involved are approximately normally distributed. When 
variables are not normally distributed, the Spearman ρ is more appropriate (e.g., Chapter 11). In 
contrast to the more commonly used Pearson r, Spearman ρ is a non-parametric measure. This 
implies that a normal distribution is not required. Because for the calculation of Spearman ρ, no 
specific form of correlation is assumed, it is not only a test for linear correlation, but for any 
relation described by a monotonic function. 
 
 
 
Chapter 7 An introduction to human Cu, Fe and Zn 
metabolism 
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The three elements under investigation in this work, Cu, Fe and Zn are all important essential 
trace elements in the human body. Humans cannot survive without essential elements, but also 
too much of these elements is detrimental (see Figure 7.1). In this chapter, the metabolism of 
Cu, Fe and Zn are shortly explained as are some diseases that will be addressees further on.  
 
 
Figure 7.1: Influence of the dose of an essential element on the health condition.84 
 
7.1 Copper metabolism 
Copper is incorporated in enzymes and is important for brain activity and energy production in 
the human body. Although Cu is one of the most important essential trace elements, the Cu 
metabolism has not been elucidated completely yet. Analysis of excreta and blood only give 
limited information and sampling tissues like skin and liver are often considered too invasive. 
Also tracer experiments are difficult as copper only has two naturally occurring isotopes (63Cu 
and 65Cu), which are both relatively abundant (about 69.15 % and 30.85 %, respectively51), while 
stable isotopes to be used as tracers are preferably of relative low abundance.85 Given the 
limitations of research on human beings, even now the models for human copper metabolism 
mostly rely on animal studies.86-89 The first model from a study on man only dates from 1994.90 
After long-term high copper intake, increased indices of copper status were observed together 
with changes in several indices of immune function. The physiology behind these changes is 
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unknown.91 In patients with cholestasis, bile is prevented from flowing from the liver to the 
duodenum.92 As Cu homeostasis is achieved through regulation of the excretion of excess Cu by 
the biliary system, absorption of too much Cu will lead to an overload, accompanied with toxic 
effects. In Wilson’s disease, a genetic disorder affecting copper metabolism, copper 
accumulation, particularly in liver and brain occurs. This will eventually lead to severe liver 
cirrhosis and psychiatric disturbances and to death if the disease is not treated.93 
Copper deficiency is very rare and no literature was found on humans with deficient copper 
levels, except for patients with Menkes disease. In individuals with Menkes disease, the copper 
cannot exit from enterocytes to the circulation, therefore leading to copper deficiency.94 The 
majority of symptoms arise from the lack of activity of copper-dependent enzymes. The illness 
starts to express mostly at an age of two to three months and is characterized by sparse and 
coarse hair (kinky hair disease), growth failure and deterioration of the nervous system. Other 
signs and symptoms for Menkes disease include development delay, spasms in limbs, weak 
muscle tone, sagging facial features, seizures, sub-normal body temperature and mental 
retardation.  
The copper metabolism is closely entangled with the iron metabolism as copper is a cofactor in 
many enzymes involved in the iron metabolism. For example, during copper deficiency, 
hemoglobin production is inefficient despite normal serum iron levels, since bone marrow iron 
utilization is copper-dependent. 
The copper absorption is greatly influenced by the amount of dietary copper. The amount 
absorbed increases as the amount of copper in the diet increases. But absorption is much more 
efficient when intake is low. In addition, copper excretion is highly dependent on the amount of 
copper absorbed. Normal dietary consumption and absorption of copper exceed the metabolic 
needs. Dietary copper is absorbed in the small intestine and transported to the liver through the 
blood, where it is bound to albumin, amino acids and transcuprein. The majority of copper 
taken up by the liver is incorporated into ceruloplasmin, released into the blood and delivered 
to tissues. A simple schematic representation of the Cu metabolism is given in Figure 7.2. 
Ceruloplasmin-bound Cu (80 % of total Cu in whole blood) does not exchange with other 
An introduction to human Cu, Fe and Zn metabolism | 145  
copper-containing fractions, whereas the small percentage of albumin-bound, amino acid-
bound and transcuprein-bound Cu does exchange readily with Cu2+ or with each other. This 
small percentage is also called direct-reacting Cu (DR Cu).95 
 
 
Figure 7.2: The human Cu metabolism 
 
The amount of dietary copper influences the flow of copper through the plasma, the liver and 
the other tissues. Cells take up copper through a high-affinity transmembrane protein. Copper is 
then delivered to the Golgi apparatus, the mitochondria and Cu/Zn superoxide dismutase. To 
maintain homeostasis, excess Cu is excreted by the bile.96-98 Copper homeostasis has to be 
strongly regulated, as when present in excess, its high oxidative potential can induce reactive 
free radicals that give rise to cellular damage. For this regulation in cells, metallothioneins are 
present in the cytosol of cells.99 
 
7.2 Iron metabolism 
Iron is the most abundant essential trace metal in the human body. Most of it is found in 
hemoglobin, the respiratory protein. Iron deficiency has important consequences for human 
health and child development. Although iron is the fourth most abundant element on Earth, the 
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World Health Organization (WHO) estimates that one third of the world population is anemic, 
with iron deficiency as the main cause.100 As well as affecting a large number of children and 
women in developing countries, iron deficiency is also the most prevalent micronutrient 
deficiency in industrialized countries. The symptoms and signs of iron deficiency include pallor, 
fatigue, poor exercise tolerance and decrease in work performance.101 Since humans have no 
means of active iron excretion, also iron overload can cause serious problems, such as iron 
deposits in e.g., the liver and the heart, leading to tissue damage and fibrosis. Patients also can 
suffer from fatigue and stiff joints. In fact, disorders of iron homeostasis are among the most 
common and widespread human conditions.101 Two examples that were also addressed in this 
PhD research project are hemochromatosis (§ 7.2.1) and Anemia of Chronic Disease (ACD) (§ 
7.2.2). 
 
 Figure 7.3: The human iron metabolism. (© Cornell University) 
 
Dietary iron is absorbed by enterocytes in the intestinal epithelium. From there, the iron is 
transferred by ferroportin to blood, where it is bound to transferrin (Tf), and transported to 
iron-needing tissues, mainly bone marrow. The excess iron is stored in cells, mainly in the liver, 
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under the form of ferritin.101 These two possibilities are not mutually exclusive. Which process 
prevails, depends on the iron need of the individual concerned. In individuals with low iron 
status, the fraction of the dietary iron that needs to be absorbed is larger, necessitating a higher 
transferrin concentration, while the ferritin concentration will be lower. The transferrin-bound 
iron associates with a specific receptor (TfR), which is a transmembrane glycoprotein, expressed 
on iron-requiring cells. The density of these receptors on cells is related to the tissue’s iron 
status and erythropoietic activity. Fragments of these receptors can also be found in the 
circulation. The concentration of soluble transferrin receptor (sTfR) is proportional to the 
amount of cellular TfR.102 After internalization of the iron-transferrin – transferrin receptor 
complex, a proton pump decreases the pH within the endosome, leading to a conformational 
change in the protein complex, thus liberating iron. After iron release, the TfR-Tf complex is 
returned to the cell surface where the cycle can restart. In this way, most of the iron-transferrin 
complexes end up in the bone marrow and the iron is incorporated into hemoglobin in red 
blood cells.101, 103 
 
 
Figure 7.4: Illustration of the interplay of iron, transferrin, and (soluble) transferrin 
receptor in iron metabolism.102 
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The rate of iron absorption is regulated to match the body’s needs. Three major factors affect 
iron absorption: the size of the iron stores, the rate of erythropoiesis and oxygen need. 
Erythropoiesis is the total process by which red blood cells are produced. Absorption rises 
slowly as stores decline to lower levels and vice versa. When erythropoiesis is acutely 
stimulated, there is a prompt rise in the absorption rate as well.104 Regulatory control of iron 
status is also profoundly influenced by the diet. While the gastrointestinal mucosa has a large 
capacity to respond to the body’s needs, the actual amounts of iron that can be absorbed are 
profoundly influenced by both dietary iron content and its bioavailability. Both the presence of 
heme iron, which is well absorbed, and the balance between promoters (e.g., ascorbic acid) and 
inhibitors (e.g., phytates) of non-heme iron absorption influences the bioavailability. The 
regulation of the iron absorption has the largest effect on non-heme iron.103 
The key regulator for iron uptake, storage and distribution is hepcidin, a protein hormone 
produced by the liver. When the iron status is high, its concentration will rise. The binding of 
hepcidin to ferroportin blocks the transporter, thus downregulating the delivery of iron from 
the enterocytes into the circulation.105 
Hepcidin causes ferroportin internalization and degradation, thereby decreasing iron transfer 
from the duodenum, from macrophages involved in recycling senescent erythrocytes and from 
iron-storing hepatocytes into blood plasma. Hepcidin is feedback-regulated by iron 
concentrations in plasma and the liver and by the erythropoietic demand for iron. Genetic 
malfunctions affecting the hepcidin-ferroportin axis are a main cause of iron overload disorders, 
but can also cause iron-restricted anemias (e.g., § 7.2.2).106 
Humans have no active physiological pathway to excrete iron, but iron is lost through at least 
two sinks. First, there is the desquamation of surface cells from the skin, gastrointestinal and 
urinary tracts and second, there are the small amounts of gastrointestinal blood loss that occur 
even in normal individuals. Although these iron losses vary as a function of iron status, they only 
do this within a narrow range. While such variations may be the result of a regulatory process, it 
seems more likely that they merely reflect variations in the iron content of desquamated 
cells.103 
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7.2.1 Hemochromatosis 
Hereditary Hemochromatosis (HH) comprises a group of autosomal genetic disorders 
characterized by excessive absorption of iron in the intestine. Without therapeutic intervention; 
the excess iron will start to build up in tissues and free iron rapidly catalyzes the generation of 
free radicals leading to oxidative damage, resulting in, among other, liver cancer and cirrhosis, 
diabetes and arthritis. The excess iron deposition also leads to organ and skin pigmentation. 
Next to the genetic factor, the development of this condition is also affected by an individual’s 
gender. Men have a higher risk of developing HH than women. In men iron builds up more 
quickly as male individuals do not lose iron through menstruation. Also dietary habits influence 
the prognosis of the disease. Individuals that consume iron-rich diets will suffer from iron 
overload more quickly. Also a high alcohol consumption can accelerate the buildup of iron.107, 108 
Five types of hereditary hemochromatosis have been identified in man on the basis of clinical, 
biochemical and genetic characteristics.105, 109 In 70 to 90 % of the patients, the disease is 
associated with a mutation in the HFE gene, which is located on the short arm of chromosome 6 
at location 6p22.2. This type of mutation leads to hemochromatosis type 1,107, 109, 110 the most 
common autosomal recessive disorder in Northern Europe.109 
Three HFE mutations give rise to the majority of incidences of hemochromatosis type 1. The first 
mutation results in a replacement of cysteine at position 282 by tyrosine (Cys282Tyr), the 
second in replacement of histidin at position 63 by aspartate (His63Asp) and the third in a 
replacement of serine at position 65 by cysteine (Ser65Cys). Recent reports have suggested that 
many more rare mutations in the HFE gene are possible (e.g., Gly43Ala, Leu46Trp, Val53Met, 
Gly93Arg) and that also a deletion in the chromosome region of the HFE gene could be linked to 
hereditary hemochromatosis type 1.108 As humans have two copies of all autosomal genes, 
these mutations may be present in either one, termed heterozygous occurrence, or in both 
copies, thus resulting in homozygous occurrence. When a patient is heterozygous for two or 
more mutations, this is called compound heterozygous. From the above, it is clear that 
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hemochromatosis is, both from a genetic as well as from a phenotypic point of view, a very 
heterogeneous disease. 
Patients with hemochromatosis type 1 can be treated efficiently and safely by phlebotomy. 
Initially, blood is withdrawn at a rate of 500 mL per week until the serum ferritin concentration 
drops below 50 µg L-1. Afterwards, both the amount of blood removed during such a treatment 
and the interval between two successive treatments is determined on an individual basis. The 
amount of blood ideally removed by phlebotomy is a good indication of the severity of the 
patient’s condition and is expressed as the amount of blood removed by phlebotomy per week. 
This treatment also works for most other types of hemochromatosis and should be chosen 
above the treatment with an orally administered chelator, as conventional phlebotomy has 
much lower side effects. 
Missense mutations in other genes, involved in the regulation of hepcidin release, transcription 
and biological activity, are responsible for rarer forms of adult onset hereditary 
hemochromatosis.107 Juvenile (JH) hemochromatosis or hemochromatosis type 2 is also an 
autosomal recessive disorder with a mutation in the gene for hemojuvelin, encoded by the HFE2 
gene (1q21.1).111 Hemojuvelin is the major inducer of hepcidin transcription. JH is more severe 
than hemochromatosis type 1 as iron overload will lead to organ damage before the age of 
thirty, while in hemochromatosis type 1, the pathological symptoms usually only become 
apparent in the fifth to sixth decade of life.105 According to the exact genetic mutation at the 
origin of JH, the subtypes 2A and 2B are distinguished. For both types of JH, it is well established 
that the cause of iron overload may be explained by decrease in the synthesis of hepcidin.109 In 
hemochromatosis type 3, the iron overload is similar to the HFE-related hereditary 
hemochromatosis, but here, it is the TFR2 gene (7q22) that is mutated. Transferrin receptor 2 is 
involved in iron-sensing in hepatocytes (liver cells).This disorder is the rarest of the different 
types of HH and only few TFR2 mutations have been reported until now.109 Type 4 is caused by 
mutations in the SLC40A1 gene (2q32), coding for ferroportin and has an autosomal dominant 
pattern, while the other types are recessive. It is characterized by peculiar clinical features, such 
as high serum ferritin levels combined with low or normal transferrin saturation values until the 
end stage of the disease. There may also be a mild iron-deficient anemia present in the initial 
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stage and a reduced tolerance to therapeutic phlebotomy. Hence, this kind of patients is better 
treated with an orally administered chelator. 
Early symptoms such as stiff joints and fatigue can result from a number of conditions that are 
more common than hemochromatosis. Hence, it can take long before a doctor considers the 
possible diagnosis of hemochromatosis. When suspecting hemochromatosis, a first test usually 
consists of the determination of transferrin saturation (TSAT). This value is a measure for the 
fraction of the serum iron bound to transferrin. Assuming that two iron atoms bind to one 
molecule of transferrin, the serum transferrin saturation (%) is calculated according to the 
equation below.112 
 
 
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
 
(7.1) 
An enhanced transferrin saturation value (≥ 45 %) is generally the earliest phenotypic 
biochemical indication for hemochromatosis.110 Iron is accumulated in the transferrin pool well 
ahead of iron overload in tissues and organs, which is reflected in increased serum ferritin 
levels. Although elevations in the serum ferritin concentration can have other causes 
(inflammation, obesity, alcohol abuse), the transferrin concentration is usually normal in these 
clinical settings. Hence, serum ferritin concentration and transferrin saturation provide a simple 
and reliable test to identify iron overload. However, this does not yet diagnose a person with 
hereditary hemochromatosis. 
Nowadays, the diagnosis of hemochromatosis can be made with certainty through DNA analysis. 
But DNA analysis for tracking down the mutations involved is time-consuming and the presence 
of one or more mutations only indicates a higher predisposition and does not provide an 
unequivocal diagnosis in an early or pre-symptomatic stage. A liver biopsy, which is quite 
invasive, can be used to assess the prognosis. 
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7.2.2 Anemia of Chronic Disease (ACD) 
Anemia of chronic disease (ACD)113-116 is the second most prevalent form of anemia, after 
anemia caused by iron deficiency. It occurs primarily in patients with diseases involving chronic 
immune activation and hence, it is also termed as anemia of inflammation. The degree and 
incidence of ACD during an infection is positively correlated with the degree of inflammation, 
meaning that a more advanced stage of the disease is associated with a more sustained anemia. 
Importantly, clinical practice has demonstrated that anemia may also develop very fast upon 
severe immune activation. In this case, the term “anemia of acute infection” would be more 
appropriate. But in both cases, the same deregulation of iron homeostasis appears to be at the 
source of the anemia. 
Bacteria, causing the infections, also need iron to survive and their iron-binding proteins form 
stronger complexes with iron than does human transferrin. When infected, our body will try to 
protect itself by decreased uptake by and retention of iron within cells, thus removing iron from 
the circulation. Hence, low amounts of transferrin and high amounts of ferritin will be produced. 
This leads to limited availability of iron for erythropoiesis. In addition, cytokine, a protein with 
an important role in the immune system, and acute-phase proteins, such as α-1 antitrypsin and 
α-2 macroglobulin, will negatively affect the proliferation, differentiation and growth of 
erythroid progenitor cells. And thirdly, an increase in hepcidin levels will block the migration of 
iron from the enterocytes to the circulation. Hepcidin has been suggested as a central mediator 
of iron metabolism disorders involved in the pathogenesis of anemia of chronic disease.117 
Modulation of hepcidin and ferroportin expression during infection and inflammation couples 
iron metabolism to host defense and decreases iron availability to invading pathogens. This 
response also restricts the iron supply to erythropoietic precursors.106 In contrast to anemia by 
iron deficiency there is sufficient iron present in the body but it is unavailable for iron-needing 
processes. 
For the diagnosis of ACD113, the iron status of the patient must be determined to be able to 
exclude iron-deficiency anemia. In both cases, the serum iron concentrations are low and the 
transferrin saturation is reduced. The difference between iron deficiency anemia and anemia of 
chronic disease lies in the serum ferritin and transferrin concentrations. In the case of ACD, the 
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ferritin levels are higher than normal and the transferrin levels are low, while in the case of iron-
deficiency anemia it is the other way around, ferritin levels are low and transferrin levels are 
high. A more straightforward method for identifying patients with ACD is the determination of 
the c-reactive protein (CRP) concentration. CRP is a protein, present in blood, for which the 
concentration rises as a response to inflammation. 
As mentioned above, it is of crucial importance to distinguish between anemia of chronic 
disease or anemia as a result of iron deficiency. Administering iron supplementation to patients 
with ACD can have severe consequences on their health, because the iron will be captured by 
the bacteria and not by the patient’s body. However, correction of anemia up to hemoglobin 
levels of 12 g dL-1 is associated with an improvement in the quality of life in any case.113 When 
possible, treatment of the underlying disease is the best therapeutic approach for ACD. 
 
7.3 Zn metabolism 
Zinc is a trace element that, as a building block in various enzymes, is of vital importance for all 
living organisms. In humans, zinc plays a major catalytic, structural and regulating role, such that 
it influences a large variety of biological processes. More than 20 different zinc metalloenzymes 
have been identified. Therefore, it is considered the second most important trace element – 
after Fe – in the human body.56, 118  
Zinc deficiency is mainly caused by a maladapted diet or a physiological condition that requires 
extra zinc. Conditions that influence absorption in the intestine, such as diarrhea, also 
effectuate zinc deficiency. An example of a physiological condition that requires extra zinc is 
pregnancy and also children require more zinc for their growth. In populations that uniquely or 
predominantly consume vegetable food, which contains low amount of bioavailable zinc, risks 
for zinc deficiency are sensibly higher. Such populations are not only situated in developing 
countries, but also in industrialized countries (e.g., vegetarians)119. Zinc deficiency comes with 
lagging growth, deterioration of the immune system and reproduction organs, skin disorders, 
loss of hair, diarrhea and diminished sensory perception. A well-known and easily recognizable 
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sign of zinc deficiency are the white bands or spots on finger nails, although an occasional spot 
is just an indication that the immune system has overcome an infection of any kind. 
Zinc concentration in plasma is a good indicator for zinc deficiency, but it does not give 
information on the zinc status on a cellular level. Since the human body has mechanisms for 
homeostasis for essential elements and these mechanisms are strong for an element as 
important as Zn, it can take weeks or even months before the consequences of insufficient Zn 
uptake become visible in the plasma.120 
As the metabolism of different trace metals is closely entangled, the absorption of iron and 
copper is suppressed if too much zinc is absorbed. So next to copper and iron deficiency and 
their consequential symptoms, zinc overload can also cause nausea, diarrhea, dizziness, 
vomiting, amnesia, intestinal cramps, fatigue and failing immune system. 
About 99% of the total body zinc is intracellular. Most of the zinc (85%) can be found in the 
muscles and bones. In blood, 80% of the zinc is present in the erythrocytes, while the remaining 
20% is bound non-specifically to albumin, alfa-macroglobulin and amino acids in the blood 
plasma.121, 122 There are no real zinc stores. The absorption of zinc takes place in the small 
intestine through processes that still are poorly understood. One of these uptake processes is 
not affected by the actual zinc concentration in the body. A second process is upregulated in 
case of low concentrations of the element. Absorption is believed to be greatly retarded by 
fibers and phytates; zinc from meat has a higher bioavailability due the presence of amino acids 
that enhance zinc absorption.123, 124 Also the regulatory mechanisms are poorly understood. 
Within three hours after absorption from the gastrointestinal tract into the circulation, zinc is 
taken up by liver and eventually appears in the pancreas, kidneys and other tissues. 
Chapter 8 Previous and ongoing work on natural variation in 
the isotopic composition of Cu, Fe and Zn in a biomedical 
context 
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8.1 Cu isotope ratios 
So far, studies concerning natural variation in the isotopic composition of Cu in the human body 
are rare. Before and during this PhD, only three other studies were published. 
Albarède et al. showed that there is a difference in δ65Cu values between serum and 
erythrocytes. As mentioned below for Fe, the difference must find its origin in the 
erythropoiesis, due to the redox conversions involved in this process.125 From this study, it also 
seemed that a significant gender bias was present for the Cu isotopic composition of whole 
blood and red blood cells, while the isotopic composition of serum did not show any gender-
related difference. The serum values for δ65Cu and δ56Fe overlap with the liver values.126 
Larner et al.127 stated that the Cu metabolism is less controlled in Parkinson’s disease (PD) 
patients compared to controls, but no single pathway in Cu metabolism could be identified as 
being clearly responsible for this difference. In the context of PD, further study is needed to 
determine whether a poorer control of the Cu metabolism is evident from birth, whether poorer 
control is static or exacerbates with time, and whether Cu metabolic deterioration coincides 
with the onset of PD. 
 
8.2 Fe isotope ratios 
Walczyk and von Blanckenburg were the first to report iron isotope effects in blood as well as 
gender differences.1 They have also shown that the 56Fe/54Fe isotope ratio decreases by ca. 1 ‰ 
per trophic level throughout the food chain.2 
In a recent study by Hotz et al.128, the pig model was used to confirm the hypothesis of isotope 
fractionation during intestinal uptake. Next to the confirmation of this hypothesis, it was shown 
that also during distribution of Fe between different body tissues, isotope fractionation occurs. 
Ferritin-rich organs, such as the liver, contain a larger fraction of the heavy iron isotopes 
compared to other tissues, including blood. In this paper, the possibility of a link between the 
isotopic composition of Fe and the homeostasis of this essential element was mentioned for the 
very first time. The following tracer experiment129 showed that the δ56Fe was correlated with 
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iron absorption. The actual fraction of tracer absorbed was relied on as a measure for iron 
status. There, it was also hypothesized that the iron isotopic signature of blood should correlate 
with serum ferritin concentration, which in absence of inflammation is traditionally considered 
an indicator of storage iron (cf. iron status). This correlation was tested and could be proven 
significant for one of the two test groups. 
While the Fe isotopic signature of serum overlaps with that of the liver,126 the δ56Fe value for 
erythrocytes is 1-2 ‰ lower than that for serum. This difference can only find its origin in the 
erythropoiesis.125 Red blood cells are formed in bone marrow and during their formation, redox 
reactions occur. It is probably the conversion of Fe(III) to Fe(II) that is accompanied by isotope 
fractionation. As the metabolisms of Zn and Cu are entangled with that of Fe, the difference in 
isotopic composition between serum and erythrocytes for Cu can also be attributed to these 
redox processes occurring during erythropoiesis. Zn, however, only has one possible oxidation 
state in the human body and hence, the zinc isotopic composition of serum does not differ from 
that of red blood cells. 
Krayenbuehl et al. were the first to report that the isotopic composition of Fe in blood from 
hemochromatosis patients was affected by the disease.3 In blood from hemochromatosis 
patients, the 56Fe/54Fe isotope ratio is generally increased with respect to that of the reference 
population. In other words, the blood of these patients shows an isotopic composition closer to 
the average diet.2, 3 This effect is more pronounced for patients undergoing phlebotomy 
therapy. However, this enrichment in the heavy isotope does not seem to be significant for all 
hemochromatosis patients.2, 73 In 2012 Hotz et al.130 showed that the increase in isotopic ratio, 
in response to phlebotomy reflects the movement of heavier storage iron from ferritin-rich 
organs. This study of the iron isotopic composition of blood from patients with 
hemochromatosis showed that remobilization of Fe from the storage tissues (mainly in the liver, 
bound to ferritin) is reflected in the blood iron isotopic composition. 
 
Previous and ongoing work on natural variation in the isotopic composition of Cu, Fe and Zn in a 
biomedical context | 159  
8.3 Zn isotope ratios 
Unfortunately, the literature regarding Zn isotope fractionation in animals or plants is currently 
still scarce and information on the isotopic composition of Zn in animal tissues is most often 
limited to reference materials. Nevertheless, a few studies indicate isotope fractionation for Zn 
occurring during animal metabolism. 
John et al. were the first to observe zinc isotope fractionation during uptake by the marine 
diatom Thalassiosira oceanica.131 In these organisms, a high- and a low-affinity transport system 
have been identified for Zn. Which system is used by the organism, depends on the 
concentration of Zn2+ in the environment. High-affinity Zn uptake predominates at low [Zn2+], 
while low-affinity Zn uptake prevails at high [Zn2+]. The Zn isotope ratio of the diatoms is 
correlated with the Zn transport system which it was predominantly using. At low [Zn2+], the 
diatoms are isotopically lighter by 0.2 ‰ for δ66Zn relative to the medium they are grown in. At 
high [Zn2+], this difference rises to 0.8 ‰, with intermediate values when there is significant 
uptake through both the high- and low-affinity transport systems. This preferential uptake of 
light Zn isotopes was confirmed by other studies for other diatoms and plankton.132, 133 
Existing Zn isotope ratio data for human samples are limited to blood and hair. Hair is shown to 
be depleted in the heavier isotope, but it is unclear whether this originates from Zn isotope 
fractionation within the human body or is affected by external factors, such as the use of 
shampoo.56 Zn isotopic analysis of whole blood revealed little variations, with a range from 0.3 
to 0.4 ‰ reported for δ66Zn, which is on average 0.59 ‰ higher than the isotopic signature of 
hair.72 Moreover, no significant difference in isotopic composition of Zn has been established 
between erythrocytes and whole blood, nor between males and females,56 in contrast to the 
observations for Fe.1 
As for Fe, isotopic analysis of Zn has also shown its possible utility in medical diagnosis. In cases 
wherein the outcome of isotopic analysis of Fe in whole blood was not decisive to indicate 
hemochromatosis, the isotopic composition of zinc did show a difference with respect to  the 
control group.73 
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A recent study reported Zn isotopic fractionation among diet, feces, urine and various organs 
and blood in sheep.134 The δ66Zn variability exceeds 1 ‰. The metal-rich organs, notably the 
liver and the kidneys, as well as the red blood cells, are depleted in the light isotopes of Zn 
relative to the diet, while serum, bone and muscle are enriched in these isotopes. 
Chapter 9 The reference population: natural variations in 
the Cu, Fe and Zn isotopic composition of human whole 
blood 
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9.1 Introduction 
Several research groups are currently exploring the possibility to use isotopic analysis of 
metabolically relevant mineral elements in blood or blood serum as a minimally invasive 
diagnostic means for diseases that can otherwise only be detected at a later stage of 
progression, or by more invasive methods (e.g., reference 73). 
Before isotopic analysis of metabolically relevant metals can be relied upon for diagnostic 
purposes, it is important to gain insight into the natural variation of the isotope ratios of interest 
among healthy individuals, i.e. the reference population. Gaining insight into variations within 
the reference population also implies identification of factors that may cause changes in the 
isotope ratios studied.  
 
9.2 Experimental 
In this chapter, only whole blood samples from supposedly healthy individuals have been 
analyzed for their Fe, Zn and Cu isotopic composition using MC-ICP-MS. The first 13 samples 
were taken from abstemious individuals. This group consisted of 7 males and 6 females. From 
each group 3 individuals were vegetarian and the rest was omnivorous. These first analyses 
seemed to provide reliable results based on the quality control steps described in § 6.3.3. 
Afterwards, a more extended sample collection was performed. During their practical exercise 
“venopunction”, the students of the 3rd year of Bachelor of Medicine were asked to collect the 
blood from a fellow student in the blood tubes appropriate for this research project (see § 5.3). 
As this practical exercise took place in the afternoon, the students were not abstemious. 
Eventually this resulted in a total reference population of 57 samples. When checking the 
quality of the data of all these samples, however, a few Cu results were excluded as were 
several Zn data. In this second phase of quality control, also the first 13 samples were included. 
3 data sets from omnivores were excluded because they did not show normal mass 
fractionation behavior, however, this appeared to be the case during the first measurement 
session including only the samples from abstemious individuals. The exclusion of values that do 
not follow a normal mass fractionation distribution occurred on visual basis. Some Cu and Zn 
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samples were merely excluded because there was not enough blood for a good analysis. 
Eventually Fe results were available for all 57 samples, Cu results for 53 samples and Zn results 
for 27 samples from the reference population. The results of the isotopic analysis of the whole 
blood samples from the reference population can be found in Appendix D1. The information 
provided by the questionnaires is given in Appendix D2. 
For this reference population, the influence of several factors on the isotopic composition of 
whole blood was investigated using statistics (t-tests, ANOVA, correlation tests, PCA). From the 
questionnaires, the known varying factors were gender (male versus female), diet (omnivorous 
versus vegetarian, abstemious versus not abstemious), BMI, age and blood type. 
 
9.3 Results and discussion 
9.3.1 diet 
The first factor for which the influence on the isotopic composition was investigated, was the 
diet. The reference population consisted of 50 omnivores and 7 vegetarians for Fe, 46 
omnivores and 7 vegetarians for Cu and 21 omnivores and 6 vegetarians for Zn. A distinction 
could also be made between samples obtained from abstemious individuals and non-
abstemious individuals. From the former, there are 13 samples included in the reference 
population for Cu and Fe. For Zn, only 9 samples from abstemious individuals are included. A t-
test was used to check whether or not a significant difference on the 95% confidence level 
existed between omnivores and vegetarians and between abstemious individuals and non-
abstemious individuals, respectively. 
In the case of the Cu isotope composition, there is a significant difference in isotopic 
composition between the whole blood of vegetarians with a δ65Cu of -0.29 ± 0.60 and that of 
omnivores with a δ65Cu of -0.14 ± 0.44 (p = 0.042). Omnivores show a slightly higher δ65Cu and a 
lower spread (Figure 9.1). 
The vegetarian diet contains more copper, but a lower fraction of bioavailable copper.135 In 
total, however, the vegetarian diet contains more bioavailable Cu than the omnivorous diet. 
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Hence, the human body absorbs more copper from a vegetarian diet. The differences in the 
absorbed fraction of the total dietary (bioavailable) Cu and also in the type of Cu (other isotopic 
composition in the diet) absorbed might be responsible for the difference in isotopic 
composition of whole blood between vegetarians and omnivores. But also a preferential 
excretion of one of the isotopes of Cu might contribute to this phenomenon. Which of these 
possibilities prevails cannot be deduced from this data. 
As can be seen in Figure 9.2, it was not possible to distinguish between omnivores and 
vegetarians using the Fe isotopic composition of the whole blood samples (p = 0.933 for δ56Fe 
and p = 0.991 for δ57Fe). For the whole blood samples from omnivores average δ56Fe and δ57Fe 
value of -2.71 ± 0.44 and -4.05 ± 0.63 were obtained, respectively. In the case of the vegetarians 
the whole blood samples showed an average isotopic composition of -2.67 ± 0.51 for δ56Fe and -
3.97 ± 0.78 for δ57Fe. 
 
 
Figure 9.1: Cu isotopic composition of whole blood from healthy individuals. A 
distinction is made based on dietary habits. 
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Figure 9.2: Fe isotopic composition of whole blood from healthy individuals. A 
distinction is made based on dietary habits. 
 
Results for the isotopic composition of Zn in whole blood samples from omnivores are: 0.11 ± 
0.14 for δ66Zn and 0.19 ± 0.22 for δ67Zn. From the samples from vegetarians values of 0.26 ± 
0.08 and 0.48 ± 0.0.6 were obtained for δ66Zn and δ67Zn, respectively. These results can be seen 
in Figure 9.3A. All delta values for Zn are lower for blood from omnivores than for blood of 
vegetarians (δ66Zn: p = 0.000 and δ67Zn: p = 0.000). Hence, in contrast to Fe, the isotopic 
composition of Zn in human blood is influenced by the diet. The difference in Zn isotopic 
composition between whole blood from omnivores and vegetarians is more distinct than in the 
case of the Cu isotopes. 
It needs to be noted here that the data points for the vegetarians are deviating from the 
theoretical mass fractionation line. They are plotting too high. Yet we are still confident about 
the significance of the difference in the Zn isotopic composition in whole blood between 
omnivores and vegetarians. In Figure 9.3B, the data points of the vegetarian reference 
population are shown again, together with those data for omnivores that were obtained within 
the same measurement session. In this figure, the significant difference in Zn isotopic 
composition in whole blood between omnivores and vegetarians is persistently present (δ66Zn: 
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p = 0.006 and δ67Zn: p = 0.000). If an error were to occur in the data of this measurement 
session, it would be present for all the samples. Hence, it can be concluded that the observed 
difference will for sure be present, but caution is needed when talking about the range in Zn 
isotopic composition of the whole blood samples from vegetarian individuals. 
 
  
Figure 9.3: Zn isotopic composition of whole blood from healthy individuals. A 
distinction is made based on dietary habits. A shows the total reference population, 
while B only shows the results from the one measurement session, where the 
vegetarian samples were analyzed. 
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It has been proven for a while now that enrichment in the heavy Zn isotopes occurs during the 
uptake by plants (0.08 - 0.2 ‰).56 More recently, this observation was also made by Jaouen et 
al.136 At the same time, they could observe a depletion of 0.2 ‰ when going to the next trophic 
level by comparing the Zn isotopic composition of bones of herbivores and carnivores. The 
isotopic signature for Zn in blood from omnivorous individuals relative to vegetarian individuals 
observed here supports these previous observations. 
The fact that there is a difference in isotopic composition between blood of vegetarians and 
omnivores and between different trophic levels has three possible explanations (reasoning 
adapted from that of Walczyk and von Blanckenburg, used to explain differences in Fe isotopic 
composition). (i) fractionation during uptake of Zn, (ii) preferential loss (excretion) of heavy or 
light isotopes or (iii) the blood is reflecting the isotopic composition of the diet. 
A vegetarian diet contains less bioavailable Zn, mainly due to low Zn concentration and the 
presence of phytates.123, 137 Hence, the Zn absorption from these diets will be lower and the 
metabolism will be more upregulated than is the case for people that have omnivorous diets. 
The upregulation of the Zn metabolism in vegetarian individuals could (partially) explain the 
heavier Zn isotopic composition in whole blood from vegetarians relative to that from 
omnivores if there were a preferential uptake of the lighter Zn isotopes, as seems to be the case 
from Jaouen et al.136 
Further investigation on the Zn isotopic composition in common diets was needed. Meanwhile 
the Zn isotopic composition in several common food products has been investigated.138 In 
general, vegetables, cereals and some derived products showed higher δ66Zn values, whereas a 
depletion in the heavier Zn isotopes was observed in products from animal origin, relative to 
whole blood samples (see Figure 9.4). Hence, the lower δ66Zn value observed in blood from 
omnivorous compared to vegetarian populations appears to be related with the isotopically 
light isotopic composition of Zn in food products from animal origin. Thus, a dietary effect 
seems to be reflected in the isotopic composition of Zn in human blood. This theory can be 
supported by the clearly larger spread in the delta values of Zn that were obtained for whole 
blood samples from omnivores, relative to those obtained from vegetarians. But this does not 
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exclude the possibility of fractionation during uptake of Zn in the intestine or preferential 
excretion of the heavy or light isotopes. 
 
 
Figure 9.4: δ66Zn values for food products and human blood samples.138 
 
For none of the elements investigated, a significant difference between the abstemious and the 
non-abstemious individuals could be established (p = 0.152 for δ65Cu, p = 0.467 for δ56Fe, p = 
0.649 for δ57Fe, p = 0.514 for δ66Zn and p = 0.649 for δ67Zn). The corresponding plots can be 
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found in Figure 9.5, Figure 9.6 and Figure 9.7. For Zn and Cu, only values for omnivores are 
presented, as all vegetarians but one belonged to the abstemious sampling group and the 
difference in isotopic composition of these two elements in whole blood between vegetarians 
and omnivores could give rise to a biased conclusion. The average isotopic composition of Cu, 
Fe and Zn in the whole blood samples for abstemious and non-abstemious individuals are given 
in Table 9.1. 
 
 
Figure 9.5: Cu isotopic composition of whole blood from healthy individuals. A 
distinction is made based on abstemiousness. 
 
 
Figure 9.6: Fe isotopic composition of whole blood from healthy individuals. A 
distinction is made based on abstemiousness. 
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Figure 9.7: Zn isotopic composition of whole blood from omnivorous healthy 
individuals. A distinction is made based on abstemiousness. 
 
 
Table 9.1: The Cu, Fe and Zn isotopic composition of whole blood samples. A 
distinction is made based on abstemiousness. For Cu and only the values of 
omnivores are taken into account to calculate these values. 
  abstemious 
not 
abstemious 
δ56Fe -2.73 ± 1.06 -2.70 ± 0.86 
δ57Fe -4.06 ± 0.78 -4.01 ± 1.40 
δ65Cu   0.47 ± 0.30 -0.12 ± 0.40 
δ66Zn   0.14 ± 0.22   0.11 ± 0.12 
δ67Zn   0.17 ± 0.34  0.20 ± 0.22 
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9.3.2 Gender 
A second parameter that was investigated for its influence on the isotopic composition of Cu, Fe 
and Zn in whole blood was the gender of the blood donors. For Fe, 22 males and 34 females 
were included in the reference population. For Cu, this was 19 males and 33 females and for Zn, 
9 males and 18 females. The significance of the differences between both groups on the 95 % 
confidence level was tested using a t-test. 
In Figure 9.8, the Cu isotopic composition of the whole blood samples is depicted, making a 
distinction based on the donor’s gender. The observable difference in isotopic composition of 
whole blood Cu between males and females is significant (p = 0.000). Whole blood samples 
from males show an average Cu isotopic composition of 0.00 ± 0.40 while samples from females 
have an average δ65Cu value of -0.22 ± 0.48. It seems that the effect on the isotopic composition 
of the gender is more distinct than the effect of the diet. Albarède et al.125 report a difference in 
the isotopic composition of Cu in whole blood between male (δ65Cu = 0.17 ‰) and female 
(δ65Cu = 0.01 ‰) subjects, based on a population of 50 anonymous young donors for whom no 
information on the dietary habits was collected, but whether or not the reported difference is 
significant was not mentioned. 
A possible explanation for this gender-based difference in whole blood Cu isotopic composition, 
is the fact that women have to take up more Cu from their diet than men to maintain 
homeostasis due to monthly losses of Cu through menstruation. In this work, this hypothesis 
was experimentally investigated. The results of this study are discussed in Chapter 10. 
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Figure 9.8: Cu isotopic composition of whole blood from healthy individuals. A 
distinction is made based on gender. 
 
The δ56Fe values for male and female whole blood samples are -2.86 ± 0.40 and -4.26 ± 0.60, 
respectively. For δ57Fe an average value of -2.61 ± 0.36 was obtained for the samples originating 
from males and -3.89 ± 0.54 for those from females. From these results (Figure 9.9), it can be 
seen that blood of males is enriched in the lighter isotope relative to blood of females. A t-test 
confirmed that there is a significant difference between the averages of these two groups for 
both δ56Fe (p = 0.004) and δ57Fe (p = 0.005). This observation agrees with earlier results 
reported in the literature.1-3 The lighter isotopic composition of blood from male donors relative 
to that from female donors could, like for Cu, possibly be attributed to menstruation. According 
to Hunt et al,123 female subjects need to replace 40 times more iron than male subjects to 
maintain homeostasis. This is a direct consequence of Fe excretion by menstrual blood loss. 
Walczyk and von Blanckenburg1 stated that the isotopic composition of Fe in blood is not 
primarily determined by (i) the diet, (ii) the heterogeneous distribution of Fe isotopes in the 
human body or (iii) the favored loss of a certain isotope but by (iv) the favored uptake of the 
lighter isotopes. Hence, it could be postulated that the female body needs to take up a larger 
fraction of the heavy isotopes as well to compensate for the Fe loss during menstruation. Also 
for Fe, the results of a systematic assessment of the influence of menstruation on its isotopic 
composition in blood are provided in Chapter 10. 
This reasoning may also apply to Cu with the difference that the heavier isotope is preferred 
during partial take up in the intestine, however, the other possibilities should not be excluded 
without further research. 
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Figure 9.9: Fe isotopic composition of whole blood from healthy individuals. A 
distinction is made based on gender. 
 
In case of Zn, the isotopic composition of the whole blood samples is shown in Figure 9.10. For 
the sake of clarity, only values for omnivores are plotted. The average values for the total male 
population are: 0.17 ± 0.20 for δ66Zn and 0.31 ± 0.32 for δ67Zn . For the total female population 
values of 0.13 ± 0.16 and of 0.24 ± 0.30 were obtained for δ66Zn and for δ67Zn, respectively. 
There is no significant difference between the Zn isotopic composition in whole blood from 
males compared to that from females (p = 0.315 for δ66Zn and p = 0.241 for δ67Zn). These 
observations were confirmed by a t-test. Albarède et al.125 reported very similar mean values for 
males (δ66Zn = 0.39 ‰ relative to JMC-ZnLyon. This equals δ
66Zn = 0.09 ‰ relative to IRMM-3702) 
and females (δ66Zn = 0.41 ‰ relative to JMC-ZnLyon. This equals δ
66Zn = 0.11 ‰ relative to 
IRMM-3702) and did not observe an influence of gender on the isotopic composition of Zn in 
whole blood. 
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Figure 9.10: Zn isotopic composition of whole blood from healthy individuals. A 
distinction is made based on gender (only omnivores are shown). 
 
 
9.3.3 Blood type 
The blood donors provided information on their blood type through the questionnaire. 15 
people did not know their blood type. This resulted in a reference population for comparison of 
the isotopic composition of Cu, Fe and Zn in whole blood samples from individuals with different 
blood types as shown in Table 9.2. As can be seen, the blood types O+ and A+ are well 
represented, but the rarer blood types only appear for a limited number of samples. For the B+ 
blood type, no sample was available in our pool. 
It was checked for only the A+ and O+ blood types whether or not there was a significant 
difference between the two blood types in terms of isotopic composition of Cu, Fe and Zn of 
whole blood using a t-test (p < 0.05)(see Table 9.3). The results for the other blood groups are 
also shown in the following figures for illustrative purposes, but were not included in the 
statistical tests. 
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Table 9.2: Amount of donors per blood type, forming the reference population for 
Cu, Fe and Zn isotopic analysis. 
blood 
type 
individuals in reference population 
Cu Fe Zn 
O+ 17 17 9 
O- 3 3 1 
A+ 12 15 6 
A- 3 3 3 
B+ - - - 
B- 1 1 - 
AB+ 1 1 1 
AB- 1 1 - 
 
 
Table 9.3: The isotopic composition of Cu, Fe and Zn in whole blood samples from 
individuals with blood type A+ or O+. 
  O
+ A+ 
δ65Cu -0.19 ± 0.48 -0.06 ± 0.36 
δ56Fe -2.66 ± 0.46 -2.78 ± 0.44 
δ57Fe -3.95 ±  0.70 -4.15 ± 0.64 
δ66Zn  0.18 ±  0.16  0.12 ± 0.20 
δ67Zn  0.33 ± 0.32  0.26 ± 0.40 
 
In Figure 9.11, the Cu isotopic composition of the reference population is shown, making a 
distinction based on blood type. The t-test did not reveal a significant difference between the O+ 
and the A+ blood type (p = 0.104). For Fe, the t-test provided the same result: p = 0.138 for δ56Fe 
and p = 0.106 for δ57Fe (see Figure 9.12). 
 
The reference population: natural variations in the Cu, Fe and Zn isotopic composition of human 
whole blood | 177  
 
Figure 9.11: The Cu isotopic composition of whole blood from healthy individuals. A 
distinction is made based on blood type. 
 
 
 
Figure 9.12: The Fe isotopic composition of whole blood from healthy individuals. A 
distinction is made based on blood type. 
 
The corresponding plots for Zn can be found in Figure 9.13. Also for Zn, no significant 
differences in isotopic composition between the A+- and the O+-group could be established 
using a t-test (p = 0.206 for δ66Zn and p = 0.192 for δ67Zn). 
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Figure 9.13: The Zn isotopic composition of whole blood from healthy individuals. A 
distinction is made based on blood type. 
 
Although, in this paragraph, no influence of the blood type on the isotopic composition of any of 
the investigated elements in whole blood could be established. It is not possible to draw final 
conclusions as not all blood types were represented to a sufficient extent. Hence, a more 
thorough study should be carried out to give clarity on this aspect. 
 
9.3.4 BMI 
In the questionnaire that every blood donor had to fill out, they were asked for their actual 
weight and length. From these parameters, their BMI (body mass index) was calculated using 
the equation below. 
 
 2)(
)(
mlenght
kgweight
 (9.1) 
Afterwards, potential correlations and their significance were investigated using Pearson r. The 
results from this test show that for none of the elements investigated, there is a significant 
correlation between the isotopic composition of whole blood and the BMI of the blood donor. 
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The correlation coefficients are given in Table 9.4 and the results in Figure 9.14 for Cu, Figure 
9.15 for Fe and Figure 9.16 for Zn. 
 
Table 9.4: Pearson r and the corresponding p-values for the correlation between the 
BMI and the isotopic composition of the whole blood samples of the reference 
population. 
  r p 
δ56Fe -0.044 0.746 
δ57Fe -0.039 0.774 
δ65Cu 0.134 0.335 
δ66Zn 0.215 0.281 
δ67Zn 0.162 0.419 
 
 
 
Figure 9.14: The Cu isotopic composition of whole blood from healthy individuals, 
relative to the BMI. 
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Figure 9.15: The Fe isotopic composition of whole blood from healthy individuals, 
relative to the BMI. 
 
 
 
Figure 9.16: The Zn isotopic composition of whole blood from healthy individuals, 
relative to the BMI. 
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9.3.5 Age 
A last parameter from the questionnaire for which the influence on the isotopic composition of 
the reference population can be checked was the age. However the age range was too narrow 
to evaluate this properly. The students were all between 19 and 22 years old and in the total 
reference population the age range was only 19 to 32 years of age. The influence of the age will 
be addressed again in the chapter about menstruation (Chapter 10). 
 
9.3.6 Statistics with all information 
The loading plot, resulting from Principal Component Analysis (PCA), is shown in Figure 9.17. 
Most of the information is contained in the Zn and Fe isotopic composition, as can be seen in 
the component matrix in Table 9.5. The Fe isotopic composition varies along the x-axis, and 
allows distinction between male and female subjects, while the Zn isotopic composition varies 
along the y-axis and permits distinguishing omnivores from vegetarians. The figure shows that 
based on the Cu isotopic composition, it should be possible to distinguish between vegetarians 
and omnivores, as well as between males and females, as was indeed shown in § 9.3.1 and § 
9.3.2. From the loading plot, it can be concluded that the gender of an individual has a larger 
effect on the Cu isotopic composition in whole blood than do the dietary habits. These 
conclusions are all the same as in the above paragraphs. 
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Figure 9.17: Loading plot, resulting from Principal Component Analysis with all δ-
values obtained. 
 
 
Table 9.5: The resulting component matrix from Principal Component Analysis with 
all obtained δ-values. 
  PC1 PC2 
δ56Fe 0.056 0.972 
δ57Fe 0.060 0.979 
δ65Cu -0.455 -0.732 
δ66Zn 0.957 0.088 
δ67Zn 0.954 0.167 
δ68Zn 0.935 0.139 
 
To further confirm that there is a significant difference in the isotopic composition of whole 
blood Fe between males and females, of whole blood Cu between males and females, and 
between omnivores and vegetarians, and of whole blood Zn between omnivores and 
P
C
2
 (
3
3
.5
4
2
 %
) 
PC1 (51.354 %) 
δ57Fe 
δ56Fe 
δ65Cu 
δ66Zn 
δ67Zn 
δ68Zn 
The reference population: natural variations in the Cu, Fe and Zn isotopic composition of human 
whole blood | 183  
vegetarians, two-way ANOVA was relied on to assess the influence of both gender and dietary 
habits on the isotopic composition of these three elements in whole blood. Two-way ANOVA 
revealed that there is a significant effect of the gender on the Fe isotopic composition (for δ56Fe 
p = 0.001 and for δ57Fe p = 0.000) and on the Cu isotopic composition (p = 0.000) but not on the 
Zn isotopic composition (p for δ66Zn  equals 0.651 and p for δ67Zn equals 0.517). The effect of 
the diet was significant for the Cu and Zn isotopic composition (δ56Fe : p = 0.622; δ57Fe: p = 
0.515; δ65Cu: p = 0.026; δ66Zn: p = 0.000 and δ67Zn: p = 0.000). This shows that the average Fe 
and Zn isotopic composition is indeed different between males and females, and vegetarians 
and omnivores, respectively. For the Cu isotopic composition, both gender and dietary habits 
exert an influence. Taking into account the loading plot, gender is expected to influence the 
isotopic composition of Cu in whole blood to the largest extent. 
In Figure 9.18, the score plot, corresponding to the loading plot in Figure 9.17, is shown. 
Although they are positioned close to one another, four groups seem to be distinguishable. The 
Zn isotopic composition splits the results according to diet, while the Fe isotopic composition 
discriminates according to gender. It was already mentioned above that a t-test showed that 
the differences in Fe and Zn isotopic composition between males and females and omnivores 
and vegetarians, respectively ,are significant at the 95 % confidence level. However, hierarchical 
cluster analysis was not able to recognize the four groups in this score plot; there was always an 
overlap. 
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Figure 9.18: Score plot, resulting from Principal Component Analysis with all δ-values 
obtained. All cases with δ-values for their Cu, Fe and Zn isotopic composition are 
represented here. A distinction is made based on gender and diet. 
 
When performing discriminant analysis with all δ values, the SPSS software is able to distinguish 
between the four groups (omnivorous males, omnivorous females, vegetarian males and 
vegetarian females) that are present in the reference population. Discriminant analysis is less 
critical than cluster analysis on finding these groups as you provide the information on gender 
and diet as input variables. However, if there were no actual groups to be distinguished, also 
discriminant analysis would not find any groups. Hence, it can be concluded that males and 
females and omnivores and vegetarians are indeed distinguishable based on their Cu, Fe and Zn 
isotopic composition. 
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Figure 9.19: The plot provided by SPSS as a result of discriminant analysis. A 
distinction can be made between males and females along the y-axis. While 
vegetarians and omnivores can be distinguished along the x-axis. 
 
 
9.4 Conclusion 
The Cu and Fe isotopic compositions in whole blood show to be influenced by the gender. A 
possible explanation for this might be found in the menstruation because the iron isotopic 
composition seems to be primarily determined by the favored uptake of the lighter isotopes. 
The possible relation between the Cu and Fe isotopic composition of whole blood and 
menstruation was systematically investigated in the context of this research project and is 
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reported on in Chapter 10. For Fe, the effect of upregulated or downregulated uptake in the 
intestine was also studied in more detail and will be discussed in Chapter 10. 
The Zn isotopic composition is governed by the diet, as is also the Cu isotopic composition, but 
to a lower extent. An explanation for this observation can be (i) a different isotopic composition 
of the omnivorous and the vegetarian diets, (ii) the preferential loss of one of the isotopes, (iii) a 
consequence of heterogeneous distribution of the different isotopes of these elements in the 
human body or (iv) it can just be attributed to up- or down- regulation of Cu and/or Zn uptake in 
case of one of these diets. Further research is still needed to identify the exact causes of these 
differences in the isotopic composition of whole blood but it has been shown that the Zn 
isotopic composition of blood at least partially reflects the Zn isotopic composition of the diet. 
Other parameters investigated – blood type, age and BMI – were not demonstrated to have an 
influence on the isotopic composition of any of the elements investigated. 
Most of the information is contained in the Fe and Zn isotopic composition. After PCA, it was 
not possible to distinguish between omnivorous males, omnivorous females, vegetarian males 
and vegetarian females using HCA as the four different groups were positioned too close to 
each other. When using discriminant analysis, the four groups were distinguishable, confirming 
the results from the previously conducted t-tests. Hence, it is indeed possible to distinguish 
between groups of different gender and showing different dietary habits, i.e. omnivorous versus 
vegetarian. 
Chapter 10 The influence of menstrual blood loss and age on 
the isotopic composition of Cu, Fe and Zn in human whole 
blood 
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10.1 Introduction 
The isotopic signature of Zn in whole blood seems to be governed by the diet.55 Previous 
research showed that there is a significant difference in isotopic composition of Fe and Cu 
between men and women.1, 2, 55 This observation led researchers to the hypothesis that the 
difference in isotopic composition between men en women is caused by the women’s 
menstruation. In this chapter the influence of the menstruation on the isotopic composition of 
Cu, Fe and Zn of whole blood is investigated. For this purpose two groups of non-menstruating 
women are investigated for their whole blood isotopic composition of Cu, Fe and Zn. The first 
group consists of 10 women in their menopause. However, women in the menopause are 
generally older, making it possible that the potentially observed difference in isotopic 
composition of their blood is also age related. Hence the second group of non-menstruating 
women consisted of 7 women who are not menstruating due to an intrauterine device (IUD or 
coil), in this case from the brand Mirena®. 
The menopause is the time in a woman’s life when menstrual cycles stop and the ovaries cease 
functioning. The body undergoes a variety of changes on account of this and due to aging. The 
transition from a reproductive state to a non-reproductive state is not abrupt but tends to occur 
over a period of years. During this period, called the perimenopause, the menstrual cycle 
lengths become more irregular, menstrual cycles are skipped and the amount and duration of 
blood loss declines. This is caused by the reduced secretion of the hormones estrogen and 
progesterone by the ovaries as the follicle stores are depleted. As a response to the decline in 
follicles, the follicle-stimulating hormone (FSH) concentration will rise. 
Medically the start of the menopause is defined the day after the last menstrual period, which 
can be very small and can be known with certainty only in retrospect a year or more after the 
event. On average this occurs at an age of 51 in industrialized countries. After 12 months of 
amenorrhea (absence of any spontaneous menstruation) a women is classified as in the 
postmenopause. However, the terms menopause and postmenopause are used 
interchangeably. The women in this study are not menstruating anymore and hence, can be 
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found in their postmenopause. However, in this chapter, the term menopause will be used for 
convenience. 
Due to menopause, transient symptoms (which are unpleasant and can be disabling) arise, such 
as hot flashes, urogenital problems and mood changes. The most common symptom is the hot 
flashes. They are described as a sudden onset of sensation of heat, sweating and flushing that 
occurs most often in the face and then spreads to the head, neck and chest lasting one to five 
minutes. Chills, clamminess, and anxiety also may accompany hot flashes. Urogenital problems 
are caused by physiological responses to low concentration of estrogen and androgens. 
Additional symptoms, such as anxiety, depression, mood changes, urinary incontinence and 
leakage, sleep disturbances, cognitive changes, somatic complaints and sexual dysfunction have 
been associated with the menopausal transition. Some of these symptoms are secondary to 
vasomotor and urogenital symptoms, others are related to other causes.139 There is also a direct 
relationship between the lack of estrogen after menopause and the development of 
osteoporosis.140 Osteoporosis is a disease that weakens bones, increasing the risk of sudden and 
unexpected fractures. Literally meaning "porous bone," it results in an increased loss of bone 
mass and strength. 
The frequency and intensity of the symptoms vary widely among women. Most of them manage 
these symptoms with self-care approaches , such as wearing layers of clothing, and lowering 
stress. Some women ask health providers for help to manage menopausal symptoms, especially 
frequent and severe vasomotor symptoms and vaginal dryness, which interfere with healthy 
living. By far hormone replacement therapy (HRT) is the most effective treatment currently 
available for hot flashes. There seems to be a dose-response effect, but low doses often are 
effective in controlling symptoms. Postmenopausal estrogen therapy reduces the risk for 
fractures secondary to osteoporosis.141 
The intrauterine device, used by the second group of women participating in this study, is 
Mirena®. The Mirena®-IUD is a small T-shaped silastic object, which is placed in the uterus. The 
vertical part of Mirena® contains levonorgestrel, a hormone similar to progestogen. Mirena® 
releases the hormone at an initial rate of 20 µg per day and declines to a rate of 14 µg per day 
The influence of menstrual blood loss and age on the isotopic composition of Cu, Fe and Zn in 
human whole blood | 191  
after 5 years, which is still in the range of clinical effectiveness.142 The hormonal IUD releases 
the levonorgestrel directly into the uterus and only a small amount is absorbed into the rest of 
the body, providing normal menstrual cycles. 
Levonorgestrel is a second generation synthetic progestogen and its effect is similar to the 
effect of natural progesterone. It causes the endometrium to reach a phase of rest so that it is 
not build up anymore.143 Hence, an egg cannot settle in and the women cannot get pregnant, 
however the egg can still be fertilized. The mucus in the opening to the uterus also becomes 
thicker, so that sperm cannot get through and in some women the ovulation is prevented. But 
in general, women with a Mirena® will have normal hormonal cycles with shorter and less or 
even absent bleedings.144 For the women in this study, the latter situation was the case. 
 
10.2 Experimental 
Venous blood was drawn from 10 women in their menopause and from 7 women, who are not 
menstruating because of a Mirena®-IUD. The women in their menopause have an age range of 
49 to 68 years and the women with a Mirena® are between 30 and 52 years old. The Cu, Fe and 
Zn isotopic compositions of the whole blood samples of these two groups of women are given in 
Appendix E, together with the information from the corresponding questionnaires. 
The isotopic composition of these blood samples from non-menstruating women are compared 
with the results from 29 menstruating females (aged from 19 to 32) from the reference 
population and 17 males (aged from 19 to 30) from the reference population. For these results 
the reader is referred to Chapter 9. 
After mass discrimination correction and calculation of the delta values, statistical analysis using 
the SPSS program was relied upon to identify significant differences. For a comparison between 
two groups, a t-test was used, while multiple group comparisons were realized with analysis of 
variance (ANOVA). Outliers were identified using box plots and correlations were checked for 
significance using Pearson r. 
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10.3 Results and discussion 
In Figure 10.1, the Cu isotopic composition of whole blood from (i) the reference population, (ii) 
menopausal women and (iii) women not menstruating due to a Mirena®-IUD is shown. The 
blood from non-menstruating women (menopause and Mirena®) shows a heavier Cu isotopic 
composition (δ65Cu = 0.19 ± 0.24) than the blood from menstruating women. Hence, the δ65Cu 
values are shifted towards these of males (p = 0.032). Statistics proved that the difference 
observed between menstruating and non-menstruating women is significant (p = 0.000). 
Between the two groups that make up the non-menstruating population (women in their 
menopause and women with Mirena®), no significant difference is established (p = 0.994). For 
the group of women in their menopause an average Cu isotopic composition of 0.17 ± 0.58 was 
obtained and for women with Mirena® a δ65Cu value of 0.20 ± 0.22 was established. One value 
for the Mirena®-group is an outlier, however the same conclusions are obtained with and 
without this value in the data set. 
 
 
Figure 10.1: The isotopic composition of Cu in whole blood from women in their 
menopause, women not menstruating due to a Mirena®-IUD and a reference 
population consisting of men and menstruating women. On the x-axis the isotopic 
composition is expressed as the δ65Cu value, the y-axis splits up the groups for the 
sake of clarity. 
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The results for Fe, shown in Figure 10.2 are very similar to those for Cu. Again, an apparent 
outlier seems occur in the Mirena®-group, but this value is not originating from the same blood 
sample as the outlier observed for the results from Cu isotopic analysis. Using the box plots 
however, this value was not identified as an outlier. As a result, this value was taken into 
account when performing the statistical tests. The non-menstruating women show average 
values of -2.89 ± 0.48 and -4.24 ± 0.56 for δ56Fe and δ57Fe, respectively. There is a significant 
difference in Fe isotopic composition of blood between menstruating women and non-
menstruating women (p = 0.010 for δ56Fe and p = 0.027 for δ57Fe). For the menopausal women 
(δ56Fe = -2.95 ± 0.50 and δ57Fe = -4.28 ± 0.56) and those with Mirena® (δ56Fe = -2.71 ± 0.60 and 
δ57Fe = -4.03 ± 0.88), there is a shift to lighter Fe isotopic signatures when compared to 
menstruating women, making the results overlap with those for the male reference population 
(p = 0.629 for δ56Fe and p = 0.868 for δ57Fe). Between menopausal women and the women with 
a Mirena® no significant difference was present in terms of the Fe isotopic composition in blood 
(p = 0.838 for δ56Fe and p = 0.980 for δ57Fe). 
  
Figure 10.2: The isotopic composition of Fe, expressed as δ56Fe and δ57Fe, for whole 
blood from women in their menopause, women not menstruating due to a Mirena® 
IUD and a reference population consisting of men and menstruating women. 
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Since for both Cu and Fe, the groups of menopausal women and women with Mirena® have 
indistinguishable isotopic compositions in their blood, an age effect is not expected and the 
observed difference in Cu isotopic composition between the menstruating and the non-
menstruating female population is expected to be attributable to the presence or absence of 
menstruation, together with a possible effect of time since the last menstruation, only. 
However, a possible effect of time since the last menstruation could not be checked in the 
present work as this information was not received. 
What was possible to check, was a potential correlation between the age of the women and the 
isotopic composition of the corresponding blood samples. In the case of Fe, there was no 
significant correlation between the Fe isotopic signature and age for women in their menopause 
(for δ56Fe: R = -0.280, p = 0.433; for δ57Fe: R = -0.451, p = 0.191). Hence, it can be stated that, 
when assuming that all women reach menopause at more or less the same age, women in 
menopause will have an Fe isotopic composition that doesn’t change when they age and that 
corresponds with the Fe isotopic composition of men. However, it has to be emphasized that 
this assumption is only valid for women that are not menstruating for over a year. Hence, 
women in their transition will probably show gradually decreasing delta values for Fe. Also for 
the women with a Mirena®-IUD, no significant correlation was observed between their whole 
blood Fe isotopic composition and their age (for δ56Fe: R = -0.146, p = 0.783; for δ57Fe: R = -
0.263, p = 0.615). This leads to the same conclusion as above: there is no indication that age 
affects the isotopic composition of Fe. This conclusion for the Mirena® samples is more solid 
than the conclusion for the menopause samples, since the most important difference between 
the women with a Mirena® is indeed their age. The Cu isotopic composition also did not show a 
correlation with age for any of the two groups (menopause: R = 0.528, p = 0.116; Mirena®: R = -
0.760, p = 0.079). This indicates that the Cu isotopic composition also does not seem to be age-
dependent. 
While the Cu and Fe isotopic analysis of whole blood provides similar information, Zn tells a 
different story. In Figure 10.3, the whole blood isotopic composition of Zn for women in their 
The influence of menstrual blood loss and age on the isotopic composition of Cu, Fe and Zn in 
human whole blood | 195  
menopause, women with Mirena® and the reference population is shown as δ66Zn and δ68Zn. 
The results for δ67Zn are also available, but this representation of a three-isotope plot is chosen 
for the sake of clarity. The heavy Zn isotopic signature for one of the Mirena®-group samples is 
identified as outlier and was not taken into account for statistical data treatment. Although this 
is again a value belonging to one of the Mirena® samples, this value does not originate from one 
of the samples that were identified as outlier on the basis of their Cu or Fe isotopic composition.  
There is no significant difference in the Zn isotopic composition of whole blood between 
menstruating and non-menstruating women (p = 0.337 δ66Zn and p = 0.345 for δ68Zn). Non- 
menstruating women have an average δ66Zn of 0.11 ± 0.14 and an average δ67Zn of 0.22 ± 0.28. 
Also between the results for men, on one hand, and those for the different groups of women, 
on the other, no significant difference is established (see Table 10.1). However the Zn isotopic 
signature for blood from menopausal women (δ66Zn = 0.11 ± 0.08 and δ68Zn = 0.21 ± 0.14) is 
significantly lighter than that from women with a Mirena® (δ66Zn = 0.07 ± 0.08 and δ68Zn = 0.13 
± 0.18) at the 90% confidence level. This difference can possibly be explained by the difference 
in hormonal levels in the blood of these two groups of women. For women in their menopause, 
the estrogen level is decreased, while this is not the case for women with a Mirena®. Due to the 
local delivery of low concentrations of levonorgestrel, the IUD will generally not influence the 
hormonal cycle of a woman. Hence, the focus should be on the lower hormonal levels in women 
in their menopause. 
 
Table 10.1: Resulting p-values of One-way ANOVA with a Scheffé post hoc test for 
comparing the Zn isotopic composition for the whole blood samples of reference 
males and those of reference females, menopausal women and women with 
Mirena®. 
Dependent variable group I group J p 
δ66Zn reference males reference females 0.984 
  
Mirena® 0.513 
  
menopause 0.969 
δ68Zn reference males reference females 0.997 
  
Mirena® 0.513 
    menopause 0.995 
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The observed difference in Zn isotopic composition in blood between menopausal women and 
women with a Mirena® can possibly be linked to Zn carriers in the plasma. Theoretically, Zn 
protoporphyrines could offer a potential explanation, as Zn will replace Fe in the 
protoporphyrines when heme production is inhibited by Fe deficiency. However, the women in 
this study do not show any sign of iron deficiency and the Fe isotopic composition, which is 
reflecting the iron status of an individual,145 is not correlated with the Zn isotopic composition 
(for the correlation between δ66Zn and δ56Fe: R = 0.288, p = 0.094). Hence, the Zn 
protoporphyrines can be excluded as a (major) cause for the observed difference in Zn isotopic 
composition between blood samples of women in their menopause and women with a Mirena®. 
In human blood plasma, Zn is predominantly transported by albumin and α2-macroglobulin. The 
concentrations of α2-macroglobulin are affected by estrogen concentrations.
146 As the estrogen 
concentration declines when women approach and reach menopause, this will correspondingly 
affect the α2-macroglobulin concentration.
147 We therefore hypothesize that the Zn isotope 
composition follows these well-known changes in α2-macroglobulin plasma reference values. 
 
 
Figure 10.3: The isotopic composition of Zn, expressed as δ66Zn and δ68Zn, for whole 
blood from women in their menopause, women not menstruating due to a Mirena® 
IUD and a reference population consisting of men and menstruating women. 
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10.4 Conclusions 
The isotopic composition of Cu and Fe in whole blood is significantly different between 
menstruating and non-menstruating women. Non-menstruating women – women in their 
menopause, as well as women that are not menstruating because of a Mirena®-IUD – show 
whole blood isotopic compositions of Cu and Fe that are not significantly different from those 
for men. The difference in isotopic composition of Cu and Fe between whole blood from males 
and females can thus be attributed to menstruation. For both these elements, an age effect 
seems to be absent. 
For Zn, the whole blood isotopic composition was not significantly different for men, 
menstruating women and non-menstruating women. However, a significant difference (90% 
confidence level) in whole blood Zn isotopic composition between women in their menopause 
and women that are not menstruating due to an intrauterine device was established. A possible 
explanation for this difference may lie in the decreasing α2-macroglobulin concentrations with 
menopause. 
Chapter 11 The relationship between the iron isotopic 
composition of human whole blood and iron status 
parameters 
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11.1 Introduction 
The iron metabolism and the importance of iron for the human body was described in § 7.2. 
From §7.2 it is clear that iron deficiency is one of the most common and widespread conditions 
in the world and that also iron overload is not to be taken lightly. Hence, the iron status of an 
individual is an important measure for health and tests for determining the iron status of a 
person are routinely used in patient care. The iron status of an individual gives information on 
the iron stores of the body and of the iron content of the blood. The actual serum iron 
concentration may strongly fluctuate by as much as 30 % in one day. Due to this fluctuation of 
the serum iron concentration, this is not a good indicator of iron status. Better parameters for 
iron status are more constant over time. The traditional medical parameters for iron status are: 
the serum concentrations of ferritin, transferrin and soluble transferrin receptor and transferrin 
saturation. All these parameters were already mentioned in § 7.2, describing the iron 
metabolism and § 7.2.1, describing hemochromatosis into more detail. 
 
 
Figure 11.1: Mean and standard error for serum iron concentration across 24 h of 
the day, under day and night sleep conditions. A cosine curve for the night sleep 
condition has been added to illustrate the normal circadian pattern. The asterisk (*) 
indicates the sample sets for which there is a significant difference (p < 0.05) 
between the two conditions (day sleep vs. night sleep).148 
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As previous research has shown that also the isotopic composition of Fe in blood and tissues is 
dependent on the metabolism, the study described in this chapter assessed whether Fe isotopic 
composition in whole blood provides information as to an individual’s iron status. 
 
11.2 Experimental 
Serum samples from the reference population, already described in Chapter 9, consisting of 43 
(16 males and 27 females) healthy (or at least apparently healthy) young adults (20 – 30 years) 
were analyzed for the iron status parameters. The results of the iron isotopic analysis of the 
whole blood samples were already discussed in Chapter 9. The values for the iron status 
parameters belonging to the reference samples can be found in Appendix D3.In addition to the 
reference population, also a more limited number of serum and whole blood samples from (i) 
10 patients (7 males and 3 females) treated for hemochromatosis type I (§ 7.2.1) and (ii) 5 
patients (2 males and 3 females) suffering from Anemia of Chronic Disease (ACD) (§ 7.2.2) were 
included. The delta values for Cu, Fe and Zn for these samples and the results for the iron status 
parameters can be found in Appendix F1. 
The following iron status parameters were determined in the serum samples: iron 
concentration ([Fe], µg dL-1); ferritin concentration (sFer, µg L-1); transferrin concentration (Tf, g 
L-1); soluble transferrin receptor (sTfR, mg L-1) and transferrin saturation (TSAT, %). The values of 
these parameters for the different blood samples can be found in Appendix D3. Also the C-
reactive protein (CRP) concentrations were determined to evaluate the general health 
conditions of the individuals. CRP is an acute-phase protein, the concentration of which rises in 
response to inflammation. Serum ferritin was determined by electrochemiluminescence 
immunoassay on a Modular E 170 analyzer (Roche Diagnostics). The concentration of serum 
soluble transferrin receptors (sTfR) was assayed by fixed-time immunonephelometry on a BN II 
nephelometer (Siemens, Marburg, Germany). Transferrin saturation (TSAT) was calculated from 
measurements of serum iron concentration by spectrophotometry (ferrozine method) and 
serum transferrin concentration by immunoturbidimetry using commercial reagents on a Cobas 
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6000 analyzer (Roche Diagnostics). The transferrin concentration was calibrated against the BCR 
CRM 470 reference material.149 These measurements were all carried out at the Ghent 
University Hospital. Assuming that two iron atoms bind to one molecule of transferrin, serum 
transferrin saturation (%) was calculated according to the equation below.112 
 
 
 
71.0
Lgntransferriserum
dLgironserum
TSAT

 (11.1) 
 
11.3 Results and discussion 
After all data were collected and adequately treated, the 56Fe values were plotted against the 
corresponding iron status parameters. As the iron status parameters are not normally 
distributed, potential significance of the correlation between each of the iron status parameters 
and the isotopic composition was checked using Spearman ρ (rho) (§ 6.4.6). Hence, the 
significant correlations in this study are not necessary linear. Hence, in the figures, the best-
fitting straight line as provided by excel is added for visualization purposes only. Also the 
difference between males and females (as established in previous studies with iron isotopes) 
was re-assessed at the 95 % confidence level using a t-test. After data treatment with every iron 
status parameter separately, statistical analysis was also done with all available data. 
 
11.3.1 Serum iron concentration 
Although the iron concentration ([Fe]) is not a good measure for iron status, also the potential 
link between this parameter and the Fe isotopic composition was assessed. Figure 11.2 shows 
no significant correlation (ρ = -0.284, p = 0.065) between the two parameters, as a result of 
which, no trend line is indicated. There also is no significant difference between the serum iron 
concentration in blood of male and female individuals. 
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Figure 11.2: Whole blood 56Fe (‰) as a function of serum Fe concentration (µg dL-
1). The open diamonds represent the results for the female individuals, the closed 
diamonds those for the male individuals. 
 
 
11.3.2 Serum ferritin concentration 
In Figure 11.3, the Fe isotopic composition is plotted versus the serum ferritin concentration 
(sFer). There is a significant inverse relation between the two parameters (ρ = -0.690, p = 0.000), 
while serum ferritin concentrations are significantly higher for male individuals.  
In general terms, when healthy individuals have a low serum ferritin concentration, this 
indicates a low iron status. Figure 11.3 points out that the blood of such individuals shows a 
heavier isotopic signature than the blood of individuals with high serum ferritin concentrations, 
corresponding with high iron status. In case of a low iron status, efforts of the metabolism are 
needed to upregulate the iron uptake. It has been proven that there is only partial uptake of 
iron during digesting, causing fractionation in favor of the lighter isotopes.2 Hence, it can be 
stated that when a larger fraction of the total bioavailable iron is absorbed, the portion of heavy 
isotopes will become larger, causing the iron in blood to become isotopically heavier. 
Additionally, when the iron status is low, a smaller fraction of iron will be transferred to the 
stores. Since this transfer to the storage sites favors the heavier isotope, a smaller fraction of 
the absorbed iron going to the stores, will cause a larger fraction of the heavier isotopes to 
-3.5
-3.0
-2.5
-2.0
-1.5
0 50 100 150 200

5
6
Fe
 (
‰
) 
[Fe] (µg dL-1) 
Males
Females
The relationship between the iron isotopic composition of human whole blood and iron status 
parameters | 205  
remain in the blood, making the blood of a person with low iron status isotopically heavier. As a 
third response, iron from the stores can be used to fulfill the metabolism’s needs. The iron 
originating from storage is isotopically heavier than the iron in blood.2 All three aspects work 
synergistically and explain the relation between serum ferritin concentrations and 56Fe. 
 
 
Figure 11.3: Whole blood 56Fe (‰) as a function of serum ferritin concentration (µg 
L-1). The open diamonds represent the results for the female individuals, the closed 
diamonds those for the male individuals. The trend line is the best-fitting straight 
line through the data points and is only intended as a means of visualizing the 
statistically significant trend observed. 
 
 
11.3.3 Serum transferrin concentration 
The significant relationship (ρ = 0.631, p = 0.000) between the serum transferrin concentration 
(Tf) and 56Fe is shown in Figure 11.4. As can be seen, there is also a significant difference in 
serum transferrin concentrations between male and female individuals. It can be seen that if 
the serum transferrin concentration is high, the Fe isotopic signature of the blood is heavier. 
Persons with a high transferrin concentration in their blood are generally in “need“ of additional 
iron. Their body produces more transferrin to be able to transport more iron. According to the 
above reasoning, taking up a larger fraction of bioavailable iron in the gut or making use of liver-
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stored iron and/or transferring less iron to the stores, indeed causes the heavy isotopes to be 
more abundant. 
 
Figure 11.4: Whole blood 56Fe (‰) as a function of serum transferrin level (µg L-1). 
The open diamonds represent the results for the female individuals, the closed 
diamonds those for the male individuals. The trend line is the best-fitting straight 
line through the data points and is only intended as a means of visualizing the 
statistically significant trend observed. 
 
 
11.3.4 Soluble transferrin receptor 
Also the relation between soluble transferrin concentration (sTfR) and 56Fe, shown in Figure 
11.5, is significant. (ρ = 0.423, p = 0.005). There is no significant difference in soluble transferrin 
receptor concentrations between male and female individuals, probably explained by weaker 
correlation. 
The more iron a cell needs, the higher the transferrin receptor density on its surface will be. 
Hence, also the amount of soluble transferrin receptor in blood will be higher. In agreement 
with the above results, when this iron status parameter indicates low iron status (= high sTfR), a 
heavier isotopic composition (= high 56Fe) is observed.  
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Figure 11.5: Whole blood 56Fe (‰) as a function of soluble transferrin receptor 
concentration (mg L-1). The open diamonds represent the results for the female 
individuals, the closed diamonds those for the male individuals. The trend line is the 
best-fitting straight line through the data points and is only intended as a means of 
visualizing the statistically significant trend observed. 
 
 
11.3.5 Transferrin saturation 
A person with low iron status will typically have a low serum iron concentration (= numerator) 
and high serum transferrin concentration (= denominator), resulting in a low transferrin 
saturation. On the basis of the data presented so far, It can already be predicted that a low 
transferrin saturation, which generally indicates low iron status, will coincide with higher delta 
values. The relation between transferrin saturation (TSAT) and 56Fe is show in Figure 11.6. And 
indeed, both the relation between whole blood Fe isotopic composition and this parameter (ρ = 
-0.463, p = 0.002) and the difference between male and female individuals in terms of 
transferrin saturation prove to be significant and low transferrin saturations coincide with 
heavier isotopic signatures. 
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Figure 11.6: Whole blood 56Fe (‰) as a function of serum transferrin saturation 
levels (%). The open diamonds represent the results for the female individuals, the 
closed diamonds those for the male individuals. The trend line is the best-fitting 
straight line through the data points and is only intended as a means of visualizing 
the statistically significant trend observed 
 
 
11.3.6 All iron status parameters 
Principal Component Analysis (PCA) was used to produce a loading plot that visualizes these 
relationships in terms of the information contained in the different parameters. The loading plot 
in Figure 11.7, obtained through PCA, shows that 56Fe and 57Fe contain the same information. 
Their vectors have the same magnitude and direction. The information in sFer, Tf and sTfR, 
namely the iron status, is very similar to the information obtained from the isotopic 
composition. These iron status parameters are all in the direction of the x-axis, as are the delta 
values. The serum iron concentration is not a good iron status parameter and shows no relation 
to the iron status parameters and the isotopic composition. The vector for [Fe] is perpendicular 
to the x-axis and hence, coincides with the y-axis. Then there is only the transferrin saturation 
left to discuss. This parameter’s information shows more agreement with the y-axis than with 
the x-axis. Hence, TSAT still contains some of the same information the common iron status 
parameters contain but is more related to the iron concentration in serum. This is logical as 
TSAT is calculated from [Fe]. 
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Figure 11.7: A loading plot produced through Principal Component Analysis for all 
iron status parameters, determined in the serum samples (iron concentration, 
ferritin concentration, transferrin concentration, soluble transferrin receptor 
concentration, saturation) and the isotopic composition of the whole blood samples 
(56Fe and 57Fe). 
 
Conclusively, for the reference population investigated, a low iron status agrees with a heavier 
isotopic composition of Fe in whole blood. In this context, the 56Fe value shows a significant 
relation with all of the common iron status parameters investigated. 
 
11.3.7 Patient samples 
In a second phase, also whole blood from patients suffering from either hemochromatosis type I 
or ACD were analyzed for Fe isotopic composition. These results are plotted together with the 
values for healthy individuals in a three-isotope plot in Figure 11.8 and the data for these 
samples can be found in Appendix F1. For the whole blood samples from the hemochromatosis 
patients an average δ56Fe of -2.33 ± 0.47 and an average δ57Fe of -3.43 ± 0.67 was found. For 
the patient suffering from ACD the δ56Fe and δ57Fe were -3.05 ± 0.65 and -4.29 ± 0.97, 
respectively. 
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Isotope ratios of whole blood from hemochromatosis patients plot at the “low iron status side”. 
At first sight, this might be surprising, as these patients have an extremely high iron status. 
However, if all parameters involved are taken into account, this observation makes sense. In a 
healthy individual, high iron uptake, leading to a heavier isotopic signature, occurs in case of a 
low iron status. In the case of hemochromatosis, the uptake of iron is strongly upregulated and 
hence, the metabolism acts in the same way as the metabolism of healthy individuals with low 
iron status. Therefore, the results for whole blood of hemochromatosis patients plot at the 
“high iron uptake side”. 
A recent study showed that the delta values change during phlebotomy treatment, intended to 
bring the iron stores to a normal value (checked based on the serum ferritin concentration). 
However, no correlation was found between the isotopic composition of blood and the duration 
of therapy and between the isotopic composition of blood and the amount of iron removed 
during treatment. Also after reaching normal serum ferritin concentrations, patients are still 
treated periodically by phlebotomy. On regular intervals blood is still removed. These intervals 
can be found in Appendix F2. Figure 11.9 shows the significant relation between the bleeding 
need and the Fe isotopic composition. The higher the bleeding need, or the more upregulated 
the iron uptake, the heavier the isotopic signature. The plot in Figure 11.9 only shows results for 
hemochromatosis patients who regained normal ferritin values as a result of their treatment. 
Hemochromatosis patients under treatment, who have not yet reached normal ferritin 
concentrations in their serum form a separate group with similar isotopic composition but much 
higher ferritin values. At first sight, the same trend seems to be present for this group, but this 
could not be confirmed as there were only two such samples available for study. 
Isotope ratios for blood of ACD patients plot at the “high iron status side”. Indeed, In case of 
ACD, hepcidin, which plays an important role in the regulation of human iron metabolism, is 
produced in higher amounts. Consequently, the body does not “want” iron in the blood and 
hence, the metabolism agrees with that of persons with high iron status. 
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Figure 11.8: Fe Isotopic composition of whole blood from healthy individuals (open 
diamonds), hemochromatosis patients (closed triangles) and ACD patients (closed 
squares). 
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Figure 11.9: Whole blood 56Fe (‰) as a function of bleeding need (cc week-1) for 
phlebotomy-treated hemochromatosis type 1 patients, who have reached normal 
serum ferritin concentration levels as a result of their treatment. 
 
 
11.4 Conclusions 
There is no significant relation between whole blood Fe isotopic composition and serum Fe 
concentration. This shows that the isotopic composition of Fe is not dramatically influenced by 
the typically rapid and strong fluctuations in serum Fe content, rendering the isotopic 
composition suited as a long term indicator. The iron isotopic composition of blood mainly is the 
iron isotopic composition of the Fe in the red blood cells (heme groups in hemoglobin). As only 
ca. 1 mg of the total ca. 2-4 g of body iron is replaced or lost per day, this parameter evolves 
only slowly and is therefore a long-term indicator that does not suffer from abrupt changes in 
the Fe concentration in serum. 
The isotope ratios of blood-iron show a significant relation with the iron status parameters: 
serum ferritin concentration, serum transferrin concentration, soluble transferrin receptor 
concentration and, to a lower extent, transferrin saturation. Just as the isotopic composition of 
iron, these parameters differ significantly between male and female individuals, except for 
transferrin saturation. Hence, the isotopic composition of Fe in whole blood reflects the iron 
status and the behavior of the metabolism as a reaction to this status. When the uptake is 
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upregulated and/or iron from the stores is mobilized and/or a smaller fraction of the absorbed 
iron is transferred to the storage sites, the whole blood Fe isotopic composition becomes 
heavier and vice versa. Since, during their fertile period, women generally have low iron status 
compared to men, also the previously mentioned difference in isotopic composition of whole 
blood between men and women comes down to the difference in iron status. The aberrantly 
heavy Fe isotopic signature of whole blood in hemochromatosis patients130 is a consequence of 
an extremely upregulated iron uptake. When treated with phlebotomy, this effect is further 
enhanced by an increased presence of iron coming from the storage, which is characterized by a 
heavier isotopic composition as well, in the blood. The whole blood of patients with ACD shows 
a light Fe isotopic signature, which can be seen as a consequence of a downregulated iron 
uptake, transfer of a larger amount of iron to the storage sites and no mobilization of storage 
iron to the circulation. 
Finally, it is worth mentioning that during the writing of this manuscript, Hotz et al.129 came to 
the similar conclusion that δ56Fe was correlated with iron absorption. A stable isotopic tracer 
was used and the actual fraction of tracer absorbed was relied on as a measure for iron status. 
They also hypothesized that the iron isotopic signature of blood should correlate with serum 
ferritin concentration. This correlation was tested and could be proven significant for one of the 
two test groups. The present study focused on the natural isotopic composition of blood-Fe 
without intervention of any kind, while the actual iron status was assessed according to the 
parameters typically used in a contemporary clinical context. The significant correlation 
between the serum ferritin concentration and the isotopic signature of blood was confirmed 
and, in addition, significant correlations were discovered for serum transferrin, soluble 
transferrin receptor concentration and, to a lower extent, transferrin saturation.  
Chapter 12 Is the haptoglobin phenotype reflected in the iron 
isotopic composition of blood? 
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12.1 Introduction 
Haptoglobin (Hp) is a protein present in blood plasma. Haptoglobin captures hemoglobin (Hb) 
that is released into the blood stream during hemolysis of red blood cells. By capturing free Hb, 
Hp protects against toxic effects associated with Hb and plays an important role in the iron 
recycling process. The toxicity of Hb arises from the heme iron, which can react with 
endogenous hydrogen peroxide to produce free radicals, which in turn may cause severe 
oxidative tissue damage.150 The Hp-Hb complexes are rapidly removed from the circulation by a 
specific receptor (CD163) found on macrophages.151 
The gene coding for haptoglobin is polymorphic and three major haptoglobin phenotypes can 
be distinguished: Hp 1-1, Hp 1-2 and Hp 2-2.152 These phenotypes are the result of the two 
major human Hp gene allelic forms denoted Hp1 and Hp2. The Hb binding capacity depends on 
the phenotype. Individuals with Hp 1-1 have the highest hemoglobin binding capacity; while Hp 
2-2 individuals have the lowest hemoglobin binding capacity. The Hp 1-2 phenotype is 
characterized by an intermediate binding capacity for hemoglobin. This means that Hp 1-1 
individuals are more effective in recycling iron than Hp 1-2 ones, who, on their turn, are more 
effective than Hp 2-2 individuals. 
The frequencies of Hp1 and Hp2 in populations vary worldwide depending on racial origin, but 
both have been found in every population examined to date. Since the haptoglobin phenotypes 
have been linked to several diseases, in both positive and negative aspects, the differences in 
frequency are probably the result of natural selection.153 
Since haptoglobin influences the iron homeostasis of the human body, the haptoglobin 
phenotype of all samples in the reference population was determined and compared with the 
iron isotopic composition. A relation between these two parameters could be expected as 
people with different haptoglobin phenotypes have a slightly different iron metabolism. 
 
  218 |Is the haptoglobin phenotype reflected in the iron isotopic composition of blood?  
12.2 Experimental: Hp-typing using starch gel electrophoresis 
The Hp phenotype was determined for the 57 samples that make up the reference population 
using starch gel electrophoresis of Hb-supplemented serum, followed by visualization of Hp-Hb 
bands by staining the gel with metal-enhanced peroxidase reagents. 
The serum samples obtained from the reference population were prepared by adding 10 µL of a 
Hb solution (vide infra) to 60 µL of sample. To prepare the Hb solution, heparin-treated 
peripheral blood was washed three times with approximately 5 mL of 0.15 M NaCl. This means 
that the NaCl solution was added, the sample was centrifuged for 10 minutes at 3000 rpm and 
the NaCl solution was removed again. The exact volumes of this process are not of great 
importance since no specific reactions are induced. This step only separates the red blood cells 
from the plasma. After washing, 2 mL of distilled water was added to the residue, containing the 
red blood cells. The cells are now in a hypotonic environment and hence, take up water through 
osmosis. As the cells take up more water they swell. But, they have a breaking point. The 
concentration of NaCl in the cell (0.15 M) is sufficiently higher than the concentration in distilled 
water (0 M) to lyse the cells (see Figure 12.1). This step destroys the cell membranes and hence, 
releases the Hb. To speed up this process the sample was vortexed. Afterwards it was 
centrifuged again to separate the proteins in the cytoplasm of the cell from the 
cellmembranes.154 When adding the Hb solution to the serum samples, red Hb-Hp complexes 
are formed. The fact that the compounds of interest are colored, facilitates evaluating the 
progress during the electrophoretic separation procedure. 15 to 20 µL of each sample was 
applied to a ± 3 mm² Whatman no. 3 paper.  
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Figure 12.1: The effect of a hypertonic, isotonic and hypotonic environment on red 
blood cells. 
 
Zone electrophoresis in starch gel is described by Smithies.155 The gel was prepared using 24 g of 
11.5 % hydrolyzed starch (Connaught Laboratories, Willowdale, Canada) in 200 mL of 0.1 M 
tris/citrate buffer with a pH of 8.86. The mixture is heated in a conical closed flask using a 
Bunsen burner. The flask was constantly and vigorously swirled until a homogeneous solution 
was obtained. Air bubbles were removed by applying negative pressure until the boiling stops. 
The gel is poured in a suited plastic frame, shown in Figure 12.2, and allowed to stiffen for at 
least 1 hour at 4 °C. Before use, the top of the gel is smoothened by cutting off the top layer. 
This is done by pulling a fishing wire between the top plastic plate and the middle plastic plate. 
 
 
Figure 12.2: The plastic frame used for pouring the starch gel. 
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To apply the samples onto the gel, an incision is made over the total width of the gel at ± 2 cm 
from and parallel to the bottom. The paper pieces, containing the samples are inserted into the 
incision next to each other. In this way, 15 samples can be analyzed using a single gel. The 
experimental setup for electrophoresis is shown in Figure 12.3.  A potential difference is applied 
over the gel using filter paper wads, soaked in a borate buffer (0.03 M H3BO4 and 0.012 M 
NaOH) with a pH of 8.4, and hanging into vessels also containing this running buffer, as electrical 
contacts. Electrodes are put in both buffer-containing vessels. A potential difference of 200 V, 
resulting in a current of 30-40 mA, is applied for 1-2 hours. During electrophoresis, the gel is 
protected from dehydration with a cellophane film. The arrow in Figure 12.3 indicates the 
migration direction of the Hb-Hp complexes – since the complex is negatively charged, it will 
migrate towards the positive electrode. 
 
 
Figure 12.3: The general layout of the gel electrophoresis unit. 
 
After electrophoresis, the proteins on the gel were colored to get an even better image of the 
separation. Since the Hb-Hp complexes are already red of their own, a preliminary typing was 
already performed before coloring to make sure that results were obtained even if something 
went wrong during the coloring process. The preliminary typing is typically consistent with the 
result after coloring. 
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Before coloring,  the gel was removed from the frame. To do this, the gel is freed from the 
edges of the frame using a scalpel and from the bottom using fishing wire. In order to observe 
the Hb-Hp complexes in a region of the gel where no edge-effects are present, the gel was also 
cut in half along its length in a horizontal plane by means of a fishing line. The two pieces of gel 
are separated from each other and put in a tray for coloring. In this way two copies, as also 
shown in Figure 12.5, are obtained and the middle part of the gel, that was not in contact with 
the air, the cellophane film or the frame, is visible. 
The coloring agent was prepared using 40 mg 3-amino-9-ethylcarbazole (AEC) in 10 mL N,N-
dimethylformamide (DMF). To color one gel, 5 mL of this solution was mixed with 100 mL 
acetate buffer at a pH of 4.6. The final mixture was poured onto the gel and also 4 mL of H2O2 
was added under constant but gentle shaking, after which the gel was incubated at 37 °C for 1 
h. Afterwards, the coloring agent was removed by pipetting it off and the gel was rinsed with 5 
% acetic acid. 
The band pattern, obtained after electrophoresis (and coloring) provides the basis for 
distinguishing between the three Hp phenotypes. Figure 12.4 shows a schematic representation 
of the bands corresponding to these phenotypes. In reality, the different types can be less 
obvious to recognize (Figure 12.5), certainly when the serum samples used already have a 
certain age. Even when being very careful in storing the blood samples, there is always a certain 
degradation of the proteins. This is why a few samples could not be typed, as indicated by the “-
“ symbol in Table 12.1. 
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Figure 12.4: Band distributions of Hp 1-1, Hp 2-1 and Hp 2-2 using starch gel 
electrophoresis.153 
 
 
 
Figure 12.5: One of the gels that were made during this study for phenotype 
assignment. 
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12.3 Results and discussion 
In Table 12.1, the Hp phenotypes determined for the individuals of the reference population (22 
males and 34 females) are given. The iron isotopic composition of the reference population is 
plotted per group of haptoglobin phenotype in Figure 12.6. A distinction is made between men 
and women as these two groups show a significant difference in iron isotopic composition, as 
discussed in § 9.3.2. The Fe isotopic composition per groups of haptoglobin phenotype is also 
given in  for males and females separately. 
Table 12.1: The Haptoglobin phenotype for the individuals comprising the reference 
population. “-“ indicates that the haptoglobin phenotype could not be determined 
with sufficient certainty. 
sample haptoglobin phenotype sample haptoglobin phenotype 
H001 2-2 H026 2-1 
H002 - H027 2-1 
H003 2-2 H028 2-1 
H004 1-1 H029 2-1 
H005 2-1 H030 1-1 
H006 2-1 H031 2-2 
H007 2-1 H032 1-1 
H008 2-1 H033 2-1 
H009 2-1 H034 2-2 
H010 2-2 H035 1-1 
H011 2-2 H036 2-2 
H012 2-2 H037 2-1 
H013 2-2 H038 2-1 
H014 2-2 H039 - 
H015 1-1 H040 2-1 
H016 2-1 H041 2-2 
H017 1-1 H042 2-1 
H018 1-1 H043 2-1 
H019 2-1 H044 2-1 
H020 2-2 H045 2-1 
H021 2-2 H046 2-1 
H022 2-1 H047 2-1 
H023 - H048 2-1 
H024 2-1 H049 2-1 
H025 2-1 H050 - 
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Figure 12.6: The iron isotopic composition of whole blood samples per haptoglobin 
phenotype, for men and women. 
 
 
Table 12.2: The Fe isotopic composition of the whole blood samples for the 
reference population. A distinction is made based on haptoglobin phenotype and 
gender. 
    δ56Fe δ57Fe 
Males Hp 2-2 -2.81 ± 0.48 -4.13 ± 0.82 
 
Hp 2-1 -2.86 ± 0.34 -4.31 ± 0.54 
 
Hp 1-1 -2.95 ± 0.34 -4.29 ± 0.48 
Females Hp 2-2 -2.64 ± 0.40 -3.99 ± 0.48 
 
Hp 2-1 -2.59 ± 0.26 -3.78 ± 0.60 
  Hp 1-1 -2.62 ± 0.66 -4.04 ± 0.78 
 
To test whether there are significant differences in iron isotopic composition between the 
different haptoglobin phenotypes, one-way ANOVA was performed. Data for men and women 
were treated separately. Unfortunately, no significant differences were established between 
either of the haptoglobin phenotype groups, neither for men, nor for women. Based on the link 
between the Hb polymorphism and the iron status parameters,156 on the one hand, and the link 
between the iron status parameters and the isotopic composition of Fe in whole blood (Chapter 
11), on the other, it is surprising that these data showed no effect of the Hb genotype on the 
isotopic composition of Fe in whole blood. 
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12.4 Conclusions 
This study was deemed interesting, because of the variations in haptoglobin phenotype 
frequencies in populations worldwide and the protein’s relation with human iron metabolism. 
However, no relation was found between whole blood isotopic composition and haptoglobin 
phenotype. 
Summary and conclusions 
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In this work, the natural isotopic composition of Cu, Fe and Zn in whole blood was determined 
using multi collector – inductively coupled plasma – mass spectrometry (MC-ICP-MS). The 
eventual goal was to assess the applicability of this type of analysis in medical diagnosis. The 
ideal tool for diagnosis is non-invasive and able to diagnose the disease with sufficient certainty 
and at an early stage of progression. To accomplish this, it was important in a first phase to gain 
insight in the natural variation in the isotopic compositions of Cu, Fe and Zn in human whole 
blood within a healthy population. Therefore, a reference population was sampled first. From 
this part of the study, additional information on the metabolism could be extracted. The blood 
donors did not follow any special treatment or controlled diet prior to blood collection. Hence, 
the results from this study are widely applicable. Eventually, this research involved a total of 102 
samples, 77of which were originating from healthy individuals and 25 from patients. 
Before the collection and analysis of blood samples could start, the research had to be approved 
by an ethical commission to make sure the rights of the voluntary blood donors were honored. 
The blood samples were only drawn from individuals that already needed to have blood drawn 
for other (health care related) research. The blood was collected in special blood tubes, suited 
for trace element analysis. All volunteers read and signed an informed consent. They also 
completed a questionnaire concerning their physical characteristics, dietary habits and, for the 
women, their menstruational pattern. 
A method for the high-precision isotopic analysis of Cu, Fe and Zn in human blood was 
developed. This method did not only consist of measurement and data treatment; also a 
protocol for sample digestion and target element isolation, together forming the sample 
preparation (Chapter 5) was optimized. The sample preparation was carried out in a class 10 
clean lab to avoid contamination to the largest possible extent. 
Although blood is already a solution, it still needed to be digested because the subsequent 
element isolation procedure requires the target elements to be present as free ions. The whole 
blood samples were digested by adding 7 mL of 14 M HNO3 to 3 mL of sample in a Savillex 
beaker. The beaker was put on a hotplate at 110 °C for 14 h (overnight). To see whether the 
digestion was complete, visual observation was relied upon. The digest thus obtained was put 
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on a hot plate at 95 °C and allowed to evaporate until dryness and the residue was redissolved 
in the appropriate medium for the isolation step. 
In order to obtain accurate and precise isotopic compositions, isolation of the target elements is 
required. Cu, Fe and Zn could be isolated within one run from the whole blood matrix by anion 
exchange chromatography using the commercially available resin AG MP-1. For this purpose, 
the target elements need to be present as negatively charged chlorine complexes. This is why 
the samples are redissolved in 5 mL of 8 M HCl + 0.001 % H2O2. For Cu and Fe to elute at the 
appropriate time, they have to be present in their highest oxidation states. For this purpose, an 
extra 50 µL of H2O2 was added to the samples and the mixture was allowed to stand for at least 
1 hour. In this step, a small amount of precipitation was formed. Hence, the samples were 
centrifuged before the element isolation commenced. 
For the optimization of the isolation protocol, the optimal amounts of resin and reagents had to 
be determined, as well as the acid concentrations used for the different steps in the isolation 
procedure. It is important that the target element fractions are pure and that the recovery is 
quantitative. The latter eliminates the effect of on-column fractionation, which is present in the 
case of all three target elements. For optimization of the isolation protocol, a SeronormTM Trace 
Elements Whole Blood L-3 standard was used. The final protocol used 2 mL of resin, packed in a 
Bio-Rad Poly-Prep column. The resin was cleaned with 5 mL of 7 M HNO3 and 5 mL of Milli-Q 
H2O. Then, a stopper was placed on top of the resin bed to avoid the resin from swirling up and 
the associated tailing of the different eluting fractions. Afterwards, 5 mL of 8 M HCl, 5 mL of 
Milli-Q H2O, 5 mL of 0.7 M HNO3 and again 5 mL of Milli-Q H2O were added for further cleaning 
of stopper and resin. After cleaning, the resin is conditioned using 10 mL of 8 M HCl + 0.001 % 
H2O2. The sample is loaded and first, the matrix is eluted with 8 mL of 8 M HCl + 0.001 % H2O2. 
Quantitative recoveries of pure element fractions of Cu, Fe and Zn were obtained with 12 mL of 
5M HCl + 0.001% H2O2, 7 mL of 0.6 M HCl and 8 mL of 0.7 M HNO3, successively. It was also 
shown that reuse of the resin is possible for at least three times without a loss in separation 
performance. After target element isolation, the Cu and Zn fractions were evaporated and 
redissolved in 0.7 M HNO3 two times in order to remove chlorine, which can cause the 
formation of interfering species in the plasma. 
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All isotope ratio measurements were carried out using multi-collector ICP-MS. The instrument 
used is a Thermo Scientific Neptune. The method development and validation is described in 
more detail in Chapter 6. The pure elemental fractions were diluted as to contain 1 mg L-1 of Cu, 
Fe or Zn. An internal standard was added to be able to correct for mass discrimination. For the 
Cu samples, the internal standard was Zn, also in a concentration of 1 mg L-1 and vice versa. For 
the Fe samples, Ni was used as an internal standard. For the isotope ratio measurements, the 
instrument was operated in medium resolution mode. Measuring on the interference-free 
plateau assured correct isotope ratios without influence of interferences. The method 
developed was applied to the SeronormTM standard and the results obtained were in agreement 
with previously published data for this standard. 
The isotopic composition of the blood samples is expressed as δ values, relative to standard 
reference materials the δ value of which is set as zero. For Cu, the SRM used is NIST SRM 976; 
for Fe, IRMM-014 was used and for Zn, IRMM-3702. These isotopic reference materials were 
measured as bracketing standards. Also quality control in-house standards were measured. 
These were prepared from commercially available elemental standard solutions and measured 
every 4 to 5 samples to check whether the isotopic composition obtained was still accurate. For 
Fe and Zn, the resulting δ values were also plotted on a three isotope plot to check the 
agreement of these results with the theoretical mass fractionation line. 
The δ values presented in this work are corrected for mass discrimination by offline data 
treatment. The correction was based on internal standardization using Russell’s law. Also other 
data treatment methods were tested and, in general, the results were very similar. However, 
internal standardization appeared to be the most robust and accurate method. 
In a first phase of the research, only samples from healthy individuals were analyzed to gain 
insight in the natural variation in Cu, Fe and Zn isotopic composition of whole blood within the 
reference population (Chapter 9). The potential influence of the parameters diet, gender, BMI 
and blood type on the isotopic composition was evaluated. The potential age effect was only 
evaluated later (Chapter 10), as the initial reference population offered too narrow an age 
range. 
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In case of the diet, no difference could be established for any of the three target elements 
between abstemious and non-abstemious individuals. Between omnivores and vegetarians, a 
significant difference was established in case of the whole blood Zn isotopic composition and, to 
a lower extent, also the whole blood Cu isotopic composition. Further research is still needed to 
reveal the exact causes for the difference observed but it has been shown that the Zn isotopic 
composition of whole blood at least partially reflects the Zn isotopic composition of the diet.  
When a distinction is made between donors based on their gender, a significant difference is 
observed between males and females for the isotopic composition of Cu and Fe in whole blood 
but not for that of Zn. Menstruation has often been suggested as a possible explanation for this. 
Women have to take up more Fe and Cu from their diet to maintain homeostasis. Hence, we 
realized that the isotopic composition of Fe in whole blood can possibly also be related to the 
iron status as well. To test this hypothesis, further research on the iron status and the influence 
of menstruation and age was conducted, as described in Chapter 10 and Chapter 11. 
For the other two parameters under investigation – blood type and BMI – no influence on the 
isotopic composition of Cu, Fe or Zn in human whole blood could be established. However it is 
necessary to stress in this context that not all blood types were sufficiently represented in the 
reference population. 
In general, it can be concluded from the results found for the reference population that most of 
the information is contained in the isotopic composition of Fe and Zn. It was also seen that, as 
expected because of the absence of redox reactions in the case of Zn, the spread in isotopic 
composition was lower for Zn than for Fe. The spread in the Cu isotopic composition was 
smaller than that for Fe but larger than that for Zn. This can possibly be attributed to the much 
lower concentration of Cu in the blood, compared to Fe and the presence of different oxidation 
states of Fe in the human body. 
As mentioned above, the influence of the menstruation was further investigated and the 
corresponding results are summarized in Chapter 10. For this purpose, the isotopic composition 
of Cu, Fe and Zn was determined in whole blood samples from two groups of non-menstruating 
women. The first group consisted of women in their menopause, while in the second group the 
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women were not menstruating due to an intrauterine anti-conception device (IUD) from the 
brand Mirena®. It was shown that the isotopic composition of whole blood Cu and Fe from non-
menstruating women is significantly different from that from menstruating women. Also, there 
was no significant difference in the isotopic composition of these two elements in whole blood 
between men and non-menstruating women, nor was there between the two groups of non-
menstruating women. Hence, it can be concluded that the gender-observed difference in 
isotopic composition of Cu and Fe in whole blood is indeed caused by the menstruation and the 
associated Cu and Fe losses. For Zn, no significant difference was found between menstruating 
women, non-menstruating women and men in terms of their whole blood isotopic composition. 
However, there was a significant difference between the women in their menopause and 
women that are not menstruating due to an intrauterine device. No explanation for this 
difference could be found yet. This part of the research extended the age range of the 
investigated population to an age of 68 years. Now, the effect of the age on the isotopic 
composition of Cu, Fe and Zn in whole blood was evaluated and no age effect was found for any 
of the elements under investigation. 
In Chapter 11, the assessment of a possible link between an individual’s iron status and the 
isotopic composition of Fe in whole blood is reported on. For this purpose, iron status 
parameters that are conventionally used in health care to estimate an individual’s iron status 
were determined in serum samples from the reference population. The iron concentration, 
ferritin concentration, transferrin concentration, soluble transferrin receptor concentration and 
the transferrin saturation were then compared to the Fe isotopic composition of the 
corresponding whole blood samples. The serum iron concentration, which is not a good 
indicator for the iron status, did not show a significant correlation with the Fe isotopic 
composition of the whole blood. This proves that the isotopic composition is not influenced by 
the typically rapid and strong fluctuations in serum iron concentration, rendering the isotopic 
composition suited as a long term indicator. The isotopic composition of blood-iron does show 
significant correlations with the other iron status parameters. A higher iron status comes with 
lower δ values and vice versa. This reflects the response of the body to the iron status in terms 
of iron uptake, distribution between blood and stores and mobilization of storage iron. The loss 
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of iron through the menstruation indeed causes women to have generally lower iron status than 
men. Hence, it can be said that the influence of the menstruation on the Fe isotopic 
composition mentioned above is caused by the lower iron status of menstruating women. 
Next to healthy individuals with different iron statuses, also whole blood from patients suffering 
from either hemochromatosis type I or anemia of chronic disease (ACD) were analyzed for their 
Fe isotopic composition. The former results plotted with the values of low iron status, while the 
latter plotted with the values of high iron status. By taking a closer look at the aberrant iron 
metabolism that comes with these diseases, it can be seen that the patient samples confirm the 
conclusions drawn for the reference population. Patients with hemochromatosis type I have a 
strongly upregulated iron uptake, like healthy individuals with low iron status. The metabolism 
of patients suffering from ACD tries to remove iron from the circulation by downregulating the 
iron uptake, moving more absorbed iron to the stores and by not using any iron from these 
storage sites, which is in agreement with the responses of the human body to high iron status. 
This suggests that the conclusions drawn for healthy individuals are extendable to patients with 
aberrant iron metabolism. 
As a general conclusion, it can be said that the isotopic analysis of metabolically relevant 
transition metals to serve as a diagnostic tool for diseases that influence the metabolism of 
these elements is promising. Especially for iron, relevant information, among other on the iron 
status, has been shown to be enclosed in the isotopic composition in whole blood. The results 
for the copper isotopic composition of blood were very similar, so it can be expected that also 
for this element, information on the metabolism is present. Probably, also the Cu isotopic 
composition of whole blood will show a correlation with the copper status of an individual but 
this status cannot be determined yet in health care, thus making it impossible to investigate this 
hypothesis. In general, the medical knowledge on this trace element is much more limited than 
for iron, making it more difficult to discover the metabolic background for influences of 
different parameters on the isotopic composition of Cu in whole blood and come to a 
conclusion concerning the health condition of an individual. Also for Zn, physicians are searching 
for a reliable way to determine the zinc status of an individual for already more than a decade 
and even the metabolism of this second most important trace element in the human body has 
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not been completely elucidated yet. The isotopic composition of Zn in whole blood is governed 
by external parameters (e.g., diet) and mostly the governing parameters are different from 
those for Cu and Fe. Hence, also Zn can hold important information which will be 
complementary to the information found through Fe isotopic analysis. 
It is not without reason that this research field has developed rapidly in the last years in 
research groups all over the world. This work forms the basis for future research at Ghent 
University as well. Follow-up studies will focus on, among other, the isotopic composition of 
whole blood samples from pre-symptomatic individuals with genetic mutations that indicate 
hemochromatosis. The link between the isotopic composition and the aggression of this disease 
will also be investigated. The field will also be extended to other diseases affecting transition 
metal uptake and/or excretion, such as Crohn’s disease, cholestasis, liver cirrhosis and fulminant 
liver disease. 
Samenvatting en besluit 
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In dit werk werd de natuurlijke isotopische samenstelling van Cu, Fe en Zn in volbloed bepaald 
d.m.v. multi-collector inductief gekoppeld plasma – massaspectrometrie (MC-ICP-MS). Het 
uiteindelijke doel was om de toepasbaarheid van dit type analyses voor medische diagnose in te 
schatten. Het ideale middel voor diagnose is niet-invasief en kan de ziekte in een vroeg stadium 
en met voldoende zekerheid vaststellen. Om dit te verwezenlijken, was het in een eerste fase 
belangrijk om inzicht te verwerven in de natuurlijke variaties in de isotopische samenstelling van 
Cu, Fe en Zn in menselijk volbloed binnen de gezonde populatie. Hiertoe werden eerst 
bloedstalen afgenomen van een referentiepopulatie. Uit dit deel van het onderzoek kon 
bijkomende informatie worden gewonnen over het metabolisme van deze drie 
transitiemetalen. De bloeddonoren ondergingen noch speciale behandeling noch volgden zij 
een speciaal dieet voorafgaand aan de bloedafname. Bijgevolg zijn de resultaten van dit 
onderzoek zeer ruim toepasbaar. Uiteindelijk werden in totaal 102 bloedstalen afgenomen, 
waarvan 77 afkomstig van gezonde individuen en 25 van patiënten. 
Voor overgegaan kon worden tot het verzamelen en analyseren van de bloedstalen moest dit 
onderzoeksproject goedgekeurd worden door een ethische commissie. Dit om te verzekeren dat 
de rechten van de vrijwilligers, die meewerkten aan dit onderzoek, geëerbiedigd werden. De 
bloedstalen werden genomen van individuen die al bloed moesten laten afnemen voor ander 
(medisch gerelateerd) onderzoek. Het bloed voor dit onderzoeksproject werd opgevangen in 
speciale bloedbuizen, geschikt voor spoorelementanalyse. Alle vrijwilligers hebben een 
informatie- en toestemmingsformulier gelezen en getekend. Ze werden ook gevraagd een 
vragenlijst in te vullen omtrent hun fysieke karakteristieken, hun eetgewoonten en, voor de 
vrouwen, hun menstruatiepatroon. 
Een methode voor de zeer precieze isotopische analyse van Cu, Fe en Zn werd ontwikkeld. Deze 
methode bestaat niet alleen uit het meten van de stalen en de dataverwerking. Een protocol 
voor de staalvoorbereiding (Hoofdstuk 5), bestaande uit digestie van de bloedstalen en isolatie 
van de doelelementen, werd ook geoptimaliseerd. De staalvoorbereiding werd uitgevoerd in 
een klasse 10 clean lab om contaminatie zo veel mogelijk te vermijden. 
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Hoewel bloed in wezen al een oplossing is, moeten de stalen toch nog opgelost worden. Dit is 
nodig omdat de doelelementen voor de elementisolatie in de oplossing aanwezig moeten zijn 
als vrije ionen. De volbloedstalen worden opgelost door toevoegen van 7 mL 14 M HNO3 aan 3 
mL staal in een Teflon Savillexbeker. De beker wordt voor 14 u (overnacht) op een 
verwarmplaat geplaats bij 110 °C. Het punt van volledige digestie wordt via visuele waarneming 
bepaald. De verkregen oplossing wordt op een verwarmplaat geplaatst bij 95 °C en uitgedampt 
tot alle vloeistof verwijderd is. Het residu wordt vervolgens heropgelost in een gepast medium 
voor de elementisolatiestap. 
Om accurate en precieze isotopische samenstellingen te bekomen, moet het doelelement 
geïsoleerd worden. Cu, Fe en Zn kunnen in één scheiding uit de volbloedmatrix geïsoleerd 
worden via anion uitwisselingschromatografie met het commercieel beschikbare hars AG MP-1. 
Hiervoor moeten de doelelementen aanwezig zijn in de oplossing als negatief geladen 
chloridecomplexen. Bijgevolg worden de stalen heropgelost in 5 mL 8 M HCl + 0.001 % H2O2. 
Opdat Cu en Fe op het gewenste tijdstip zouden elueren, moeten ze in de oplossing aanwezig 
zijn in hun hoogste oxidatietoestand. Hiertoe wordt een extra hoeveelheid van 50 µL H2O2 
toegevoegd aan de stalen en het mengsel blijft minimum 1 uur staan. Tijdens deze stap kan zich 
een kleine hoeveelheid neerslag vormen. Bijgevolg worden de stalen vlak voor de 
elementisolatiestap gecentrifugeerd. 
Voor het optimaliseren van de isolatieprocedure moesten de optimale hoeveelheden voor hars 
en reagentia bepaald worden, evenals de concentraties van de zuren, die gebruikt worden bij de 
verschillende stappen van de isolatieprocedure. Het is van belang dat de fracties van de 
doelelementen zuiver zijn en dat ze kwantitatief elueren. Dit laatste elimineert het effect van 
isotopische fractionatie door het hars, een fenomeen dat voor alle drie de doelelementen 
optreedt. Voor de optimalisatie van het isolatieprotocol werd gebruik gemaakt van een 
“SeronormTM Trace Elements Whole Blood L-3”-standaard. Het uiteindelijke protocol maakt 
gebruik van 2 mL hars, gepakt in een Bio-Rad Poly-Prep kolom. Het hars wordt gezuiverd met 5 
mL 7 M HNO3 en 5 mL MilliQ-H2O. Vervolgens wordt een stopper bovenop het hars geplaatst 
om te voorkomen dat het zal opwervelen tijdens het laden van het staal en de reagentia, wat 
gepaard zou gaan met piekverbreding van de eluerende fracties. Vervolgens worden hars en 
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stopper verder gezuiverd door toevoegen van 5 mL 8 M HCl, 5 mL Milli-Q H2O, 5 mL 0.7 M HNO3 
en opnieuw 5 mL Milli-Q H2O. Na verdere zuivering wordt het hars geconditioneerd met 10 mL 8 
M HCl + 0.001 % H2O2. Het staal wordt vervolgens geladen en als eerste elueert de matrix met 8 
mL 8 M HCl + 0.001 % H2O2. Achtereenvolgens worden zuivere fracties met kwantitatieve 
opbrengst voor Cu, Fe en Zn bekomen met 12 mL 5 M HCl + 0.001 % H2O2, 7 mL 0.6 M HCl en 8 
mL 0.7 M HNO3, respectievelijk. Er werd ook aangetoond dat het hars minstens drie keer 
hergebruikt kan worden zonder in te boeten aan scheidingsprestatie. Na doelelementisolatie 
worden de zuivere fracties van Cu en Zn twee maal uitgedampt en heropgelost in 0.7 M HNO3. 
Dit om residueel chloor, dat aanleiding kan geven tot vorming van interfererende species in het 
plasma, uit de oplossingen te verwijderen. 
Alle isotopische analyses werden uitgevoerd d.m.v. multi-collector ICP-MS. Het gebruikte toestel 
is de Thermo Scientific Neptune. De methodeontwikkeling en -validatie wordt in meer detail 
toegelicht in Hoofdstuk 6. De zuivere elementfracties worden verdund om Cu, Fe of Zn in een 
concentratie van 1 mg L-1 te bevatten. Om voor massadiscriminatie te kunnen corrigeren wordt 
een interne standaard toegevoegd. Voor de Cu-stalen is dat Zn, ook aanwezig in een 
concentratie van 1 mg L-1, en vice versa. Voor de Fe-stalen wordt Ni toegevoegd als interne 
standaard. De isotopische samenstelling wordt gemeten bij medium resolutie. Door te meten 
op het interferentievrije plateau kunnen correcte isotopenverhoudingen, zonder invloed van 
interferenties, verzekerd worden. De volledige methode werd toegepast op de SeronormTM-
standaard en de resultaten kwamen overeen met eerder gepubliceerde waarden voor deze 
standaard in de literatuur. 
De isotopische samenstelling van de bloedstalen wordt uitgedrukt in δ-waarden, relatief t.o.v. 
standaardreferentiematerialen waarvoor de δ-waarde gelijkgesteld is aan nul. Voor Cu wordt 
NIST SRM 976 gebruikt als standaard, terwijl dit voor Zn IRMM-3702 en voor Fe IRMM-014 is. 
Deze standaarden werden gemeten vlak voor en meteen na elk staal (“bracketing”). Daarnaast 
werden ook, na elke 4 tot 5 stalen, standaarden gemeten als kwaliteitscontrole om na te gaan of 
de verkregen isotopische samenstelling nog steeds accuraat was. Deze zijn bereid uit 
commercieel verkrijgbare standaardoplossingen van slechts 1 element. In het geval van Fe en Zn 
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konden de resulterende δ-waarden ook geplot worden op een zogenaamd drie-isotopenplot om 
na te gaan of de resultaten in overeenkomst zijn met de theoretische massafractionatielijn. 
Alle δ-waarden, die in dit werk voorgesteld worden zijn gecorrigeerd voor massadiscriminatie 
via “offline” dataverwerking. De correctie gebeurde op basis van interne standaardisatie, 
gebruik makend van de wet van Russell. Ook andere methoden voor dataverwerking werden 
getest en, in het algemeen, waren de resultaten zeer gelijkaardig. Maar toch bleek de methode 
van interne standaardisatie het meest robuust en accuraat. 
In een eerste fase van het onderzoek werden enkel bloedstalen van gezonde individuen 
onderzocht om inzicht te verwerven in de natuurlijke variaties in de Cu, Fe en Zn isotopische 
samenstelling van volbloed binnen de referentiepopulatie. (Hoofdstuk 9). De potentiële invloed 
van de parameters: dieet, geslacht, BMI en bloedgroep op de isotopische samenstelling werd 
geëvalueerd. Een potentiële invloed van de leeftijd werd pas later nagegaan (beschreven in 
Hoofdstuk 10) omdat de initiële referentiepopulatie een te nauw leeftijdsbereik vertoonde. 
In het geval van het dieet, kon voor geen van de drie targetelementen een significant verschil 
vastgesteld worden tussen nuchtere en niet-nuchtere individuen. Tussen omnivoren en 
vegetariërs werd wel een significant verschil waargenomen voor wat betreft de isotopische 
samenstelling van Zn in volbloed en, in mindere mate ook wat betreft de Cu isotopisch 
samenstelling in volbloed. Verder onderzoek is nog steeds nodig om de exacte reden achter 
deze verschillen te kunnen aanduiden maar er is reeds aangetoond dat de Zn isotopische 
samenstelling in volbloed ten minste gedeeltelijk de isotopische samenstelling van het dieet 
weerspiegelt. 
Wanneer een onderscheid gemaakt wordt tussen de bloeddonoren op het vlak van geslacht, 
kan voor de volbloedstalen een significant verschil opgemerkt worden in de isotopische 
samenstelling van Cu en Fe, maar niet van Zn. Vaak wordt de menstruatie hiervoor naar voor 
geschoven als oorzaak. Vrouwen moeten meer Fe en Cu opnemen uit hun voedsel om 
homeostase te behouden. Bijgevolg realiseerden we ons dat de ijzerstatus van een individu 
mogelijk ook gerelateerd is aan de isotopische samenstelling van Fe in volbloed. Om deze 
hypothese te testen werd verder onderzoek uitgevoerd op de invloed van de ijzerstatus 
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enerzijds en menstruatie en leeftijd anderzijds op de isotopische samenstelling. De resultaten 
van dit onderzoek kunnen teruggevonden worden in Hoofdstuk 10 en Hoofdstuk 11 
respectievelijk. 
De andere twee parameters die onderzocht werden (bloedgroep en BMI), hadden geen invloed 
op de isotopische samenstelling van Cu, Fe en Zn in volbloed. Hoewel het in deze context wel 
belangrijk is om te benadrukken dat niet alle bloedgroepen voldoende vertegenwoordigd waren 
in de referentiepopulatie. 
In het algemeen kan geconcludeerd worden vanuit de resultaten voor de referentiepopulatie 
dat de meeste informatie vervat zit in de isotopische samenstelling van Fe en Zn. Er kon ook 
waargenomen worden dat de spreiding in isotopische samenstelling van Zn minder groot was 
dan deze voor Cu en Fe. Dit was te verwachten aangezien Zn in het menselijk lichaam geen 
redoxreacties ondergaat. De spreiding in de isotopische samenstelling van Cu was kleiner dan 
deze voor Fe. Dit kan mogelijk te wijten zijn aan de veel lagere concentratie van Cu in het bloed 
in vergelijking met Fe en/of het feit dat Fe in verschillende oxidatietoestanden kan aanwezig zijn 
in het menselijk lichaam. 
Zoals hierboven reeds aangegeven, werd de invloed van de menstruatie verder onderzocht. De 
resultaten hiervan zijn terug te vinden in Hoofdstuk 10. Hiertoe werd de isotopische 
samenstelling van Cu, Fe en Zn in volbloed bepaald voor twee groepen niet-menstruerende 
vrouwen. De eerste groep bestaat uit vrouwen in de menopauze terwijl de tweede groep 
bestaat uit vrouwen die niet menstrueren als gevolg van een spiraaltje van het merk Mirena®. Er 
werd aangetoond dat de isotopische samenstelling van Cu en Fe in volbloed van niet-
menstruerende vrouwen significant verschilt van deze van menstruerende vrouwen. Bovendien, 
was er noch een significant verschil in de isotopische samenstelling van deze twee elementen in 
volbloed tussen mannen en niet-menstruerende vrouwen, noch tussen de twee groepen van 
niet-menstruerende vrouwen onderling. Bijgevolg kan geconcludeerd worden dat het 
geobserveerde verschil in de Cu en Fe isotopische samenstelling van volbloed tussen de 
geslachten inderdaad veroorzaakt wordt door de menstruatie en het hiermee geassocieerde 
verlies aan Cu en Fe. Voor Zn werd geen significant verschil gevonden tussen menstruerende, 
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niet-menstruerende vrouwen en mannen in termen van de isotopische samenstelling van 
volbloed. Er was wel een significant verschil inzake Zn isotopische samenstelling van volbloed 
tussen vrouwen in de menopauze en vrouwen die niet menstrueren door een spiraaltje. 
Hiervoor kon nog geen verklaring gevonden worden. Dit deel van het onderzoek vergrootte de 
spreiding in leeftijd tot een leeftijd van 68 jaar. Hierdoor kon het effect van de leeftijd op de 
isotopische samenstelling van volbloed alsnog nagegaan worden maar geen invloed van de 
leeftijd op de isotopische samenstelling van de drie onderzochte elementen werd gevonden. 
Hoofdstuk 11 rapporteert over de mogelijke link tussen de ijzerstatus van een individu en de 
isotopische samenstelling van Fe in volbloed. Hiertoe werden de ijzerstatusparameters, die 
routinematig gebruikt worden in de gezondheidszorg om de ijzerstatus van een persoon in te 
schatten bepaald in de serumstalen van de referentiepopulatie. De Fe-concentratie, de 
ferritineconcentratie, de transferrineconcentratie, oplosbare transferinereceptorconcentratie 
en de transferinesaturatie werden dan vergeleken met de Fe isotopische samenstelling van de 
overeenkomstige volbloedstalen. De Fe-concentratie in serum, wat eigenlijk geen goede 
indicator is voor de ijzerstatus van een individu, vertoonde geen significante correlatie met de 
isotopische samenstelling van Fe in volbloed. Dit bewijst dat de isotopische samenstelling van Fe 
in volbloed niet beïnvloed wordt door de snelle en sterke variatie in de Fe-concentratie in 
serum. Dit toont aan dat de isotopische samenstelling van Fe in volbloed en indicator is op lange 
termijn. De isotopische samenstelling van Fe in volbloed vertoont wel een significante correlatie 
met de andere ijzerstatusparameters. Een hogere ijzerstatus komt overeen met lagere δ-
waarden en vice versa. Dit reflecteert de reactie van het lichaam op de actuele ijzerstatus in 
termen van ijzeropname, verdeling van het opgenomen ijzer tussen bloed en opslagorganen, en 
de mobilisatie van opgeslagen Fe. Het verlies van Fe door menstruatie introduceert inderdaad 
een algemeen lagere ijzerstatus bij vrouwen dan bij mannen. Bijgevolg kunnen we stellen dat de 
invloed van de menstruatie op de Fe isotopische samenstelling van volbloed een gevolg is van 
deze lagere ijzerstatus bij menstruerende vrouwen. 
Naast volbloed van gezonde individuen met verschillende ijzerstatussen werd ook volbloed van 
patiënten die lijden aan hemochromatose type I of anemie door chronische ziekte (anemia of 
chronic disease, ACD) geanalyseerd voor hun Fe isotopische samenstelling. Van deze eerste 
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groep plotten de resultaten bij de stalen met een lage ijzerstatus, terwijl de laatste plotten bij 
de resultaten met een hoge ijzerstatus. Als we eens dieper ingaan op het afwijkend 
metabolisme dat met deze aandoeningen gepaard gaan, kan men inzien dat de resultaten van 
de patiëntenstalen de conclusies die getrokken werden voor de gezonde referentiepopulatie 
ondersteunen. Patiënten met hemochromatose type I vertonen een sterk verhoogde 
ijzeropname, net zoals individuen met een lage ijzerstatus. Het metabolisme van patiënten met 
ACD probeert Fe te verwijderen uit de bloedbaan door de opname van Fe te verminderen, door 
reeds geabsorbeerd Fe naar de opslagweefsels te transporteren en door geen gebruik te maken 
van reeds opgeslagen Fe, wat overeen komt met de reactie van het metabolisme op een hoge 
ijzerstatus. Dit suggereert dat de conclusies die getrokken werden voor de gezonde 
referentiepopulatie te veralgemenen zijn naar patiënten met een afwijkend ijzermetabolisme. 
Als een algemene conclusie kan gesteld worden dat de isotopische analyse van metabolisch 
relevante transitiemetalen als diagnostisch middel voor aandoeningen die het metabolisme van 
deze elementen beïnvloeden, veelbelovend is. Zeker voor Fe is het aangetoond dat relevante 
informatie, o.a. over de ijzerstatus, vervat zit in de isotopische samenstelling van dit element in 
volbloed. De resultaten voor de Cu isotopische samenstelling van volbloed waren steeds 
gelijkaardig aan deze van Fe. Bijgevolg kan het verwacht worden dat ook voor dit element 
informatie over het metabolisme aanwezig is in de isotopische samenstelling van volbloed. 
Mogelijk zal ook de isotopische samenstelling van Cu in volbloed een correlatie vertonen met de 
koperstatus van een individu. Maar de koperstatus kan nog niet worden bepaald in de 
gezondheidszorg, bijgevolg is het tot nu toe onmogelijk deze hypothese te onderzoeken. 
Algemeen is de medische kennis over dit spoorelement veel beperkter dan voor Fe. Dat maakt 
het ook moeilijker om de metabolische verklaring voor de effecten van sommige parameters op 
de Cu isotopische samenstelling in volbloed te achterhalen en uitspraken te doen over de 
gezondheidstoestand van een individu. Ook voor Zn is de medische wereld al meer dan een 
decennium op zoek naar een betrouwbare manier om de zinkstatus van een individu te bepalen 
en ook voor dit element is het metabolisme nog niet volledig opgehelderd. De isotopische 
samenstelling van Zn in volbloed blijkt beïnvloed te worden door externe parameters (bv. het 
dieet) en de meeste parameters met invloed zijn verschillend van de beïnvloedende parameters 
  246 |Samenvatting en besluit  
voor Cu en Fe. Bijgevolg kan ook de Zn isotopische samenstelling van volbloed belangrijke 
informatie bevatten, dewelke complementair is aan de informatie verkregen via Fe isotopische 
analyse van volbloed. 
Het is dan ook niet voor niets dat dit onderzoeksveld zich de laatste jaren snel heeft ontwikkeld 
in onderzoekgroepen over de hele wereld. Dit werk legde ook de basis voor toekomstig 
onderzoek aan de UGent. Verdere studies zullen zich onder andere focussen op de isotopische 
analyse van volbloedstalen afkomstig van presymptomatische individuen met één of meerdere 
mutaties indicatief voor hemochromatose. De link tussen de isotopische samenstelling en de 
ernst van de ziekte zal ook onderzocht worden. Het onderzoeksveld zal zich ook uitbreiden naar 
andere aandoeningen die de opname van transitiemetalen kunnen beïnvloeden zoals de ziekte 
van Crohn, cholestase, levercirrose en fulminant leverlijden. 
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Questionnaire 
 
 
Date: ………………………………… 
Date of birth: ........................  Place of birth: …………………………….. 
Gender:      (m)       (w) 
Length:………………m ..............  Weight: ........................ kg 
Residence place: ...................  
Profession/Study: ................. ………... ................................... 
Place of employment/school:……………………………………………………. 
 
1. Do you have stress?     (y) (n) 
2. What is your blood type? ………………….. 
3. Do you suffer from high blood pressure?  (y) (n) 
4. Do you have specific eating habits?   (y) (n) 
(Vegetarians and vegans also belong in this category) 
If yes, please describe:  ………………………………………………….. 
5. Did you emaciate a lot lately?    (y) (n) 
 
 
 
 
Appendix A2: Questionnaire non-menstruating women 
(translated from original in Dutch) 
 Appendix A2: Questionnaire non-menstruating women (translated from original in Dutch) | 263  
Questionnaire 
The influence of menstrual blood loss and age on the isotopic composition of Cu, Fe and Zn 
in human whole blood 
 
 
Date: ………………………………… 
Date of birth: .........................  
Gender:      (m)       (w) 
Length:………………m...............  Weight: ........................ kg 
 
1. What is your blood type ? ………………….. 
2. Do you have high blood pressure?    (y) (n) 
3. Do you follow a specific diet?     (y) (n) 
(Vegetarian and vegans also belong here) 
If yes, please specify: ………………………………………………….. 
4. Did you emaciate a lot lately?   (j) (n) 
5. In this part of the research three groups of women are investigated. 
To which one do you belong? 
a) normal menstruating 
b) menopause 
c) not menstruating due to a contraceptive 
if you belong to group b or c, please give an indication of the time elapsed since your last 
period: ……………………… 
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Informed consent form for participants to experiments 
 
 
1. Title of the research project 
 
Development and evaluation of methods, based on multi-collector – inductively coupled plasma - mass 
spectrometry, for high-precision isotopic analysis of Cu, Fe and Zn in human blood, applicable in medical 
diagnosis. 
 
2. Goal of the research project 
 
You have been asked to participate to a research project, organized by Ghent University in corporation 
with the Ghent University Hospital, in order to find new methods for diagnosing diseases that can 
otherwise not be diagnosed, or only with difficulty or with insufficient certainty. 
 
3. Description of the research project 
 
The concentration as well as the natural isotopic composition of 
iron, copper and zinc (Fe, Cu and Zn) will be determined in your 
blood. Isotopes are atoms of the same element (same number of 
protons in the nucleus), but with a different mass (different 
number of neutrons in the nucleus). The three elements 
investigated here have different naturally occurring isotopes. 
Hence, this research project has no relation to radioactivity. In 
the human body and actually in every chemical or physical 
reaction, the heavy or the light isotope is slightly advantaged, so 
that it can be expected that the isotopic composition will be 
different depending on the reactions that occur. Hence, blood of 
  268 |Appendix B: Informed consent (translated from original in Dutch)  
individuals that have a condition or illness that affects the metabolism of one or more of these elements 
may show an aberrant isotopic composition. In this work, the blood samples (and more specifically the 
proteins and cells in it) have to be dissolved, such that all elements are present as free cations. This is 
necessary for the subsequent isolation of Cu, Fe and Zn from the solution. Eventually three separate 
solutions of pure Cu, Fe or Zn are obtained. These pure solutions can then be measured with a mass 
spectrometer to determine the concentration and isotopic composition of these elements. A mass 
spectrometer is an instrument that can separate ions (ions are atoms that have attracted or lost one or 
more electrons – in this work positively charged ions are used) based on their mass-to-charge ratio (m/z). 
The different ions are detected separately so that it can be determined how much of each ion is present in 
the sample. In the mass spectrometer used in this work, the atoms in solution are converted to ions in the 
gas phase in a plasma. 
The results of different subgroups (age, gender, …) will be compared. This will help us to gain insight in 
normal variations in isotopic composition within the reference population. If results are significantly 
different for certain patient groups, this may be a new tool for the diagnosis of this disease. In further 
research, this information can also be used to elucidate the metabolism of the transition metals in the 
human body. 
From every participant approximately 6 mL of blood will be drawn for this research project. 
The time this will cost for the volunteer is expected to be no longer than the time for the normal blood 
collection that was already planned for clinical reasons. 
In total, 12 individuals per subgroup will participate in this research project. There will be about 10 
different subgroups, resulting in a maximum of 120 participants. 
 
4. What is expected from the participant? 
 
For the research project to be successful, it is extremely important that you are fully cooperative with the 
researcher and that you follow his/her instructions carefully. You are also asked to give permission for the 
use of the information provided through the questionnaire. Obviously this information will be treated 
anonymously. 
You also have to satisfy the following requirements: 
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- You did not emaciate a lot lately 
- You were not recently hospitalized 
- You are not taking any prescribed medication 
- You did not spend more than one month outside of Europe in the last year 
 
5. Participation and termination 
 
Participation to this research project is voluntary.  
The participation does not provide therapeutical advantage. Your participation can help to provide better 
care for future patients. 
You can refuse to participate and at any moment you can withdraw from participating to the research 
project without being obliged to give a reason and without influence on the relation with and/or 
treatment from the researcher or treating physician.  
Your participation to the research project will be terminated if the researcher believes this is in your own 
interest. You can also be rejected preliminary from the research project if you are not following the 
procedures that are described in this information form adequately or if you do not respect the items 
described. 
When participating, you are asked to sign the consent form. 
 
6. Procedures 
 
During the research project, you will be asked to fill in a questionnaire. Based on this information, it will 
be determined to which subgroup you belong. Your blood pressure will be measured and blood will be 
drawn to an amount of ~6 mL. 
 
 
 
7. Risks and benefits 
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The risks of this research project are not higher than the risks for any other venopunction. Also no 
benefits are expected for the participants through their participation. 
You have the right to ask questions at any time concerning possible and/or known risks or disadvantages 
of this research project. If information comes to light during this research project which could influence 
your preparedness to participate, you will be informed about this. If you would however suffer any 
disadvantage from your participation, you will receive proper treatment. 
This research project was approved by an independent commission for medical ethics connected to the 
Ghent University Hospital and is performed according to the guidelines for good clinical practice 
(ICH/GCP) and the statement of Helsinki, emplaced to protect volunteers participating to experiments. 
The approval of the ethical commission should by no means be considered a push to participate in this 
research project. 
 
8. Costs 
 
Your participation to this research project will not bring any extra costs for you. 
 
9. Compensation 
 
No compensation is provided for the participation to this research project. 
 
10. Confidentiality 
 
In agreement with the Belgian law of December 8, 1992 and the Belgian law of August 22, 2002, your 
privacy will be respected and you will have access to the collected data. Any incorrect data can, on your 
demand, be corrected. 
Representatives of the client, auditors, the Commission for Medical Ethics and the competent authorities 
have direct access to your file (= the questionnaire) to check the procedures of the research project or to 
check the data, without violating the confidentiality. However, this is only possible within the boundaries, 
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determined by the concerning laws. By signing the consent form after reading the information form, you 
also consent with this accessibility. 
If you agree upon participating to this research project, your personal data, collected for this research 
project, will be coded (feedback to your personal file within the hospital will stay possible). 
Reports wherein you are identified will not be openly available. If the results of this study are published in 
any way, your identity will remain confidential information. 
 
11. Injuries as a consequence of participation to the research project: 
 
The researcher will provide a compensation and/or medical treatment in case of damage and/or injury as 
a consequence of participation to the research project. For this purpose, a fault liability insurance in 
accordance with the law concerning experiments on the human person of May 7, 2004 is taken. At that 
moment, your information can be transferred to the insurer. 
 
12. Contact 
 
If you suffer of any injury as a consequence of participation to this research project, or if you wish 
additional information on this research project or about your rights and duties, you can always contact 
the following people during the course of this research project. 
 
Lana Van Heghe 
Department of Analytical Chemistry 
Ghent University 
Krijgslaan 281 – S12 
B-9000 GHENT 
Tel: +32(0)9 264 48 40 
Lana.VanHeghe@UGent.be 
 
Prof. Dr. Hans Van Vlierberghe 
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Department of Gastroenterology and Hepatology 
Ghent University Hospital 
De Pintelaan 185 – 1K12IE 
B-9000 GHENT 
Tel: +32 (0) 9 332 23 71 
Hans.VanVlierberghe@UGent.be 
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Consent form 
 
I, the undersigned, have read the document entitled “Informed consent for participants to experiments”, 
dated April 14, 2011, pages 1 to 4 and received a copy of this document. I agree with the content of the 
documents and I also agree to participate to the research project. 
 
I received a copy of this signed and dated consent form. I received an explanation about the nature, the 
goal, the duration and the foreseeable effects of the research project and about what is expected from 
me. I have received an explanation concerning possible risks and advantages accompanying the research 
project. I have had the opportunity and sufficient time to ask questions concerning the research project, 
and I have received a satisfactory response to all my questions. 
I agree to fully cooperate with the supervising researcher. I will notify him/her if I experience unusual 
symptoms. 
 
I am aware that this research project was approved by an independent Commission for Medical Ethics 
connected to the Ghent University Hospital and that this research project will be executed according to 
the guidelines for good clinical practice (ICH/GCP) and the statement of Helsinki, prepared for the 
protection of people that participate to experiments. This approval was by no means the impetus to 
decide to participate in this research project. 
I may retire from the study at any time without giving a reason for this decision and this will not in any 
way affect my further relation with the researcher. 
 
I understand that auditors, representatives of the client, the Commission for Medical Ethics or competent 
authorities will possibly want to inspect my data to control the collected information. By signing this 
document, I give permission for this. I am also aware that certain data will be transferred to the client. I 
give permission for this, even if this means that my data are passed on to a country outside of the 
European Union. At any time, my privacy will be respected. 
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I am willing to participate in this research project voluntarily. 
 
Code of the volunteer:  _________________________________________ 
 
Date:    _________________________________________ 
 
Signature: 
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I confirm that I have explained to the above volunteer: the nature, purpose, and the effects of the study 
provided. 
The volunteer agreed to participate by placing his/her personally dated signature. 
 
Name of the person who gave a preliminary explanation: ________________________ 
 
Date:       ________________________ 
 
 
Signature: 
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Afz: Commissie voor Medische Ethiek COMMISSIE VOOR MEDISCHE  
 ETHIEK 
Gastro-enterologie Voorzitter: 
Kliniekgebouw 12-E - 1ste Verdieping Prof. Dr. R. Rubens 
Prof. dr. Hans VAN VLIERBERGHE Secretaris: 
ALHIER Prof. Dr. D. Matthys 
CONTACT TELEFOON FAX E-MAIL 
Secretariaat +32 (0)9 332 56 13 +32 (0)9 332 49 62 ethisch.comite@ugent.be 
 +32 (0)9 332 59 25 
UW KENMERK ONS KENMERK  DATUM KOPIE 
 2011/276 10-mei-11 Zie "CC" 
BETREFT  
Advies voor monocentrische studie met als titel: 
Ontwikkeling en evaluatie van methoden, gebaseerd op multi-collector ICP masssaspectroscopie, voor hoge  
precisie isotopenanalyse van Zn, Fe en Cu in bloed, toepasbaar in de medische diagnostiek. 
Belgisch Registratienummer: B670201111272 
* Adviesaanvraagformulier (versie 2, dd. 18/04/2011) (volledig ontvangen dd. 19/04/2011)  
* Begeleidende brief  dd. 15/04/2011 
* Vragenlijst voor bloeddonoren dd. 14/04/2011 
* IWT-overeenkomst dd. 24/02/2010 
* Antwoord onderzoeker via mail dd. 10/05/2011 op opmerkingen EC dd. 06/05/2011 
* (Patiënten)informatie- en toestemmingsformulier  dd. 9/05/2011 
Advies werd gevraagd door: 
Prof. dr. H. VAN VLIERBERGHE ; Hoofdonderzoeker 
BOVENVERMELDE DOCUMENTEN WERDEN DOOR HET ETHISCH COMITÉ BEOORDEELD. 
ER WERD EEN POSITIEF ADVIES GEGEVEN OVER DIT PROTOCOL OP 10/05/2011. INDIEN DE STARTDATUM NA 9/05/2012 IS,  
VERVALT HET ADVIES EN MOET HET PROJECT TERUG INGEDIEND WORDEN. 
Vooraleer het onderzoek te starten dient contact te worden genomen met het Trial Bureau (09/332 05 00). 
THE ABOVE MENTIONED DOCUMENTS HAVE BEEN REVIEWED BY THE ETHICS COMMITTEE. 
A POSITIVE ADVICE WAS GIVEN FOR THIS PROTOCOL ON  10/05/2011. IF THE STARTING DATE OF THE PROTOCOL IS AFTER  
9/05/2012, THE POSITIVE ADVICE IS RECALLED AND THE PROJECT HAS TO BE SUBMITTED AGAIN TO THE ETHICS COMMITTEE. 
Before initiating the study, please contact the Trial Bureau (09/332 05 00). 
DIT ADVIES WORDT OPGENOMEN IN HET VERSLAG VAN DE VERGADERING VAN HET ETHISCH COMITE VAN  17/05/2011 
THIS ADVICE WILL APPEAR  IN THE PROCEEDINGS OF THE MEETING OF THE ETHICS COMMITTEE OF 17/05/2011 
°  Het Ethisch Comité werkt volgens 'ICH Good Clinical Practice' - regels 
°  Het Ethisch Comité beklemtoont dat een gunstig advies niet betekent dat het Comité de verantwoordelijkheid voor het onderzoek op zich neemt.  
 Bovendien dient U er over te waken dat Uw mening als betrokken onderzoeker wordt weergegeven in publicaties, rapporten voor de overheid enz., 
  die het resultaat zijn van dit onderzoek. 
°  In het kader van 'Good Clinical Practice' moet de mogelijkheid bestaan dat het farmaceutisch bedrijf en de autoriteiten inzage  krijgen van de  
 originele data. In dit verband dienen de onderzoekers erover te waken dat dit gebeurt zonder schending van de privacy van de proefpersonen. 
°  Het Ethisch Comité benadrukt dat het de promotor is die garant dient te staan voor de conformiteit van de anderstalige informatie- en  
 toestemmingsformulieren met de nederlandstalige documenten. 
°  Geen enkele onderzoeker betrokken bij deze studie is lid van het Ethisch Comité. 
°  Alle leden van het Ethisch Comité hebben dit project beoordeeld. (De ledenlijst is bijgevoegd) 
 
 
 
 
 
 
 
 
Universitair Ziekenhuis Gent Wendy Van de Velde 
De Pintelaan 185,B- 9000 Gent 09/332 56 13 
www.uzgent.be wendy.vandevelde@uzgent.be 
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CONTACT TELEFOON FAX E-MAIL 
Secretariaat +32 (0)9 332 56 13 +32 (0)9 332 49 62 ethisch.comite@ugent.be 
 +32 (0)9 332 59 25 
UW KENMERK ONS KENMERK  DATUM KOPIE 
 2011/276 10-mei-11 Zie "CC" 
Vervolg blz. 2 van het adviesformulier betreffende project EC UZG  2011/276 
°  The Ethics Committee is organized and operates according to the 'ICH Good Clinical Practice' rules. 
°  The Ethics Committee stresses that approval of a study does not mean that the Committee accepts responsibility for it. Moreover, please keep in  
 mind that your opinion as investigator is presented in the publications, reports to the government, etc., that are a result of this research. 
°  In the framework of 'Good Clinical Practice', the pharmaceutical company and the authorities have the right to inspect the original data. The  
 investigators have to assure that the privacy of the subjects is respected. 
°  The Ethics Committee stresses that it is the responsibility of the promotor to guarantee the conformity of the non-dutch informed consent forms with  
 the dutch documents. 
°  None of the investigators involved in this study is a member of the Ethics Committee. 
° All members of the Ethics Committee have reviewed this project. (The list of the members is enclosed) 
Namens het Ethisch Comité / On behalf of the Ethics Committee 
Prof. dr. R. RUBENS 
Voorzitter / Chairman 
CC: UZ Gent - Trial Bureau 
 UZ Gent - Beheer en algemene directie 
 FAGG - Research & Development;  Victor Hortaplein 40, postbus 40  1060 Brussel 
 Prof. dr. M. DE VOS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Universitair Ziekenhuis Gent Wendy Van de Velde 
De Pintelaan 185,B- 9000 Gent 09/332 56 13 
www.uzgent.be wendy.vandevelde@uzgent.be 
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sample 56Fe 57Fe 
65Cu 66Zn 67Zn 68Zn
H001 -2.752 ± 0.047 -4.255 ± 0.071 -0.052 ± 0.104 
         H002 -2.503 ± 0.044 -3.717 ± 0.084 -0.159 ± 0.027 
         H003 -2.915 ± 0.038 -4.409 ± 0.060 0.396 ± 0.030 
         H004 -3.052 ± 0.033 -4.674 ± 0.081 
            H006 -2.772 ± 0.035 -4.167 ± 0.088 -0.152 ± 0.031 
         H007 -2.543 ± 0.046 -3.926 ± 0.082 0.260 ± 0.028 
         H008 -2.804 ± 0.035 -4.492 ± 0.069 -0.044 ± 0.028 
         H009 -2.751 ± 0.032 -4.167 ± 0.060 -0.162 ± 0.025 
         H010 -2.825 ± 0.032 -4.014 ± 0.057 
   
0.074 ± 0.029 0.212 ± 0.070 0.140 ± 0.035 
H011 -2.682 ± 0.035 -4.041 ± 0.066 -0.278 ± 0.083 
         H012 -2.462 ± 0.037 -3.910 ± 0.061 
            H013 -2.467 ± 0.034 -3.567 ± 0.080 -0.261 ± 0.027 
         H014 -2.306 ± 0.035 -3.578 ± 0.064 0.001 ± 0.026 
         H015 -3.074 ± 0.031 -4.459 ± 0.061 0.154 ± 0.040 
         H016 -3.046 ± 0.031 -4.539 ± 0.068 
            H017 -2.239 ± 0.038 -3.599 ± 0.067 -0.121 ± 0.022 
         H018 -2.790 ± 0.033 -4.346 ± 0.064 -0.101 ± 0.026 
         H019 -2.772 ± 0.048 -4.126 ± 0.062 -0.232 ± 0.079 
         H020 -3.113 ± 0.023 -4.638 ± 0.047 
            H021 -2.699 ± 0.021 -4.047 ± 0.031 -0.397 ± 0.011 
         H022 -2.429 ± 0.027 -3.613 ± 0.043 -0.186 ± 0.090 
         H024 -2.719 ± 0.026 -4.050 ± 0.048 -0.266 ± 0.053 
         H025 -2.925 ± 0.025 -4.373 ± 0.044 -0.155 ± 0.118 
         H026 -2.512 ± 0.023 -3.715 ± 0.032 -0.200 ± 0.041 0.112 ± 0.030 0.180 ± 0.057 0.203 ± 0.037 
H027 -2.611 ± 0.028 -3.871 ± 0.039 -0.036 ± 0.032 
         H028 -2.916 ± 0.023 -4.298 ± 0.038 -0.157 ± 0.024 
         H029 -2.481 ± 0.022 -3.636 ± 0.034 0.037 ± 0.037 0.101 ± 0.023 0.154 ± 0.067 0.233 ± 0.043 
H030 -2.829 ± 0.021 -4.166 ± 0.035 -0.154 ± 0.035 0.095 ± 0.028 0.113 ± 0.075 0.157 ± 0.040 
H031 
         
0.218 ± 0.025 0.267 ± 0.064 0.350 ± 0.033 
H032 -2.831 ± 0.022 -4.124 ± 0.042 -0.064 ± 0.127 
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H033 -2.744 ± 0.021 -3.987 ± 0.039 -0.064 ± 0.107 0.177 ± 0.023 0.287 ± 0.060 0.335 ± 0.036 
H034 -2.882 ± 0.022 -4.264 ± 0.031 -0.401 ± 0.072 
         H036 -2.860 ± 0.016 -4.088 ± 0.015 -0.183 ± 0.019 0.185 ± 0.006 0.324 ± 0.050 0.497 ± 0.162 
H037 -2.395 ± 0.013 -3.508 ± 0.014 -0.246 ± 0.025 0.149 ± 0.023 0.197 ± 0.060 0.260 ± 0.035 
H038 -2.690 ± 0.022 -3.989 ± 0.033 -0.152 ± 0.012 0.042 ± 0.023 0.039 ± 0.071 0.073 ± 0.040 
H039 -2.929 ± 0.010 -4.329 ± 0.017 -0.004 ± 0.006 -0.011 ± 0.006 0.009 ± 0.062 0.029 ± 0.095 
H040 -2.591 ± 0.016 -3.016 ± 0.019 -0.256 ± 0.025 0.180 ± 0.006 0.601 ± 0.322 0.738 ± 0.421 
H041 -2.746 ± 0.010 -4.043 ± 0.018 0.244 ± 0.026 0.071 ± 0.002 0.181 ± 0.106 0.154 ± 0.099 
H042 -2.589 ± 0.011 -3.828 ± 0.018 -0.520 ± 0.031 0.210 ± 0.002 0.352 ± 0.059 0.426 ± 0.045 
H043 -2.524 ± 0.010 -3.758 ± 0.015 -0.376 ± 0.024 0.138 ± 0.003 0.241 ± 0.070 0.233 ± 0.037 
H044 -2.790 ± 0.009 -4.110 ± 0.015 -0.121 ± 0.030 0.092 ± 0.003 0.134 ± 0.080 0.171 ± 0.034 
H045 -2.383 ± 0.009 -3.521 ± 0.014 -0.574 ± 0.051 0.165 ± 0.008 0.433 ± 0.177 0.277 ± 0.037 
H046 -2.816 ± 0.011 -4.157 ± 0.014 0.157 ± 0.011 0.038 ± 0.004 0.128 ± 0.007 0.122 ± 0.034 
H047 -2.571 ± 0.010 -3.794 ± 0.014 -0.131 ± 0.089 0.114 ± 0.004 0.231 ± 0.127 0.210 ± 0.041 
H049 -2.448 ± 0.009 -3.593 ± 0.014 -0.288 ± 0.032 0.051 ± 0.003 0.170 ± 0.055 0.128 ± 0.035 
VV1 -2.531 ± 0.068 -3.804 ± 0.056 -0.486 ± 0.079 0.257 ± 0.031 0.467 ± 0.107 1.047 ± 0.242 
VV2 -2.611 ± 0.009 -3.750 ± 0.046 -0.291 ± 0.057 0.269 ± 0.055 0.422 ± 0.056 0.822 ± 0.140 
VV3 -2.279 ± 0.030 -3.320 ± 0.043 -0.750 ± 0.045 0.232 ± 0.030 0.493 ± 0.050 1.142 ± 0.314 
VM1 -2.969 ± 0.014 -4.406 ± 0.038 0.232 ± 0.173 0.205 ± 0.006 0.489 ± 0.005 0.820 ± 0.305 
VM2 -2.622 ± 0.040 -3.999 ± 0.027 -0.208 ± 0.201 0.307 ± 0.027 0.509 ± 0.085 0.708 ± 0.032 
VM3 -3.016 ± 0.005 -4.450 ± 0.013 -0.221 ± 0.035 0.298 ± 0.030 0.501 ± 0.163 0.736 ± 0.261 
OV1 -2.540 ± 0.070 -3.846 
 
0.013 -0.142 
 
0.090 0.103 ± 0.007 0.261 ± 0.077 0.861 ± 0.295 
OV2 -2.759 ± 0.063 -4.305 ± 0.031 0.174 ± 0.027 0.036 ± 0.034 0.016 ± 0.077 0.013 ± 0.024 
OV5 -2.645 ± 0.008 -3.804 ± 0.060 -0.094 ± 0.056 0.189 ± 0.033 0.307 ± 0.062 0.776 ± 0.213 
OM1 -3.265 ± 0.034 -4.820 ± 0.054 0.087 ± 0.017 0.137 ± 0.021 0.143 ± 0.097 0.189 ± 0.025 
OM2 -2.497 ± 0.075 -3.839 ± 0.067 -0.119 ± 0.168 0.250 ± 0.023 0.351 ± 0.117 0.435 ± 0.016 
OM3 -2.810 ± 0.011 -4.281 ± 0.014 -0.282 ± 0.019 0.256 ± 0.040 0.341 ± 0.011 0.748 ± 0.333 
OM4 -2.900 ± 0.011 -4.167 ± 0.078 0.056 ± 0.220 0.133 ± 0.060 0.235 ± 0.063 0.657 ± 0.176 
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sample age gender BMI blood type diet 
H001 20 ♀ 19.13 O+ omnivore 
H002 22 ♀ 18.81 
 
omnivore 
H003 20 ♂ 25.13 
 
omnivore 
H004 20 ♂ 20.09 A+ omnivore 
H006 20 
 
24.22 A+ omnivore 
H007 20 ♂ 20.90 O+ omnivore 
H008 21 ♂ 20.52 
 
omnivore 
H009 19 ♀ 21.26 O- omnivore 
H010 20 ♂ 27.78 A+ omnivore 
H011 20 ♀ 22.77 A+ vegetarian 
H012 20 ♀ 23.53 A+ omnivore 
H013 20 ♂ 23.30 A+ omnivore 
H014 19 ♀ 21.01 AB+ omnivore 
H015 20 ♂ 21.15 A+ omnivore 
H016 20 ♂ 22.92 
 
omnivore 
H017 20 ♀ 18.78 AB- omnivore 
H018 20 ♀ 20.70 O+ omnivore 
H019 20 ♀ 21.45 O+ omnivore 
H020 20 ♂ 23.50 
 
omnivore 
H021 20 ♀ 19.05 O omnivore 
H022 51 ♀ 25.47 A+ omnivore 
H024 20 ♀ 20.82 A omnivore 
H025 20 ♂ 17.92 A+ omnivore 
H026 20 ♀ 20.18 
 
omnivore 
H027 20 ♀ 20.57 
 
omnivore 
H028 22 ♂ 21.39 A+ omnivore 
H029 20 ♀ 20.57 A- omnivore 
H030 20 ♀ 20.57 A- omnivore 
H031 20 ♀ 21.22 AB+ omnivore 
H032 19 ♂ 16.42 O+ omnivore 
H033 20 ♂ 23.84 
 
omnivore 
H034 20 ♀ 24.11 B- omnivore 
H036 20 ♀ 21.19 O+ omnivore 
H037 20 ♀ 21.72 O+ omnivore 
H038 22 ♀ 22.99 O+ omnivore 
H039 20 ♀ 18.56 A- omnivore 
H040 25 ♀ 
 
O- omnivore 
H041 21 ♂ 23.63
 
omnivore 
H042 20 ♀ 20.18 
 
omnivore 
H043 20 ♀ 19.38 O+ omnivore 
H044 20 ♀ 19.53 
 
omnivore 
H045 20 ♀ 22.66 O+ omnivore 
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H046 20 ♂ 20.31 A+ omnivore 
H047 20 ♀ 18.78 A+ omnivore 
H049 20 ♀ 21.33 O- omnivore 
VV1 21 ♀ 20.20 O+ vegetarian 
VV2 27 ♀ 19.96 O+ vegetarian 
VV3 32 ♀ 22.59 A+ vegetarian 
VM1 30 ♂ 26.17 O+ vegetarian 
VM2 26 ♂ 23.66 A+ vegetarian 
VM3 27 ♂ 19.87 
 
vegetarian 
OV1 25 ♀ 21.09 O+ omnivore 
OV2 24 ♀ 21.71 A+ omnivore 
OV5 25 ♀ 26.73 O+ omnivore 
OM1 26 ♂ 27.47 O+ omnivore 
OM2 26 ♂ 40.12 
 
omnivore 
OM3 25 ♂ 23.45 O- omnivore 
OM4 28 ♂ 23.04 O+ omnivore 
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sample Ferr (µg L-1) [Fe] (µg dL-1) Tf (g L-1) sTfR (mg L-1) TSAT (%) 
H001 60.29 92.8 2.83 1.24 26.44 
H002 60.51 121.8 3.34 0.95 29.41 
H003 199.60 108.8 2.46 1.10 35.67 
H004 209.00 92.4 2.35 0.83 31.71 
H006 45.46 83.0 3.29 1.34 20.35 
H007 59.65 130.3 2.92 1.30 35.99 
H008 95.41 109.3 2.19 1.49 40.25 
H009 44.70 97.7 2.69 1.56 29.29 
H010 222.60 50.7 2.46 1.27 16.62 
H011 20.75 62.8 2.99 1.01 16.94 
H012 33.17 62.7 3.38 1.27 14.96 
H013 11.26 57.5 4.10 1.71 11.31 
H014 35.77 72.1 2.75 1.23 21.14 
H015 325.50 154.4 2.31 1.27 53.90 
H016 186.30 96.1 2.80 1.25 27.68 
H017 102.90 34.7 4.10 1.52 6.83 
H018 128.70 94.2 3.12 0.88 24.35 
H019 48.68 67.6 3.71 1.06 14.69 
H020 254.70 113.7 3.34 1.08 27.45 
H021 29.72 76.8 4.02 1.13 15.41 
H022 35.50 106.3 3.56 1.11 24.08 
H024 59.76 144.2 3.29 1.29 35.35 
H025 84.90 119.9 2.98 1.38 32.45 
H026 15.42 151.0 4.14 1.90 29.41 
H027 45.76 86.9 4.14 1.51 16.93 
H028 131.10 116.5 2.97 0.97 31.63 
H029 26.31 156.4 3.96 1.39 31.85 
H030 120.90 169.8 3.22 1.05 42.53 
H031 61.92 52.4 3.76 1.08 11.24 
H032 93.75 117.2 2.63 1.08 35.94 
H033 84.20 81.1 3.36 0.98 19.47 
H034 17.70 38.4 2.78 1.46 11.14 
H036 48.67 96.9 3.18 1.19 24.57 
H037 31.09 75.3 3.34 1.20 18.18 
H038 71.97 58.7 4.49 1.18 10.54 
H039 93.26 112.1 2.72 1.13 33.24 
H040 32.59 106.6 3.03 1.35 28.37 
H041 99.93 127.8 3.04 1.26 33.90 
H042 14.57 38.3 3.83 1.81 8.06 
H043 22.07 89.0 4.02 1.26 17.85 
H044 95.66 145.2 2.81 0.78 41.67 
H045 22.53 128.5 4.40 1.44 23.55 
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H046 66.16 136.8 3.18 1.16 34.69 
H047 14.20 107.2 3.09 1.31 27.98 
H049 14.50 46.2 3.84 1.52 9.70 
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sample age BMI Group 56Fe 57Fe 
65Cu 66Zn 67Zn 68Zn 
H051 62 32.85 menopause -3.064 ± 0.343 -4.374 ± 0.377 
 
0.103 ± 0.018 0.298 ± 0.043 0.210 ± 0.017 
H052 63 26.23 menopause -2.834 ± 0.089 -4.192 ± 0.085 0.326 ± 0.026 0.061 ± 0.020 0.210 ± 0.051 0.136 ± 0.001 
H053 68 26.03 menopause -2.854 ± 0.446 -4.269 ± 0.392 0.332 ± 0.027 0.108 ± 0.007 0.196 ± 0.058 0.200 ± 0.003 
H054 68 21.94 menopause -2.675 ± 0.066 -4.093 ± 0.043 0.334 ± 0.023 0.050 ± 0.036 0.172 ± 0.046 0.096 ± 0.056 
H055 66 20.45 menopause -3.333 ± 0.005 -4.729 ± 0.011 0.805 ± 0.028 0.127 ± 0.007 0.341 ± 0.054 0.290 ± 0.006 
H056 39 30.82 Mirena® -2.848 ± 0.018 -4.177 ± 0.033 0.222 ± 0.048 0.036 ± 0.011 0.106 ± 0.100 0.088 ± 0.005 
H064 56 27.01 menopause -3.075 ± 0.090 -4.108 ± 0.138 
    H066 66 22.38 menopause -3.289 ± 0.152 -4.636 ± 0.148 -0.183 ± 0.039 0.130 ± 0.087 0.284 ± 0.209 0.239 ± 0.190 
H067 49 28.63 menopause -2.854 ± 0.046 -4.219 ± 0.030 -0.149 ± 0.018 0.165 ± 0.130 0.347 ± 0.126 0.325 ± 0.279 
H068 37 30.11 Mirena® -2.593 ± 0.137 -3.836 ± 0.156 0.339 ± 0.014 0.079 ± 0.040 0.104 ± 0.075 0.128 ± 0.048 
H069 54 19.81 menopause -2.570 ± 0.024 -3.815 ± 0.044 0.078 ± 0.022 
   H096 49 22.86 Mirena® -3.147 ± 0.037 -4.591 ± 0.015 0.161 ± 0.028 0.116 ± 0.046 0.174 ± 0.050 0.224 ± 0.031 
H099 36 20.96 Mirena® -2.191 ± 0.051 -3.249 ± 0.013 0.136 ± 0.014 0.018 ± 0.016 0.045 ± 0.026 -0.001 ± 0.069 
H101 58 18.96 menopause -2.967 ± 0.035 -4.400 ± 0.065 0.201 ± 0.013 0.123 ± 0.033 0.209 ± 0.007 0.206 ± 0.133 
H102 45 19.13 Mirena® -2.868 ± 0.005 -4.407 ± 0.034   1.572 ± 0.036* 0.059 ± 0.014 0.062 ± 0.079 0.095 ± 0.024 
H103 30 21.34 Mirena® -2.782 ± 0.308 -4.077 ± 0.293 0.317 ± 0.014   0.272 ± 0.036*   0.397 ± 0.041*   0.493 ± 0.085* 
H104 52 33.08 Mirena® -2.554 ± 0.038 -3.852 ± 0.049 0.047 ± 0.012 0.120 ±0.009 0.166 ± 0.010 0.227 ± 0.052 
* Outlier, excluded from statistical analysis 
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sample gender Condition Ferr (µg L-1) [Fe] (µg dL-1) Tf (g L-1) sTfR (mg L-1) TSAT (%) 56Fecorr 
57
Fecorr
S001 ♀ hemochromatosis 56.90 155.70 2.90 0.99 43.30 -1.945 ± 0.046 -2.869 ± 0.088 
S003 ♂ hemochromatosis 9.68 14.10 3.04 5.11 3.74 -2.095 ± 0.042 -3.052 ± 0.070 
S005 ♂ hemochromatosis 30.93 88.30 2.18 0.95 32.66 -2.223 ± 0.067 -3.249 ± 0.112 
S006 ♀ hemochromatosis 29.13 163.10 2.15 0.90 61.18 -2.106 ± 0.059 -3.203 ± 0.084 
S007b ♂ hemochromatosis 142.00 n.a.* n.a.* n.a.* n.a.* -2.414 ± 0.048 -3.581 ± 0.077 
S007c ♂ hemochromatosis n.a.** n.a.* n.a.* n.a.* n.a.* -2.348 ± 0.037 -3.476 ± 0.060 
S008 ♂ hemochromatosis n.a.** n.a.* n.a.* n.a.* n.a.* -2.659 ±0.063 -3.874 ± 0.091 
S010 ♂ hemochromatosis 49.21 186.90 2.61 1.24 57.75 -2.531 ± 0.077 -3.739 ± 0.123 
S014 ♂ hemochromatosis 542.90 265.40 2.28 1.01 93.87 -2.599 ± 0.047 -3.803 ± 0.072 
S019 ♀ hemochromatosis 64.83 255.90 2.23 1.09 92.54 -2.336 ± 0.039 -3.424 ± 0.067 
S026 ♂ ACD 726.00 44.00 1.29 n.a.* 42.29 -3.142 ± 0.043 -4.598 ± 0.064 
S027 ♀ ACD 1014.00 75.00 1.90 n.a.* 48.95 -2.665 ± 0.058 -3.892 ± 0.019 
S028 ♀ ACD 1090.00 52.00 2.29 n.a.* 28.16 -2.916 ± 0.049 -3.789 ± 0.799 
S029 ♂ ACD 1910.00 28.00 1.44 n.a.* 24.11 -3.545 ± 0.093 -4.942 ± 0.051 
S030 ♀ ACD 1889.00 71.00 1.34 n.a.* 65.70 -2.960 ± 0.047 -4.218 ± 0.067 
* Not analyzed 
** Previously determined but not repeated for this study 
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sample δ56Fe bleeding need (cc week-1) Ferr (µg L-1) scheduled phlebotomies 
 S001 -1.945 ± 0.046 75.00 56.90 300 cc every month 
 S003 -2.095 ± 0.042 50.00 9.68 400 cc every 8 weeks 
 S005 -2.223 ± 0.067 25.00 30.93 400 cc every 4 months 
 S006 -2.106 ± 0.059 41.67 29.13 250 cc every 6 weeks 
 S007c -2.348 ± 0.037 250.00 142.00 250 cc every week 
 S008 -2.659 ±0.063 13.46 n.a.* 350 cc every 6 months 
 S010 -2.531 ± 0.077 18.75 49.21 300 cc every 4 months 
 S014 -2.599 ± 0.047 233.33 542.90 350 cc every 10 days 
 S019 -2.336 ± 0.039 37.50 64.83 300 cc every 2 months 
 * Not Analyzed for this study but previously determined 
 
 
 
 
 
 
